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Introduction 
Cancer of the uterine cervix has a high frequency in South-American and in Asian 
countries, where it accounts for 20% to 50% of all cancers and 80% to 85% of cancers 
of the female genital tract.(l'3) In the Netherlands the incidence of cervical cancer is 
relatively low as compared to the Asian and South-American continents, with approxi­
mately 1200 new cases of cervical cancer being diagnosed each year and some 300 
women dying annually due to the complications of this type of neoplasm. As in other 
West European countries it ranks about seventh in frequency of cancer related death 
in women. 
A significant decrease in frequency of this type of carcinoma in Western countries was 
seen following the introduction of the PAP screening test.(5) This also initiated exten­
sive studies into the morphological changes in the epithelial lining of the cervix, which 
precede cervical cancer. It appeared possible to identify specific premalignant changes 
both in cytological smears and tissue samples taken from the cervix. These changes are 
classified in order of severity as CIN I (cervical intraepithelial neoplasia), CIN II, and 
CIN III. 
In the Netherlands it has been estimated that a CIN lesion may be detected in approxi­
mately 1% of women aged between 35 to 55 years annually. This signifies that 20,000 
Dutch women each year will show features commensurable with CIN upon cytological 
screening of their smears.№ This large number of anticipated preneoplastic lesions does 
not coincide with the relatively low number of cervical cancers diagnosed annually. 
This demonstrates on the one hand the effectivity of screening programmes and on the 
other hand that most women whose cytologic and or histologic examination is consis­
tent with CIN do not exhibit lesions which are progressive in nature. It is estimated 
that 1 in 10 CIN lesions are truly neoplastic in nature, following a relentless course to 
cervical carcinoma. The other 90% will either persist or regress. 
On morphological grounds progressive lesions cannot be distinguished from those 
which arc regressive in nature. As at present the higher grades of premalignant lesions 
are treated as being potentially malignant, much effort has been directed toward the 
quest for markers which are capable of distinguishing progressive from regressive CIN 
lesions, i.e. the quest for prognosticators of malignancy. Important in this respect are 
Human Papilloma Virus subtypes(8,,), DNA ploidy(i0) and more specific chromosomal 
aberalions. None of these can sofar unequivocally claim the honour of being able 
to make this very important distinction. 
In this study we investigated whether the keratins arc potential candidates capable of 
making this distinction. Furthermore, we investigated the nature of reserve cells and 
their role as precursor cells for both immature and mature squamous metaplasia on 
the one hand, and their role as precursors for CIN lesions on the other hand. The 
interrelationships between the major categories of carcinoma are investigated on the 
basis of their respective keratin expression patterns and we show that the distinction 
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phenotype may bc vague. Suggestions are offered which may be able to explain the 
issues raised. In each of the respective studies the keratin phenotypes of normal 
epithelia lining the cervix, of CIN lesions and of carcinomas is expanded on, using 
recently developed monoclonal antibodies. 
Chapter 1 deals with the molecular and cell biologic background of keratins, descri-
bing their tissue distribution in epithelial and also some non-epithelial tissues. Further-
more characteristics of keratins during malignant transformation are discussed. 
Chapter 2 deals with the expression of a number of keratin subtypes in the normal cer-
vical epithelium, in metaplastic epithelia and in CIN, while in chapter 3 the role that 
reserve cells play in the development of a CIN lesion is emphasized. Subgroups of CIN 
lesions are suggested to be ear-marked as progressive in nature. The keratin expression 
patterns of CIN lesions are compared with the keratin phenotype of immature squa-
mous metaplasic epithelium, showing that this important distinction can not be made 
on the basis of the keratin phenotypes of these respective epithelia, but is based on 
morphological criteria. In Chapter 4 the keratin phenotypes of the various types of 
cervical carcinoma are described and are related to those of the CIN lesions and 
reserve cells. Chapter 5 deals with a number of keratins indicative of squamous meta-
plasia, examining their expression in the normal cervical epithelia, in metaplastic 
epithelia, in CIN lesions and cervical carcinoma. In Chapter 6 we summarize our 
observations and review the literature concerning expression of keratins in the cervix, 
comparing our own conclusions with those of other authors. Chapter 7 deals with the 
possibilities of cervix keratin phenotyping in routine pathology practice, not using 
keratin antibodies reactive with frozen tissues as was done in the studies described in 
chapters 2 through 6, but using formalin fixed paraffin embedded tissue and 
antibodies which have been described to be reactive with routinely processed tissue 
specimens, or can be made reactive with these tissues. 
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ABSTRACT 
Keratins are a family of intermediate filament proteins. In contrast to other types of 
intermediate filaments, keratins are characterized by a remarkable biochemical diver-
sity, represented in human epithelial tissues by at least 20 different polypeptides. They 
range in molecular weight between 40 and 68 kDa, and are designated 1 to 20, kera-
tin 1 being the polypeptide with the highest molecular weight and highest isoelectric 
pH and keratin 19 being the polypeptide with the lowest molecular weight and low iso-
electric pH. These polypeptides are not expressed randomly throughout epithelia but 
occur in cell-type specific combinations. Also the diverse types of carcinomas differ in 
their keratin polypeptide content. The keratin patterns of epithelial tumours are either 
identical to the keratin pattern present in the cell of origin or at least closely related to 
it. The keratin polypeptide patterns (as obtained by two dimensional gel electrophore-
sis) can be used for identification or at least a subclassification of epithelial tissues and 
carcinomas. It should be kept in mind, however, that profound changes in keratin ex-
pression can occur upon malignant transformation or progression. Several monoclo-
nal antibodies to different keratins have been prepared and different activities of such 
antibodies with different subtypes of epithelial tissues and epithelial tumors have been 
noted. 
This chapter describes the molecular background of these cytoskeletal constituents, 
and summarizes their applicability as markers for tissue differentiation and cancer 
diagnosis. 
1. GENERAL INTRODUCTION 
The application of molecular markers in tumor pathology for the recognition of malig-
nant cells is increasing at a steady pace. In particular after the implementation of pro-
cedures to derive monoclonal antibodies (mAbs), the use of these reagents in routine 
diagnosis has increased dramatically. Antibodies specific for differentiation related 
antigens and markers of proliferation are widely used in surgical pathology in particu-
lar in cases in which the classification of the tissue under examination poses problems 
that can not be solved using conventional light microscopic staining techniques. 
Amongst the differentiation markers, intermediate filament proteins (IFPs) play an 
important role, especially due to the fact that they exhibit a cell lineage-specific expres-
sion pattern.'0 As a result, antibodies to specific IFPs allow the differentiation of the 
major classes of malignancies. Even now, after a significant number of reports have 
emerged indicating that specific IFPs may be lost during malignant transformation (2), 
or that aberrant or ectopic expression can occur, the use of IFPs as differentiation 
markers remains a major diagnostic aid. 
In this study biochemical and functional properties of IFPs are discussed, with parti-
cular emphasis on the intermediate filaments of the keratin subclass. Furthermore, a 
summary on their current applications in pathology practice is given. 
2. INTERMEDIATE FILAMENTS 
2.1 Structure and function 
In most eukaryotic cells intermediate filaments constitute an important part of the 
intracytoplasmic matrix (sec figure 1). 
Figure I. Indirect immunofluorescence micrograph of cultured human hepatoma cells 
showing the typical keratin intermediate filament organization. 
This cytoskeletal component has been shown to interact with the plasma membrane at 
the periphery of the cell and with the nuclear lamina in the interior iA The diameter 
of these intermediate filaments, which has been estimated in electron microscopic 
studies, varies between 8 and 12 nm. The protein constituents of these filaments share 
the same basic structure, consisting of an alpha-helical rod domain of conserved secon-
dary structure and size, flanked by non-helical amino-terminal and carboxy-terminal 
domains of variable length, sequence and chemical characteristics/4"4 Although the 
exact mechanism of filament formation is not fully understood the rod domain seems 
to play an important role in this process. The non-helical domains of IFPs have, how-
ever, also been described to be involved in filament assembly. Several mechanisms 
have been proposed to explain IFP assembly (6'7,8) of which the most accepted theory 
at present states that assembly starts with the formation of the coiled-coil from two 
monomelic protein subunits via side-to-side interactions of the rod domains. The 
forces involved in this reaction are mainly of a hydrophobic nature. It is assumed that 
in contrast to most other intermediate filaments, keratin intermediate filaments are 
obligatorily composed of heterodimers (see below). It is believed that the second step 
in intermediate filament assembly is the interaction between two dimers resulting in a 
tetramer, followed by the formation of an octamer comprising two antiparallelly orien­
ted four-chain complexes. In the resulting structure the non-helical domains protrude 
from the filament backbone/'1 As mentioned before the non-helical end domains of 
IFPs are apparently also involved in filament assembly. They are the major sites of 
post-synthetic modifications such as limited proteolysis and phosphorylation. Phos­
phorylation of several types of IFPs has been shown to cause a reversible disassembly 
и 1
, while also specific Ca2+-activated proteases, which cleave the IFPs at cerain 
sites in the amino-terminal domain, may play a role in the assembly-disassembly cycle 
of intermediate filaments. Reassembly studies with intact and proteolitically digested 
IFP subunits demonstrated that the amino-terminal domains of several of the IFPs are 
necessary for normal filament assembly°2'13) and seem to be involved in binding of 
the filaments to the plasma membrane.04'151 The carboxy-terminal domain displays 
the highest variability, both in length and sequence and might have a subunit-specific 
function. This domain is probably involved in the binding of intermediate filaments to 
the nuclear lamina.04'161 
The general consensus regarding cellular functions of intermediate filaments is that 
these cytoskeletal constituents perform a supportive role in the cell. Amongst others 
this assumption is based on the morphological appearance of intermediate filament 
networks within cells and the observation that these filaments form a link between 
nucleus and cell surface , interacting firmly with both structures (for example 
through linkage to desmosomes). This, however, does not explain the diversity of 
subtypes found in functionally and morphologically different cell types, or the obser­
vation that certain cell types can survive and proliferate without containing a cyto­
plasmic IFP scaffold.081 Functions of the individual IFP types at specific organ sites 
also support a supposed structural role of these proteins. For instance the location of 
desmin in the Z-disc of striated muscle and in the dense bodies of smooth muscle 
indicate the anchoring function to the contractile apparatus.0 '1 The neurofilaments 
are linked to neuronal microtubules in axons and may provide stability in this highly 
apolar cell, while vimentin filaments may have a supportive function for the large fat 
droplets in li росу tic cells, this type of IFP has also been implicated in RNA processing 
0 0
 and interactions with nucleic acids.'211 
2.2 Subtyping 
Six classes of IFPs (types I to VI) are distinguishable in vertebrates, based on amino 
acid sequence relatedness and patterns of expression. 
The largest group of IFPs are the keratins of the type I (larger neutral or basic; 
including keratins K.9-K20) and the type II group (smaller acidic; including K1-K8). 
The acidic and basic/neutral keratins form obligatory pairs, resulting in heteropoly-
mers of type I and type II IFPs. Type III IFPs comprise the mesenchymal proteins 
vimentin, desmin, glial fibrillary acidic protein and peripherin. Although anligenically 
distinct, these type III IFPs are closely related with respect to their protein structure. 
In contrast to the keratins, all the type III IFPs will form homopolymers, which occur 
predominantly as single IFP species in appropriate cell types, but may also be co-ex-
pressed. Type IV IFPs comprise the neurofilament proteins, which can be subdivided 
into the high, intermediate and low molecular weight polypeptides. The type V IFPs 
are the A- and B-type nuclear lamins while the type VI IFP represents nestin a recently 
discovered addition to this multigene family.(22) 
2.3 Tissue distribution 
An important feature of intermediate filaments, making them suitable for use as diag-
nostic markers, is their cell lineage specific pattern of expression, which is highly con-
servative in tissues under different circumstances. In the normal adult the type I and II 
IFPs, i.e. the keratins, are generally expressed only in epithelial tissues, both cornifying 
and non-comifying. The various epithelia of the human body may be characterized by 
a specific keratin phenotype, which will be described below. 
Type III IFP are mainly found in mescnchymally derived cell types. 
Vimentin shows the most widespread tissue distribution. Tissues expressing this 
type of IFP include fibrocy tes, fibroblasts, osteocyts and osteoblasts, chondro-
cytes, chondroblasts, Schwann cells, melanocytes and Langerhans cells of the skin, 
some subsets of lymphocytes, plasma cells in the bone marrow and some other 
bone marrow derived cells. Furthermore, vimentin occurs in granulosa cells of the 
ovary and in mesothelial cells in which it may be co-expressed with keratins. Co-
expression with desmin is found in many of the vascular smooth muscle cells. 
Desmin shows a more restricted expression pattern. It is found in skeletal and 
cardiac striated muscle cells as well as in visceral smooth muscle cells. In vascular 
smooth muscle cells it may be expressed as the only IFP, or in combination with 
vimentin. Occasionally, however, it is not expressed at all in muscle cells. 
Glial fibrillary acidic protein (GFAP) is a useful marker for astroglial cells, of 
which the fibrillary subtype show a more intense expression pattern than the 
protoplasmic subtype. The Bergman glia in the cerebellum also express this type of 
IFP. The radial glia, oligodendrocytes and ependymal cells only synthesize 
GFAP(23) during brain development. Furthermore there may be limited expres-
sion in Schwann cells and satélite cells. 
Peripherin, a recently discovered IFP, shows a restricted staining pattern and is 
found in neurons of the peripheral nervous system or parts of the nervous system 
which are phylogenetically old.<24) 
Type IV IFPs, i.e. the neurofilament proteins, are detected in neuronal cells, predomi-
nantly axons, in which the high, middle or low molecular weight subunits are expres-
sed during different stages of development and have a variable intracellular distribu-
tion.(25) 
Type V IFPs, the lamins, are subdivided into the A- and B- subtypes. 27) They con-
stitute the fibrillary network that forms the nuclear lamina, and 4 lamin polypeptides 
have been detected and characterized in the nucleus of the human cell i.e. lamins A 
and С (A-type lamins) and Bl and B2 (B-type lamins). Recent studies indicate that 
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during embryonal development and during differentiation of embryonal cell carcino­
ma cell lines in vitro, lamins are expressed in a differentiation related pattern. In 
general undifferentiated cells or cells which have not attained their final state of diffe­
rentiation express B-type lamins, but not A-type lamins. Expression of В lamins alone 
has also been observed in small cell lung carcinomas both in vivo and in vitro, while 
lamins A and С are extensively expressed along with B-type lamins in bronchial adeno­
carcinomas and squamous cell carcinomas.'24 
The Type VIIFP is nestin (11), which is a recent new addition to the IFP family. It is 
specifically expressed in neuroepithelial stem cells. To date direct applications for this 
antibody in surgical pathology have not been reported. Its value at present is mainly in 
the field of developmental biology, in which its differentiation related expression is 
indicative of further transitions in IFP expression during neuron development. 
2.4 Co-expression patterns in normal tissues 
Although most adult mammalian tissues or cells express IFPs according to the general 
rule described above, some exceptions have been found. For example some epithelioid 
cell types, such as eye lens epithelium and the epithelioid cells lining the seminiferous 
tubules, contain vimentin but not keratins. Co-expression of IFPs has been noted 
under several conditions. Examples of this phenomenon have been reported (2',3C,3I) 
for granulosa cells and the follicular epithelium of the thyroid gland, cells of the cho-
riod plexus, the ciliary body, the adrenal cortex, the acini of the prostate, the ejacu-
latory ducts, seminal vesicles, fallopian tubes, the endometrium, rete ovari and rete 
testis cells, some endothelial cells, reticulum cells of the lymph nodes and thymus the 
stromal cells of the umbilical cord and placental villi. 
Triple expression of IFPs has been shown for the myoepithelial cells in mammary acini 
and ducts, which may contain vimentin and GFAP along with the expected keratins. 
These IFP combinations may also be found in benign hyperplastic lesions of the 
breast.(32) Co-expression of vimentin and desmin either with or without keratins has 
been found in some types of smooth muscle cells, mesothelial cells and submesothelial 
cells.28Я) The myofibroblasts in aterosclerotic plaques have also been shown to 
contain keratins along with vimentin and/or desmin. Recently these keratins were cha­
racterized as keratins 8 and 18.<33Î4) Nuclear lamin type IFPs are of course found in 
all the previously described types of cells and may be regarded as the second, third, or 
fourth type of IFP expressed in these cells. 
Epithelial cells and mesothelial cells in tissue culture often contain both vimentin and 
keratins, partly as a result of adaptation of the cells to the loss of tissue coherency. Co-
expression patterns during embryonic development are discribed below. 
2.5 Intermediate Filament proteins in malignancies 
Antibodies against IFPs have been extensively tested for their possible applications in 
the characterization of malignant tumors/3S,36ï7) These studies have made it clear 
that utilization of IFP antibodies in tumor classification is a very powerful tool. Ал 
important characteristic of tumors is that they have been shown to retain the IFPs of 
the tissue from which they originate. This means that carcinomas will be stained with 
antibodies to keratins(H $,3β) whereas mesenchymal tumors such as lymphomasc , 
most soft tissue sarcomas, osteosarcomas, chondrosarcomas , melanomas , 
seminomas(4,), Schwannomas and MFH are usually negative for keratins but positive 
for vimentin. Malignant tumors originating from striated or smooth muscle such as 
rhabdomyosarcomas and leiomyosarcomas, can be differentiated from other soft tis­
sue sarcomas on the basis of their reactivity with desmin, which is usually not expres­
sed in other sarcomas/42,44 Astrocytomas are strongly positive for glial fibrillary 
acidic protein (GFAP)(44), while ganglioneuroblastomas and some of the neuroblas­
tomas are strongly positive with neurofilament antisera. 
Certain neoplastic tissues may coexpress different types of intermediate filament pro­
teins/465 When tumor cells contain more than one cytoplasmic IFP type, vimentin is 
frequently one of them/28'29 In epithelial tumors, vimentin has been found in addition 
to keratin in pleomorphic adenomas of the parotid gland<47>, adenoid cystic carcino­
mas of the salivary gland , renal cell carcinomas and nephroblastomas ' , some 
adenocarcinomas of the lung, some thyroid carcinomas(2e'Я) and mesothelio­
mas/2,49,50) The latter type of malignacy may even loose its keratin expression espe­
cially in cases with spindle cell morphology.' Furthermore vimentin co-expression 
has been noted in adenocarcinomas of the endometrium, hepatocellular carcinomas, 
cholangiocarcinomas, small cell carcinomas and also undifferentiated adenocarcino-
(51) 
mas. 
Most mesenchymally derived tumors usually only express type III IFPs as their cyto­
plasmic IFP. However, a number of these mesenchymally derived neoplasms may in 
some cases co-express keratins. Examples of these tumors are MFH , chondroblas­
tomas c , plasmocytomas, lipomas, melanomas, some vascular tumors, some epen-
dymal tumors, malignant mixed Miillerian tumors and synovial sarcomas.(S4) Ewing 
sarcomas, which also co-express keratin with vimentin, have also been shown to 
contain neurofilament proteins. '" 
Recent reports have described some additional malignant tumors with unexpectedly 
complex IFP expression patterns, such as breast cancer and tumors of the salivary 
glands which have been shown to simultaneousy contain keratins, vimentin and 
GFAP.(5l'32'4' ,4e) Some epithelioid neuroendocrine tumors, including Merkel cell 
tumors *, may also contain neurofilament proteins in addition to keratins. 
Co-expression of vimentin and desmin has been observed in most if not all rhabdo­
myosarcomas 4 '4 , 4 4 ) and also in leiomyosarcomas. Triple expression of vimentin, des­
min and keratins has been described mainly in smooth muscle cell tumors but also in 
rhabdomyosarcomas. 4" ' GFAP and vimentin are simultaneously expressed in 
astrocytomas/43, M) 
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tially expressed in malignant tumors. In cell lines derived from small cell carcinomas of 
the lung B-type lamins were found, while A type lamins (lamins A and C) were absent. 
Both A and В type lamins were, however, found to occur in the nuclei of cell lines 
derived from squamous cell carcinomas and adenocarcinomas of the lung. 
3. KERATINS AND KERATIN ANTIBODIES 
3.1 Subtyping and biochemistry 
Of all the IFPs the keratins, found mainly in epithelial cells, are characterized by a 
remarkable diversity. They constitute a family of at least 20 different keratin polypep­
tides ranging in molecular weight between 40 and 68 kDa.(6C,61) Keratin 1 has the 
highest molecular weight and the highest isoelectric pH while keratin 19 has the lowest 
molecular weight and a low isoelectric pH. The keratins are not randomly expressed in 
epithelial tissues, but are found in certain combinations which may characterize the 
type of epithelium involved or reflect the level of maturation within the epithelium. 
Alongside the 20 different cytoplasmic ("soft") keratins which form the major consti­
tuents of the intermediate filament matrix in epithelial cells, a group of 10 additional 
("hard") keratins are found which are typical of hair and nail forming (trichocy tic) 
cells. These keratins also occur in certain papillary appendages of the tongue and some 
thymic reticulum cells (Hassal's bodies)/ As mentioned before, the soft keratins are 
divided into the type I and type II subgroups, the type I family members comprising 
the basic or neutral keratins 1-8, while the type II group comprises the acidic keratins 
9-20. 
The basic requirement for the assembly of keratin intermediate filaments is the forma­
tion of a heteropolymer, in which a member of the acidic family.forms a dimer with a 
member of the basic/neutral family. In this way keratin pairs form as shown in 
figure 2. 
What are the the mechanisms involved in keratin intermediate filament formation? 
Three discrete levels of molecular association leading to keratin filament network for­
mation can be distinguished. The three levels of protein association include protein 
stabilization by dimer and tetramer formation, filament elongation, and filament net­
work organization. The role of the alpha-helical rod domain, present within all keratin 
molecules as a typical IFP feature is quite distinct from that of the carboxyl- and 
amino-terminal domains. It has been convincingly demonstrated that single keratin 
polypeptides synthesized in the absence of their complementary keratin molecule fail 
to polymerize and are rapidly degraded.02'63'*0 These results provide a clear proof 
for the need of dimer formation as an initial and essential step in intermediate filament 
assembly. At the molecular level the stabilization of keratins is affected by interaction 
of the alpha-helical rod domain with the similar domain of its keratin counterpart. 
Acidic Basic/Neutral 
TYPE II TYPE I 
Figure Ζ Schematic representation of the differentiation relatedkeratin-pair expression 
patterns ш human epitbelia. Numbers refer to Moll's catalog. Adapted from 
Lane and Alexander?" 
The non-helical end-domains are not essentially involved in this process. The forces 
involved in the formation of coiled-coil dimers are of a hydrophobic nature. Heterodi-
mers then form hetcrotetramers by side-to-side association of complementary keratins 
in the dimer. Thereafter, end-to-end associations and lateral interactions of tetramere, 
may occur simultaneously, resulting in building-blocks for filament elongation. 
Polymer elongation proceeds amongst intact keratins, provided that heterotypic 
complexes are formed. Direct homotypic head-to-tail interaction of like polypeptides is 
an important step toward filament elongation (see figure 3). 
In this way the 8-12 nm intermediate sized filament is assembled, its thickness resulting 
from the side-to-side interactions of 8 protofilaments, which equals 32 polypeptide 
chains (see figure 3). These keratin fibrils interact sideways with certain constituents of 
the intracytoplasmic side of desmosomes. These interactions with specific membrane 
domains result in the typical appearance of keratin networks in epithelial cells, as 
visualized by electron microscopy and immunofluorescence assays (figure 1). It can 
also be appreciated from such examinations that keratin-filament-desmosome com­
plexes exert a stabilizing function not only restricted to the individual cell but also 
effectively linking up many cells, extending their structural properties to the whole 
tissue. 
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Figure 3. 
3.2 Monoclonal antibodies: epitope masking and pitfalls 
Many mAbs have been developed against the various keratins. The varying reactivity 
of these mabs with different subtypes of epithelial tissues and epithelial tumors has 
been extensively reported. In addition to broadly cross-reacting antibodies, which stain 
virtually all types of epithelial tissues, monoclonal antibodies have been developed 
which cross-react with only one of the 20 keratins and which show a tissue-specific 
staining pattern. Chain specific monoclonal or polyclonal antibodies have been des­
cribed or prepared for keratins 1, 3-8, 10,13-20.(M"92>9365) 
The aforementioned antibodies have been extensively tested for their reactivity pat­
terns in both normal tissues and tumors. One of the problems arising in the interpreta­
tion of the results of their use is that during malignant transformation certain keratins 
may be lost or structural alterations may occur due to biologic activity or neoplasia, 
rendering some keratins undetectable. This phenomenon is called epitope masking and 
may in part be overcome by staining tissues and cells with more than one mAb against 
a single keratin. We have observed examples of false negative results in the interpreta­
tion of keratin expression patterns within normal urinary bladder, transitional cell car­
cinomas and cervical intraepithelial neoplasia. In these epithelia for instance keratin 18 
can hardly be detected with the mAb RGE S3, while the keratin 18 mAb RCK 106 
gave extensive and intensive staining results/66'615 These differences in reactivity pat­
terns of the individual keratin mAbs may be due to a different structural organisation 
of the keratin filaments under specific circumstances. 
Another major problem in the utilization of keratin antibodies, and IFP antibodies in 
general, is the fixation restriction of their antigens. This has hampered the applicability 
of IFP mAbs in the past and is at present slowly being overcome by the fact that 
mAbs, which are reactive after formalin fixation and paraffin embedding, become 
available. The fixation problem is easily overcome by using frozen tissues or tissues 
which are fixed in ethanol, methanol, accton, or combinations of these organic sol­
vents. Using these methods the IFPs apparently undergo only minor damage or cross-
linking, which is strongly induced by aldehyde fixatives. Alcohol fixation of tissue 
blocks and subsequent paraffin embedding gave considerably better immunostaining 
results than formalin fixation, but was not as good as the staining results noted with 
frozen material. Apparently the heating step during paraffin embedding partly affected 
the antigenicity of IFPs. Predigestion of formalin fixed tissues with proteolytic 
enzymes may also enhance many immunohistochemical staining results considerably. 
4. KERATIN EXPRESSION PATTERNS IN EPITHELIAL 
TISSUES 
4.1 Adult tissues 
In general it is possible to distinguish 3 types of epithelium in the human body, which 
may be further subdivided on the basis of varying histological aspects and function, 
along with epithelia which are considered to be specialized e.g. hepatocytes or neuro­
endocrine cells. The various epithelia usually express keratins which are not only char­
acteristic of the type of epithelium, but also related to the degree of maturation or dif­
ferentiation within an epithelium. In summary the following keratin phenotypes can be 
distinguished in different types of epithelia: 
a. Firstly, cuboidal and columnar epithelium, or one layered epithelium, generally 
referred to as "simple epithelium" which is in direct contact with the basement 
membrane and has a free luminal surface at the apical side of the cell. This type of 
epithelium primarily expresses keratins 8 and 18 and very often keratins 7, 19 and 
20. The hepatocytes in the liver show the least complex keratin expression pattern 
containing keratins 8 and 18 only, while in addition the intrahepatic bile ducts ad­
ditionally express keratins 7 and 19.<ЫІ) In the Merkel cells of the skin keratins 8 
and 18 are found along with keratin 20.(М) Mesothelium express keratins 5, 7, 8, 
18 and 19,(2·49·70) Keratin 7 is usually not found in the columnar cells lining the 
colon and the stomach, or in the acini of the prostate and the epithelium lining the 
proximal tubules of the kidney. Keratin 7 is, however present in the epithelium 
lining the ovary, the acini of sweat glands and breast, the epithelium of the pan­
creatic, bile and prostate ducts, some cells in the collecting tubules of the kidneys, 
and columnar cells of the bronchi/7" Keratin 20 has recently been shown to be 
present in epithelial cells of prostate, bronchus, gall bladder, b.ut also colon, sto­
mach and neuroendocrine cells.'57'ω' *'' Pseudostralified epithelia of the urethra 
for example have been shown to have a some what more complex keratin expres­
sion pattern than described above for most simple epithelia. In these epithelia con­
siderable amounts of keratins 4, 7, 8,13,18 and 19 are always found/ , 7 3 ) 
The second type of epithelia are the stratified squamous epithelia which are further 
subdivided into the keratinizing, the non-keratinizing and the transitional varieties. 
The keratinizing and non-keratinizing epithelia have a basal layer which invariably 
expresses keratins 5 and 14. The above lying parabasal cell layer may also express 
this keratin subset, but will in addition express at least one extra pair of keratins 
which is characteristic of the local specializiation of the epithelium. In noncor-
nifing epithelia these keratins are usually 4 and 13, which are normally not 
expressed in the basal layer. In comifying epithelia combinations of keratins 1 and 
10 are usually found, these keratins indicate keratinization. Other keratins often 
reflect the local conditions of the epithelium in which they are expressed. For 
example keratins 2 and 11, are found in gingiva while keratin 9 is found in the 
palm of the hand and the footsole. The transparent stratified epithelium of the 
cornea is the only epithelium which has been shown to express keratins 3 and 12. 
The transitional epithelium of the urinary bladder has a keratin expression pattern 
intermediate between that of non-cornifying stratified and simple epithelium i.e. 
keratins 4, 7, 8, 13, 18 and 19 may be found through the full thickness of the 
transitional epithelium depending on the location in the urinary tract/6*'та) Keratin 
20 expression is restricted to the umbrella cells. Keratin 5,14 and 17 occur 
heterogeneously in the basal layer of transitional epithelium<72,73), with some 
sporadic staining in the other layers. 
The third type of epithelia comprize the complex or the combined epithelia. Mor­
phologically this epithelium is characterized by a basal cell layer and a layer of co­
lumnar cells both in contact with the basement membrane. This type of epithelium 
is found in glands of the breast and prostate where the basal cell compartment is 
partly formed by myoepithelial cells. It is also found in the endocervix in the case 
that reserve cells are present. The basal cells in the endocervix have been shown to 
express keratins 5, 8, 14, 17, 18 and also 19. In the breast the myoepithelial cells in 
the terminal duct and acini express keratins 5, 14 and 17, while in the large ducts 
some of the basal cells can also contain keratins 7 and 19 in addition to keratins 5, 
14 and π/ 7 4 , 7 5 ' The luminal cells in most cases of combined epithelia contain ke­
ratins 8 and 18, while certain types of epithelium also contain keratins 7 and 19. 
In squamous epithelia with a very high cell turnover keratins 6 and 16 are found. 
These keratins are normally expressed in epidermis during wound repair, patholo­
gical conditions associated with hyperproliferation i.e. psoriasis *, and in epithe­
lia which usually have a high turnover, such as the oral mucosa. They have also 
been described in carcinomas with squamous differentiation.(77) 
4.2. Embryonic development 
A reasonable number of reports have begun to elucidate the complex patterns of IFP 
expression during embryonal development. Apart from the nuclear lamins, cytoske-
letal IFP constituents are often transiently expressed in different programmes and 
routes of cell and tissue differentiation. Except for nuclear lamins, no IFPs of any kind 
are not detected in mouse embryos before the formation of trophoblast cells in the 
blastocyst/78' Keratins 8 and 18 are the first detected at the morula-blastocyst transi­
tion where they appear together with desmosomes and are restricted to the trophecto-
dermal cells. The same keratin polypeptides are found as the major cytoplasmic IF 
constituents in all embryonic cells until day 10 of mouse embryogenesis. In later phases 
of fetal development expression of other keratin polypeptides, specific of certain types 
of epithelia as described for adult tissues, takes place/79' Vimentin is not detected in 
mouse embryos until day 8.5 of gestation and it correlates in time and place to the first 
appearance of mesenchymal cell types/57,60·61·7') Neurofilament proteins are observed 
considerably later than vimentin and are restricted to cells engaged in neuronal diffe­
rentiation. Finally, glial filaments appear very late and are restricted to certain glio-
blast derivatives, especially astrocytes/80' Keratin 8 and 18 have also been shown to 
be expressed in early stages of development of the heart in mice. During further diffe­
rentiation this is followed by the expression of vimentin, and later still desmin appears. 
These 3 IFPs, are co-expressed for a short period of time, however during further de­
velopment of the heart keratin expression and later vimentin expression are down re­
gulated as the expression of desmin intensifies/81'82' 
The changing pattern of keratin expression in various epithelial tissues of the embryo 
follows certain rules. Our knowledge concerning IFP expression during organogenesis 
is extremely fragmentary and mostly restricted to animal studies. The number of 
developing organs studied is limited and includes, epidermis, lung, liver, genito-urinary 
tract and primitive neurogenic tissues. The results of these studies can be briefly sum­
marized as follows. As mentioned above the first keratins to appear in the ectoderm 
are keratins 8 and 18. ( 5 7 'ю 'ы 'W ) The skin of a 10 week old fetus has been shown to con­
tain considerable amounts of keratins characteristic of simple epithelia, namely kera­
tins 8, 18 and 19. In the 13 week old human fetus keratin 1 appears. Keratin 4 is found 
in the basal cells of the 15 week old fetus along with keratins 8 and 18, while the 
intermediate layer contains keratins 4, 10, 18, and 19, and the periderm contains kera­
tins 4, 8, 13, 18 and 19. At 20 weeks keratin 4 disappears from the basal layer and ke­
ratin 19 is only present focally. At this stage keratins 4 and 19 are not present in the in­
termediate layer anymore. At 29 weeks gestation, simple keratins are only detectable in 
scattered Merkel cells. In the suprabasal cells only keratin 10 is detected. ^ 1 , 7 " The 
hair follicle germ cells of the 13 week old fetus contain predominantly keratins 5 and 
17 and minor amounts of 8 and 18, while at 20 weeks gestation the cytokeratin pattern 
of these cells is much like that in the adult comprizing keratins 5, 6, 14 and 15 with 
minor amounts of keratins 11, 16 and 17. 
In the developing mesonephric ducts of the hamster vimentin is expressed from the 
earliest stage that these ducts are discernable in the embryo up till the time of birth. 
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to be expressed up until birth. The situation in the paramesonephric or Mullerian 
ducts of the female counterpart proved to be different. Vimentin was again expressed 
from the earliest stages on, while keratin 18 first appeared at day 12.5 post-concep-
tionen, followed by keratins 7 and 19 at day 14.5 post-conceptionen. The different pro­
grammes of IFP regulation are seen as support for the hypothesis that mesonephric 
ducts do not make a cellular contribution to the paramesonephric duct during its deve­
lopment. 
In mice there is evidence that the liver is, at a very early developmental phase, 
composed of progenitor hepatocytes expressing keratins 8, 18 and 19. These cells may 
differentiate into hepatocytes, in which case keratin 19 is lost, or they may differentiate 
into epithelial cells lining the bile ducts in which case keratin 7 expression is initiated, 
keratin 8 and 18 expression intensifies, and keratin 19 expression remains the same as 
in the progenitor cells.(M) 
During early rabbit embryo development a similar pattern of keratin 8 and 18 expres­
sion is observed in epithelial ectoderm and in neuroectoderm. Between 8.5 and 11 days 
post-conceptionen keratin expression is down regulated in the neuroectoderm and by 
the time neurulation is complete keratins are hardly expressed at all in neural tissues. 
Vimentin expression is originally weak in neuroectoderm, but increases as keratin is 
down regulated, until it has reached a high level of expression in the established пеигді 
tube of the 10 to 11 day old rabbit embryo.(85) During later stages of brain organoge­
nesis vimentin is down-regulated in neuronal cells. 
In developing human bronchiolar epithelium(86) the simple keratins 8, 18 and 19 and 
minor amounts of keratin 7 are detectable between 9-25 weeks of gestation. During 
this period the number of cells expressing keratin 7 gradually increases. After 32 weeks 
of gestation expression of keratin 14 is initiated in the basal bronchiolar cells. In deve­
loping alveolar epithelium keratins 7, 8,18 and 19 are expressed from the moment that 
terminal sac and alveoli are discernable in the developing lung. Vimentin is also pre­
sent during fetal development in bronchial epithelium, however its intensity of expres­
sion decreases with increasing gestational age. Keratin expression has also been noted 
in human peribronchial smooth muscle cells, with its level of expression decreasing 
with increasing gestational age. 
An important point arizing from these findings is the matter of co-expression of IFPs 
during different stages of embryonal tissue development. This phenomenon has been 
reported for parental endoderm cells of the mouse embryo , human amnion epithe­
lial cells<88), in embryonal cells of human and rat kidney(89) as well as the Sertoli 
cells. Some authors speculated that vimentin expression may reflect the mesoder­
mal origin of these epithelial cells, while others(78) feel that the IFP status of a cell 
reflects its level of differentiation. This latter concept has been further supported by 
the observation that embryonic epithelia of the rabbit, such as the notochord, surface 
ectoderm and the primitive intestinal tube, express vimentin alone/'0 
4.3 Benign and premalignant lesions 
The hypothesis that the keratin phenotype of a benign lesion may be indicative of its 
capacity for malignant transformation has stimulated research in this field. In general 
benign cell proliferations occuring within various tissues express the keratins occuring 
in the normal counterparts from which they have originated. 
For example in the case of cervical intraepithelial neoplasia (CIN), which originates 
from the reserve cells. The reserve cells have been shown to contain keratins 8, 14,17, 
18 and 19 and usually keratin 5. this keratin combination is expressed in approxima-
tely 50% of the CIN III lesions and in about 10% of CIN I and CIN II lesions. How-
ever, other keratins such as keratins 4 and 13 are also found in many of these lesions. 
It has been postulated that those lesions which have maintained the keratin expression 
pattern of the progenitor reserve cells may well be the progressive lesions which will 
develop into cervical cancer. This theory however has yet to be validated. ' ' ' ' ' 
Bronchopulmonary carcinogenesis is thought to progress along similiar lines as CIN 
lesions. Studies are underway to elucidate the keratin make up of premalignant bron-
chial epithelial lesions. 
In the epidermis a peculiar transition in expression of keratins is seen during malignant 
transformation. In the normal epidermis simple keratins such as keratins 7, 8,18 and 
19 are usually not expressed. However, in Bowens disease and actinic keratosis these 
simple keratins are brought to expression in a small number of cells at the dermal epi-
dermal interface. This change in keratin expression pattern is suggested to be of func-
tional importance in the malignant transformation of keratinocytes, during which pro-
cess a down regulation in the expression of keratins 1, 10 and 14 is noted (92 
In psoriasis there is a hyperproliferation of the basal cell compartment of the epidermis 
with an increased cell turnover. Profound changes in keratin expression patterns in 
comparison to the normal epithelium are observed in this condition. These are charac-
terized by an increase in keratin 16 expression which is associated with hyperprolifera-
tion, while keratin 10, which indicates keratinization, is down regulated. In normal 
skin keratin 16 is usually not expressed. 6' ì 
During dysplasia of the oral epithelia, major changes in the keratin make up have been 
noted when compared to their normal counterparts. In normal oral epithelium, depen-
ding on its exact localization, keratins 1,2, 10 and 11 which are associated with comi-
fication are frequently expressed in the hard palate and attached gingiva, as well as ge-
neral expression of stratification markers keratins 4 and 13, and the basal cell markers 
keratins 5 and 14. Simple cell markers such as keratins 8 and 18 are only found in 
Merkel cells, while keratin 19 is often found in the basal cell layer, and hyperprolifera-
tion related keratins are variably found. In dysplastic oral epithelium the expression 
pattern of keratins 1 and 10, is patchy, while the expression of the simple keratins 8,18 
and 19 tends to increase. ' 
Keratin expression patterns in premalignant breast lesions have also in part been eluci-
dated. In benign proliferative breast lesions the relative proportion of cells which ex-
press a myoepithelial keratin profile tends to increase, this is thought to reflect the ori-
gin of these benign lesions from proliferations of myoepithelial cells. These lesions, are 
not considered to be progenitors of breast carcinomas. However, in, in situ ductal car-
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cinomas and in situ lobular carcinomas keratin 14 was found to be present in most 
basal cells while in the above lying atypical cells this keratin was not found. A similar 
pattern of reactivity was observed for keratin 17. Keratin 16 could not be detected in 
in situ carcinomas while keratin 18 was detected mainly in atypical, suprabasal and 
columnar cells and usually not in the basal cells/70,75,95) 
4.4 Epithelial malignancies 
The most important field of application for mAbs to IFPs is in tumor pathology where 
they are used in the diagnosis of mostly poorly differentiated malignancies. In this field 
of diagnostic medicine the antibodies against keratins are instrumental in the distinc-
tion of epithelial malignancies from sarcomas and lymphomas of various types. 
Keratin subtype expression patterns are however being used to an increasing extent in 
the distinction of different types of epithelial malignancies. An important achievement 
of research in this area is that specific mAbs to individual keratin polypeptides can be 
exploited diagnostically for the subtyping of carcinomas. The keratin phenotype of a 
considerable number of carcinoma subtypes has now been examined. It is the object of 
the following summary to give a brief impression of the applicability of the keratins as 
differentiation markers in the typing of carcinomas. 
Carcinomas of the lung 
Adenocarcinomas of the lung express high levels of keratins 7, 8, 18 and 19 while kera-
tin 4, 10 and 13 are only sporadically expressed in this type of bronchial carcinoma. 
These latter keratins most probably indicate varying degrees of squamoid differentia-
tion, which may occur in lung adenocarcinomas. Squamous cell carcinomas of the 
lung express a broad spectrum of keratins including those typical for squamous epithe-
lium i.e. keratins 4, 5, 13, 14, and keratin 10 in the case the carcinoma is well differen-
tiated and shows signs of cornification. With a decreasing degree of differentiation the 
typical keratin phenotype associated with the high degree of organization observed in 
squamous epithelium is gradually lost, while the keratins typical for simple epithelis., 
i.e. keratins 18 and 19 are increasingly expressed. In small cell lung cancers and carci-
noids keratins 8, 18 and 19 can be found. In cases in which keratin 7 was detectable, 
electron microscopic examination revealed areas of adenocarcinomatous differentia-
tion. MAbs against keratins 4, 10 and 13 did not react with small cell lung 
(98,99) 
cancers. 
Transitional cell carcinomas 
Urinary tract carcinomas display a keratin expression pattern which is to a certain 
extent related to the degree of malignancy. Grade I and grade II carcinomas invariably 
express keratins 7, 8, 13, 18, 19 and probably keratin 20 in all tumors in a varying 
number of cells, while keratins 4 and 14 are detectable in varying numbers of cells in 
some tumors. Most grade III transitional cell carcinomas express keratins similar to 
grade I and grade II tumors, however in a number of cases tumor progression is to a 
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certain extent correlated to a decrease in keratin 13 and 20 expression (personal com­
munication dr R. Moll), while on the other hand keratin 14 becomes detectable. In a 
number of cases, however a significant difference from the typical keratin expression 
pattern of transitional cell carcinoma is noted, characterized by a reduction in the ex­
pression of keratins 7 and 8, corresponding to areas of squamous differentiation. 
Along with this reduced expression of keratins 7 and 8 an increase in the incidence of 
cells staining for keratins 4, 10 and 14 is noted/66, Л ) Furthermore recent studies have 
made it clear that the keratin 8 and 18 expression in these tumors is often found in the 
infiltrating margin of the tumor islands and that the heterogeneity of keratin expres­
sion patterns observed in primary urothelial cell cancers can also be observed in the 
metastasis of these cancers. This means that to date no specific subset of metastatic 
cells with a typical keratin phenotype has been identified in transitional cell 
carcinomas. 
In mammary cancer investigations performed so far indicate that the keratin profile 
found in the myoepithelial basal cells of the terminal ducts are only seen to a very 
limited extent in tumor cells of primary or secondary breast cancers. Most of the 
tumors studied to date express keratins 7, 8,18 and 19, while about a third of the 
breast carcinomas express keratin 17. Futhermore relatively small numbers of tumors 
have been shown to express keratins 14 and 16, while sporadically keratin 13 has also 
been detected in mammary cancers. An interesting point brought to light is the 
negative correlation in the tumors staining with basal cell markers and those staining 
with luminal cell markers. Mostly tumor cells staining with keratin 14 do not stain 
with keratin 18. While tumors that stain with keratin 14 and 17 also often express 
keratin 16 which is associated with hypcrproliferation, at least in squamous epithelia. 
Thus two groups of invasive breast carcinomas may be distinguished on the basis of 
their keratin phenotype, one group expressing predominantly basal cell keratins, while 
the second and by far the largest group, expresses keratins found in the luminal 
cells/70·75·94 
In squamous cell carcinomas of the skin the considerable heterogenety in the 
keratin expression patterns can be related to the level of tumor cell differentiation. 
Keratins 1, 2 and 10 are found in well differentiated carcinomas, in particular in areas 
showing cornification. In these same areas keratins 5 and 14 may also be present. 
These keratins are gradually lost in poorly differentiated parts of the tumor. The tran­
sition between these areas can be marked by means of immunohistochemical proce­
dures using antibodies to keratins 5 and 14, and is often shown to be abrupt.'64'92-93) 
The most striking observation however was the appearance of keratins 7, 8, 18 and 19 
in poorly diffentiated squamous eel carcinomas of the skin. These keratins are usually 
not expressed in squamous epithelium of the skin. 
In cervical cancer the keratinizing variety of squamous cell carcinoma expresses the 
most complex keratin expression pattern, including the simple epithelial keratins 8, 18 
and 19 in all cases and in a few cases keratin 7 also. Keratin 10 is expressed in most of 
these cases and keratins 4, 5,6, 13, 14, 16 and 17 are expressed in all keratinizing 
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squamous cell carcinomas. In non-keratinizing cervical squamous cell carcinomas 
keratins 6, 14, 17 and 19 are always detected, while keratins 5, 7, 8 and 18 are often 
found, and keratins 4, 10, 13 and 16 occur less frequently. Adenocarcinomas of the 
cervix always contain large amounts of keratins 7, 8, 17, 18 and 19, while also sporadic 
expression of keratins 4, 5, 6, 10, 13 and 14 is sometimes observed. ' 
Figure 4. Immunoperoxidase staining patterns of frozen sections from normal and malignant 
cervix epithelium, (a, d) the ecto-endocervical'region. After staining for keratin 18 
(a), the endocervical columnar cells stain while the squamous metaplastic 
epithelium remains negative. After staining for keratin 13, the full thickness o f the 
squamous epithelium stains except the basal cell layer, while also the endocervical 
columnar cells are negative. Cervical squamous cell carcinoma (b, c) and 
adenocarcinoma (e, f) Staining of a squamous cell carcinoma for keratin 13 (b), 
results in extensive positivity of the tumor cells while in the adenocarcinoma (e) the 
tumor cells are negative. Staining for keratin 18 showed a patchy positivity m a 
squamous cell carcinoma (c) and an intense staining of an adenocarcinoma (f) 
Adenocarcinomas, irrespective of the organ from which they originate, invariably ex­
press keratins 8 and 18. The most simple keratin expression pattern of all, consisting of 
keratins 8 and 18 is found in several neuroendocrine tumors (small cell lung carci­
noma) and hepatocellular carcinomas. These malignancies have been shown to also 
co-express some of the other simple epithelial keratins to a minor extent. "" Depen­
ding on the organ of origin an adenocarcinoma may express an additional characteris­
tic keratin combination, which can help to distinguish it from an adenocarcinoma ori­
ginating in another organ. This may be demonstrated in a number of examples. For 
instance, an adenocarcinoma of the colon or stomach will express the keratins 8, 18, 19 
and 20. Carcinomas of the ovary express keratin 7 along with keratins 8, 18 and 19, 
but not keratin 20. This typical expression pattern is also shared by carcinomas of the 
breast and lung.(l02) 
5. ECTOPIC KERATIN EXPRESSION 
In section 2.5 we briefly discussed the fact that the initial enthusiasm regarding the 
highly conservative expression of keratins, which was at first thought to be restricted 
to epithelial cells and malignancies originating in epithelial tissues only, was soon 
tempered by reports demonstrating unequivocal expression of keratins in both benign 
and malignant non- epithelial lesions. This co-expression was not only noted in adult 
tissues, but also during embryonal development as mentioned above. 
Tumors which are all considered to be of non-epithelial origin, but have been shown to 
have the capacity to express keratins include: epithelioid sarcoma(l0J), malignant fi­
brous histiocytoma °M), synovial sarcoma ' o s , leiomyosarcoma , rhabdomyo­
sarcoma, liposarcoma(IC7), Ewing's sarcoma 1C8, chondrosarcoma(1Ю, plasma­
cytoma ("0), malignant melanoma<UI), hemangiopericytoma(l07), epithelioid hema-
gioendothelioma and epithelioid angiosarcoma(ll2), chondroblastoma(" and menin­
gioma. Keratin co-expression with desmin and vimentin has been reported in 
both leiomyomas and leiomyosarcomas and the metastasis of leiomyosarcomas ' , 
both in primary tumors and in tumor metastases. Co-expression of keratin with 
desmin and vimentin has also been reported in malignant tumors originating in stria­
ted muscles(82), as well as in smooth muscle proliferations in atherosclerotic plaques. 
Expression of keratins 8 and 18 has been reported in the reticular cells of the lymph 
nodes. 
Also in the case of muscle cell tumors the ectopically expressed keratins are normally 8 
and 18™ 
In a recent study we could show that in chondroblastomas originating in various sites 
of keratin 19 and to a lesser extent keratins 7 may be found.(53) 
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6. A SURVEY OF THE PRACTICAL APPLICATIONS OF 
KERATIN ANTIBODIES 
The use of keratin antibodies is not only of assistance in the differential diagnosis of 
epithelial versus non-epithelial tumors but also of considerable importance in the 
subclassification of the different types of carcinomas. In the following we would like to 
give a short summary of the uses to which keratin antibodies may be put in pathology 
practice. 
6.1 Histopathology 
When presented with a malignant tumor which is not classifiable on the basis of 
conventional routine staining techniques alone, the pathologist may use additional im-
munohistochemical procedures. Among a broad panel of antibodies to be used in these 
assays there will invariably be a number of antibodies reactive with IFPs. In the case of 
a poorly differentiated tumor the panel of antibodies to be used in the first instance 
should consist of a broadly cross-reacting keratin antiserum, mAb, or even a cocktail 
of keratin mAbs recognizing both type I and type II keratins. Along with IFP anti­
bodies recognizing vimentin, desmin, GFAP and neurofilament, the panel may also 
comprize antibodies reacting with surface antigens such as the common leucocyte 
antigen, antibodies to mucins, other cytoplasmic constituents or nuclear components. 
In the case of a keratin positive malignacy which does not react with the other IFP 
antibodies, the tumor will be classified as a carcinoma. It may then be further subclas-
sified with the aid of polypeptide specific keratin mAbs/64'92- J ) If the question is 
whether the epithelial malignancy is an adenocarcinoma or a squamous cell carcino­
ma, antibodies to keratins 4, 5, 10 and 13 will be of considerable help, in that these 
keratins are mostly not expressed in adenocarcinomas. Positivity for these reagents will 
almost certainly indicate that the tumor is a squamous cell carcinoma/"^ It should 
be kept in mind that however that Kuruc et al ( l l 4 ) have recently shown that human 
epidermal carcinomas are negative for keratin 13. In the case that the keratin 10 anti­
body is strongly positive in small foci the tumor is very likely of a keratinizing variety. 
In the case that the keratin 10 antibody is negative and the keratin 4 and 13 antibodies 
are positive, the carcinoma will probably be of the non-keratinizing type. In this con­
text it is important to note that the initially believed distinction between adenocarcino­
mas and squamous cell carcinomas on the basis of staining with antibodies to keratin 
8, 18 and 19 is not reliable, as these keratins are very frequently observed in squamous 
cell carcinomas. In the case of squamous cell carcinoma of the lung and the cervix 
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the number of cells and tumors expressing keratin 13 also decreases. Inversely, the 
expression of keratins 8 and 18, the typical adenocarcinoma markers increase with 
decreasing degree of differentiation. Poorly differentiated squamous cell carcinomas of 
the bronchus and cervix may show considerable staining for keratins 18 and only 
sporadic positivity for keratin 13. When an epithelial tumor does not react with the 
aforementioned antibodies to keratins 4, 5, 10 or 13, but is strongly positive with anti-
bodies recognizing simple epithelia such as keratins 7, 8, 18, 19 or 20 it may well be an 
adenocarcinoma. The further distinction of an adenocarcinoma may also be aided by 
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the variation in the panel of antibodies recognizing simple keratins, depending on the 
exact differential diagnostic considerations. In this respect antibodies to keratin 7 can 
be used to subtype adenocarcinomas, since this keratin polypeptide has been detected 
in specific types of glandular tissues. For instance, in the ovary, breast, bile ducts and 
the bronchus the columnar cells contain keratin 7, but glandular epithelia covering the 
stomach, intestine and prostate do usually not express keratin 7 or express it to a much 
lesser extent. As a result a keratin 7 antibody distinguishes an ovarian carcinoma from 
a colon or stomach carcinoma. Also a poorly differentiated prostatic or colonic adeno-
carcinoma (which is keratin 7 negative) can be discriminated from a transitional cell 
carcinoma (which is keratin 7 positive). In metastatic tumors with unknown primary 
origin keratin 7 positivity will cut down the number of possibilities considerably. In the 
case a tumor is only positive for keratins 8, 18, 19 and 20 a tumor arising from the gas-
trointestinal tract must be seriously considered. Other possibilities that must be enter-
tained are tumors of neuroendocrine origin, for instance Merkel cell tumors and carci-
noids. If the tumor expresses keratins 8 and 18 only and is made up of small cells cells 
with scanty cytoplasm a small cell lung carcinoma must be seriously considered. If the 
cells are much larger their positivity with mAbs against 8 and 18 and occasionally with 
an antibody against keratin 7 could indicate a hepatocellular carcinoma. The distinc-
tion between a mesothelioma and a adenocarcinoma may also be very difficult on the 
basis of conventional histology. In this respect a keratin S antibody may be of help 
(io, 7s. ¡><¡^  espççjaijy ¡n t n e distiction of an adenocarcinoma of the lung from a mesothe-
lioma. In the former keratin 5 is only detectable in a few cells in a few cases while in 
mesotheliomas most cells have been shown to stain intensly with the antibody AE 14 
reacting with keratin 5. Probably keratin 5 is also useful in distinguishing adenocarci-
nomas originating in other tissues from mesotheliomas, i.e. renal cell carcinoma and 
colon carcinoma. 
It has to be examined in future studies whether of not a keratin 5 antibody can be used 
to distinguish atypical mesothelial cells from adenocarcinoma cells, for instance in the 
cytologic examination of effusions. 
Co-expression patterns of different types may also be of diagnostic help. For example 
the fact that certain neuroendocrine malignancies and carcinoids co-express keratins 
and neurofilaments may be of additional assistance. Co-expression of keratin with 
vimentin and desmin may be indicative of an epithelioid sarcoma. In a malignancy ari-
zing from the mammary or salivary gland keratins may be co-expressed with GFAP. 
In mesotheliomas and renal cell adenocarcinomas strong co-expression of keratin and 
vimentin alone may assist in the diagnosis. 
6.2 Cytopathology 
Especially in cytopathologic diagnoses, immunohistochemistry may be a particularly 
strong tool in determining the origin of malignant cells present in fine needle aspi-
ration biopsy specimens, sputum smears, or cytologic preparations from body cavity 
effusions. The use of mAbs in diagnostic cytopathology of body cavity effusions is 
slowly becoming more widely accepted. Broadly cross-reacting keratin antibo-
dies, mostly polyclonal rabbit antisera, and vimentin antisera can be of value when the 
nature of the cells under investigation has to be determined, but routine cytopatho-
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logic methods cannot give conclusive results. In problem cases in which the differential 
diagnosis is between anaplastic or small cell carcinoma on one hand and malignant 
lymphoma on the other hand, a positive reaction of the tumor cells with keratin anti-
bodies is a very strong indication of a carcinomatous process. A negative reaction of 
the tumor cells for keratin, together with a positive reaction for vimentin is indicative 
of a lymphoma or a sarcoma. In this context it is important to note that both epithelial 
tumor cells as well as malignant and reactive mesothelial cells co-express both types of 
IFP types when growing under certain conditions. We have noted co-expression in 
several types of adenocarcinoma but not in squamous cell carcinomas and transitional 
cell carcinomas. This is in contrast to observations of some authors who report that in 
serous effusions only mesothelial cells would co-express cytokeratins and vimentin, in 
contrast to for example, ovarian carcinoma cells. 
As the mAbs directed against cytokeratins 5, 7, 10, 13 and 18 can distinguish among 
cells derived from different types of adenocarcinomas, mesotheliomas, squamous cell 
carcinomas and transitional cell carcinomas (see above), it is obvious that the applica-
tion of such antibodies in cytopathology can help to come to a more precise differen-
tial diagnosis and can provide valuable information concerning the nature of a pri-
mary tumor. Squamous cell carcinomas may be separated from adenocarcinomas, 
based on the expression of keratins 10 and 13 in the former. These keratins are hardly 
ever detected in adenocarcinomas. In the differential diagnosis of cells in an effusion, 
antibodies to cytokeralin 7 have already proven to be useful in problem cases in which 
it was not possible to distinguish between a colon carcinoma and an ovarian carcino-
ma or between a renal cell carcinoma and a prostate carcinoma on the one hand or a 
transitional cell carcinoma on the other hand. If the question is whether the observed 
tumor is an adenocarcinoma of the stomach or colon positivity with an antibody to 
keratin 7 will to a large extent rule out this possiblity. It should however be kept in 
mind that gaslerointestinal tract carcinomas may occasionally express keratin 7(llb) 
6.3 Flow cytometry 
Flow cytometric analysis of cell suspensions of tumors has proven to be a useful tech-
nique in the estimatation and quantification of various cellular components. Special 
attention has been focussed on the measurement of the cell DNA content, the results 
of which may be used to estimate the ploidy and proliferative capacity of tumors. 
These estimations may however, be severly impaired because of the mixed cell popula-
tions found in tumor tissue fragments, rendering interpretation of the derived results 
extremely difficult. By staining cells for keratin after fixation in ethanol several cell po-
pulations may be distinguished. The keratin positive cells may be separated from the 
keratin negative cells and their DNA content may be determined separately. The addi-
tional use of a propidium iodine stain allows the separation of cell debris and loose 
cytoplasmic fragments from the cells under examination. From these data a clean 
DNA histogram for the keratin positive cells may be obtained. In malignant tumors in 
which only very few tumor cells are distinguishable by one-dimensional DNA flow 
cytometry, double labelling allows keratin positive, aneuploid tumor cells to be distin-
guished from the stromal cells and blood cells as well as from keratin positive but 
diploid normal epithelial cells. 
35 
The application of keratin and vimentin antibodies in the flow cytometric analysis of 
body cavity effusions revealed that the double-labeling assay significantly increased the 
level of tumor cell detection 0 0 6 ' ι ι 5 ) 
IFP antibodies in combination with flow cytometry can also be helpful in the study of 
skin disease/64, " ' 9 3 ) The epidermis is not homogeneous in its cellular composition. 
Apart from keratinocytes, other cell types are present such as Langerhans cells, mela­
nocytes, and in pathologic situations also inflammatory cells. The keratinocytes them­
selves are functionally heterogeneous, ranging from germanitive cells (cycling or 
resting) to those in the terminal, fully differentiated state. A proper identification and 
quantification of epidermal cellular subpopulations is a prerequisite in the elucidation 
of the processes involved in hyperproliferative diseases of the skin, for example 
psoriasis. Therefore, specific monoclonal keratin antibodies, as well as vimentin anti-
sera, were used in combination with single cell suspensions prepared from biopsy spe­
cimens by trypsination of normal and psoriatic skin. Of these, the monoclonal anti­
body directed against keratin 10, was selected for quantitative population analysis of 
the suprabasal keratinizing cells of healthy epidermis, psoriatic uninvolvcd epidermis 
and psoriatic lesions. These antibodies donot react with the basal cells in the tissues 
mentioned before. This basal cell compartment could specifically be stained with anti­
body Pab601. ("7' " 8 ) Since biochemical studies of sorted cells of epidermis reveled 
the presence of keratins 5 and 14, antibodies to these specific IFPs are now being used 
for flow cytometric analysis (FCM) of normal and hyperproliferative skin. Further­
more, an antibody recognizing keratin 16, related epidermal hyperproliferation was 
applied in these FCM studies. The results showed an increase in the germinative frac­
tion in the psoriatic lesion as compared to normal skin. Psoriatic epidermis contained 
a significantly reduced fraction of keratin 10 containing cells. While normal and unin-
volved skin of psoriatic patients contained only a minor fraction of keratin 16 positive 
cells approximately 60% of the epithelial cells in the psoriatic lesions showed a reaction 
with this antibody. As a result, multiparameter FCM of skin lesions with the anti­
bodies described above will lead to a better understanding of the mechanisms control­
ling normal and pathologic epidermal growth. 
6.4 Serum tests for keratins 
Other possible applications of antibodies to keratins in tumor diagnosis include the de­
tection of extracellular keratin, in serum, or in the vicinity of a solid cancer. The ear­
liest anti-keratin antisera were not identified as such, for example anlisera to tissue po­
lypeptide antigen or TP A, but were recently shown to recognize fragments of keratin 8 
and possibly also keratin 18 and 19.(ll9) Other groups have investigated the possibili­
ty of monitoring keratin proteins in body fluids as a diagnostic aid.020, '2 l ' 
While it seems clear that in situations of accelerated epithelial cell turnover, such as 
wound healing and tumor growth, keratin fragments can accumulate in and around 
tumors, normal levels vary greatly and must be individually acessed for each patient. 
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Changing Patterns of Keratin Expression during 
Progression of Cervical Intraepithelial Neoplasia 
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Irene Leigh and G. Peter Vooijs 
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ABSTRACT 
The expression of keratins in normal cervical epithelia, metaplastic epithelia and cervi-
cal intraepithelial neoplasia (CIN) grades I, II, and III is investigated with a panel of 
polypeptide mAbs. This approach allowed the detection of individual keratins 4, 7, 8, 
10, 13, 14, 18 and 19 at the single cell level. By using an antibody recognizing keratins 
5 and 8 (RCK 102) and two antibodies specific for keratin 8 (CAM 5.2 and M 20) it 
was also possible to derive information on the distribution of keratin 5. Our results 
show that during immature squamous metaplasia, there is an acquisition of keratins 
typical of squamous epithelium, i.e. keratins 4, 5, 13 and 14. This process continues 
during further differentiation to mature squamous metaplasia. In premalignant lesions 
the expression pattern of the progenitor reserve cells and immature squamous meta-
plastic epithelium is partly conserved. However, in most cases an induction in the 
expression of the keratins 4, 13 and 14 was observed. Furthermore, CIN III shows a 
more extensive expression of keratins typical of simple epithelia, i.e. keratins 8 and 18, 
as compared to CIN I and CIN II. 
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INTRODUCTION 
In recent years there have been a number of studies of keratin expression in normal 
and neoplastic cervical epithelium."" These studies have been based on immunohisto-
chemistry with anti-keratin mAbs and/or on gel electrophoretic analysis of tissue 
samples. In this way it has been possible to construct a picture of the keratin pheno-
type of ecto- and endocervical epithelium, squamous metaplasia, reserve cell hyperpla­
sia and, from a few cases, severe dysplasia and carcinoma of the cervix. These studies 
indicate that ectocervical epithelium contains type II keratins 1, 4, 5 and 6 and type I 
keratins 13, 14, 15 and 19, with some variability in the expression of keratins 2, 8, 10, 
11,16 and 17(1); endocervical columnar cells contain keratins 7, 8, 18 and 19, with 
variable presence of keratin 4.0) Reserve cells have been shown to contain keratins 5, 
17, 19 and varying amounts of keratin 8 №; Levy et al.(5) also suggested that keratin 13 
was present in a subpopulation of these cells. Opinions are still divided regarding the 
question of keratin 18 in reserve cells. 
The pattern of keratin expression in immature squamous metaplasia has been shown 
to differ from that of normal squamous epithelium: keratin 19 is found in the full 
thickness of metaplastic epithelium, as opposed to only basal cells in normal epithe­
l i a l Some keratin 13 and 16 expression has also been reported, but keratin 18 was not 
found.(3,,) CIN HI has not been extensively studied to date. Bobrowet al.<8) showed 
that the antibody CAM 5.2 (to keratin 8) stained some cases of severe dysplasia and 
early invasive carcinoma, and keratin 18 expression has also been reported in cases of 
dysplasia/4 
With the increasing availability of polypeptide-specific mAbs that each recognize only 
a single keratin isotype, it has now been possible to extend these investigations to a 
systematic study of a large number of immature and mature squamous metaplasias, as 
well as CIN I, II and III lesions, and to compare the keratin expression at the single 
cell level with that observed in normal endo- and ectocervical epithelium. Such 
detailed information may lead to greater insight into the etiological aspects of cervical 
intraepithelial neoplasia. 
MATERIALS AND METHODS 
Tissues 
The tissue specimens used in this study were derived from cervical cones removed in 50 
women aged between 25 and 65 years, in whom cytologic screening had shown fea­
tures consistent with dysplasia. 
Before exconization the lesions were visualized by application of 4% acetic acid solu­
tion in water to the whole ectocervix. 
Immediately after exconization each cone was divided into quadrants, which in tum 
were subdivided into three equal parts perpendicular to the cervical canal. The central 
specimen from each quadrant was fixed in a 4% formaldehyde solution and processed 
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through paraffin for H&E sections and routine light microscopical diagnosis perfor-
med independently by three qualified pathologists. The two other specimens were snap 
frozen in liquid nitrogen or liquid nitrogen cooled isopentane and stored in liquid 
nitrogen. One fragment from each quadrant was used for the immunohistochemical 
assays. 
A total of 150 specimens representing normal or metaplastic epithelia through three 
grades of CIN were used. Moreover, in many specimens normal and/or metaplastic 
epithelia and intraepithelial neoplasia were found along side of each other so that the 
following could be diagnosed: normal ectocervical epithelium in 50 specimens, normal 
endocervical cylindrical epithelium in 120 specimens, immature squamous metaplasia 
in 16 specimens, subcolumnar reserve cells in 20 specimens, mature squamous meta-
plasia in 45 specimens, CIN I in 15 specimens, CIN II in 14 specimens and CIN III in 
15 specimens. Furthermore, the subepithelial connective tissue with smooth muscle 
cells was also meticulously examined in all 150 fragments. 
Antibodies: 
Fourteen monoclonal keratin antibodies, one monoclonal vimentin antibody and one 
monoclonal desmin antibody, were used in this study. The specificity of these antibo-
dies is briefly described below. 
1. RCK 102 is a broadly reacting keratin antibody of the IgGl subclass, which 
recognizes keratins 5 and 8, and as a result stains virtually all epithelial tissues.'9 
2. RCK 103, a broadly cross-reacting antibody of the IgGl class, stains epithelial 
as well as neural tissues. Since in the prostate it decorated only basal cells in 
several studies (1C'U) this antibody was included to examine its reactivity pattern 
with reserve cells. 
3. RCK 105 (IgGl)(9) reacts only with keratin 7 in immunoblotting and stains a 
subgroup of glandular epithelia and their tumors, as well as transitional 
epithelium. 
4. RGE 53 (IgGl)(12,3), RCK 106 (IgGl)<9) and CK 18-2 (IgGl)(14) are 
monospecific for keratin 18 in immunoblotting. In general these three antibodies 
recognize columnar epithelial cells of the digestive, respiratory and urogenital 
tracts, endocrine and exocrine cells and mesothelial cells, as well as tumors origi-
nating from them. Generally no reaction is found in squamous epithelia. 
5. LP2K<l5) stains most simple epithelia and basal cells in stratified squamous 
epithelia that are not keratinizing. This antibody only recognizes keratin 19 in 
immunoblotting assays. 
6. LL002 (IgG3) stains full-thickness epidermis (but not stratum comeum), basal 
and some higher layers of non-cornified stratified epithelium and basal cells in 
complex, "mixed" epithelia of glands. It is monospecific for keratin 14 by 
immunoblotting.0* 
7. RKSE 60 (IgGl)(3,l7) reacts only with keratinizing epithelial cells, and recognizes 
keratin 10 in immunoblotting. 
8. 6B10 (IgGl)(18) reacts with non-cornifying squamous epithelium and with certain 
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ciliated pscudostratified epithelia such as the cylindrical epithelium of bronchi, 
and recognizes only keratin 4 in immunoblotting. 
9. Antibodies 1C7 (IgG2a) and 2D7 (IgG2b)<1β) both react with non-cornifying 
squamous epithelia. These antibodies recognize only keratin 13 in 
immunoblotting studies. 
10. M20 (IgGl)(1S) recognizes only keratin 8 in immunoblotting assays. 
11. CAM5.2 (IgG2a) was purchased from Becton & Dickinson (Etten-Leur, The 
Netherlands) and stains simple epithelia, some basal cells of squamous epithelia 
and sporadically smooth muscle cells. The immunoblotting assays shown in 
Figure 1 demonstrate the primary specificity of this antibody for keratin 8, and 
not keratin 18 or keratin 19. Although earlier studies reported reactivity of this 
antibody with all three keratins(20), one-dimensional immunoblotting reactivity 
with the lower molecular weight bands is due to breakdown products of keratin 
8. The specificity has also been confirmed in assays using bacterially synthesized 
individual recombinant keratins, where we have observed strong reactivity with 
keratin 8, weak but distinct cross-reactivity with the closely-related keratin 7, 
and no reactivity with either keratin 18 or keratin 19 (CM Alexander, PC Staslak 
& EB Lane, unpublished observations). The immunoblotting studies on 
cytoskeleton preparations of RT4 cells were performed as previously 
described.0"0 
12. The monoclonal antibody RV 202 (IgGl) ( , ) reacts with vimentin and therefore 
stains mesenchymal cells. 
13. Desmin antibody RD 301 recognizes muscle cells. 
Immunohistochcmistry 
Cryostat sections were fixed in cold methanol (-20e C) for five minutes, then rinsed in 
acetone and air dried. The slides were incubated with the appropriately diluted or 
undiluted antibody for 45 minutes at room temperature. 
After three subsequent 10 minute washings with PBS the peroxidase-conjugated 
rabbit-anti-mouse serum was applied to the sections for 30 minutes at room tempera­
ture. After a second series of washing steps with PBS the peroxidase was detected with 
З-атіпо-9-cthylcarbazole (AEC; Aldrich Chem. Сотр., USA). For this purpose 
40 mg of AEC was dissolved in 10 ml Ν,Ν-dimethylformamide (Merck, Darmstadt, 
FRG) and added to 190 ml of sodium acetate buffer (0.05 M, pH 4.95). Hydrogen 
peroxide was added to a final concentration of 0.01% (v/v). Sections were incubated 
for 8 minutes with this mixture, then rinsed with tap water, counterstained with 
hacmatoxylin and mounted with Kaisers glycerin-gelatin (Boom B.V. Meppel, The 
Netherlands). 
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RESULTS 
In Figure 2 a schematic representation of the keratin phenotype of normal ecto- and 
endocervical epithelium, immature squamous metaplasia, mature squamous metapla-
sia through three grades of dysplasia, as recognized by monospecific mAbs, are given. 
There were distinct variations in the expression of individual keratins in immature 
metaplasia and in the dysplasias, as compared to the expression in normal endo- and 
ectocervical epithelium. These will be described in detail. 
Throughout all the squamous epithelia scattered vimentin (RV202) positive cells could 
be detected, representing lymphocytes or Langerhans cells.(22) Many endocervical 
columnar cells showed vimentin expression of varying intensity in cervices with 
immature metaplasia, those with reserve cells and also cervices without lesions. The 
monoclonal desmin antibody stained all smooth muscle cells in the subepithelial 
connective tissue. In a number of cervices some smooth muscle cells were also decora-
ted by the antibodies specific for keratin 8. 
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Figure 2. Schematic represen­
tation of the keratin distri­
bution patterns as detected by 
the different m A bs. FUled bars 
indicate a positive reaction, 
open bars indicate a negative 
reaction, while a small square 
indicates that only a few cells 
arc positive. A partly filled bar 
means that only part of the cells 
in the respective layers is posi­
tive: a vertically divided bar 
means that both positive and 
negative areas were seen, an 
obliquely divided bar means 
that the expression pattern 
differs in the individual layers 
and a stippled bar means that a 
weakly positive reaction was 
observed. 
Abbreviations: 
К = keratin(s); 
S = superficial cells; 
1 = intermediate cells; 
В = basal cells; 
PB = parabasalcells; 
С = columnar cells; 
RC = reserve cells. 
Ecto- and endoccrvical epithelium (fig. 2a,b and fig. 3) 
The ectocervical epithelium shows a reproducible pattern of keratin expression in all 
50 specimens, with only minor variations in the staining patterns with a few antibodies 
between some specimens. RCK 102 (keratin 5 and 8) decorated all cells of the basal 
and parabasal layers, part of the cells in the intermediate layer and only sporadic stai­
ning of some superficial cells in a few tissue fragments was observed (fig. 3a). RCK 103 
stained all layers of the epithelium, with the basal layer showing a slightly more intense 
îxpression than the other layers (fig. 3b). 1C7 and 2D7 (to keratin 13) showed a similar 
expression pattern with strong staining of the parabasal, intermediate and superficial 
sells. The basal cells were negative (fig. 3c). All cells of the superficial layer and the 
majority of the cells in the intermediate layer were positive for 6B10 (keratin 4) (fig. 
3d). LL002 (keratin 14) stained the basal and parabasal cells with partial staining of 
the intermediate cells and sporadic staining of superficial cells in a few cervical 
fragments (fig. 3e). Staining with LP2K (keratin 19) was uniformly positive in the 
basal cell compartment of the epithelium (fig. 30 and in 14 of 50 cases a scattered reac-
tion of individual cells was also noted in the other layers. CAM 5.2 (keratin 8) stained 
a few basal cells in 15 cases and RKSE 60 (keratin 10) (fig. 3g) showed scattered 
decoration of cells in the intermediate and superficial cell layers in six cervical tissue 
fragments. RGE 53, RCK 106, CK 18-2, M 20 and RCK 105 were all negative in the 
ectocervical squamous epithelium. 
One hundred and twenty samples of endocervical epithelium were examined. 
AH endocervical columnar cells strongly reacted with RCK 102 (fig. 3h), RCK 103, 
RGE 53 (keratin 18), RCK 106 (keratin 18) (fig. 3i), CK 18-2 (keratin 18), M20 (kera-
tin 8) (fig. 3j), CAM 5.2 (keratin 8) and LP2K (keratin 19) (fig. 3k). RCK 105 (keratin 
7) (fig. 31) stained most, but not all columnar cells. 6B10 (keratin 4) displayed hetero-
geneous staining, with some columnar cells positive in 32 of 106 cervical fragments 
(fig. 3m). 1C7, 2D7 (keratin 13), LL002 (keratin 14) and RKSE 60 (keratin 10) were 
negative. Small groups of reserve cells were found in 20 of the 150 cervical fragments. 
All reserve cells were uniformly decorated by RCK 102 (fig. 3h), RCK 103, LP2K (fig. 
3k). Of the markers for keratin 18, RCK 106 showed the most intense reaction (fig. 3i), 
CK 18-2 was moderately positive but the RGE 53 epitope was hardly detectable. M 20 
(fig. 3j) and CAM 5.2 reacted with moderate intensity in most cases, some being 
negative. RCK 105 (fig. 31), 6B10 (fig. 3m) and LL002 did not react in these cells. 
Immature squamous metaplasia (fig. 2c and fig. 4) 
In 16 fragments immature squamous metaplasia was diagnosed (fig. 4a). This epithe-
lium showed an expression pattern which only partly resembled normal ectocervical 
epithelium and mature squamous metaplastic epithelium. Immunureactivity of all epi-
thelial layers was noted with RCK 102 (fig. 4b) and RCK 103, and with LP2K (keratin 
19) (fig. 4h) which all showed staining of varying intensity. RCK 106 (fig. 4d) decora-
ted the superficial cells. The underlying epithelial cells were mostly positive with 
various intensity. Two cervices were completely negative with RCK 106. CK 18-2 (fig. 
4c), RGE 53 and 6B10 (fig. 4i) reacted in 7 different cases out of 16 and were negative 
in the rest. M20 (fig. 4e) and CAM 5.2 (fig. 4f) both to keratin 8, showed strong reacti-
vity with the superficial columnar cells when present. The underlying cells showed 
some dispersed reactivity in 7 out of 16 cases. 1C7 and 2D7 (to keratin 13) reacted Witt 
a few dispersed cells in seven out of 16 cases (fig. 4j). LL002 (keratin 14) (fig. 4k) 
decorated with varying intensity all epithelial layers with exception of the superficial 
layer, in 8 out of 16 cases. The other cases were negative. RCK 105 (keratin 7) (fig. 4g) 
and RKSE 60 (keratin 10) (fig. 41) were negative. 
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Figure 3. Immunoperoxidase staining patterns of frozen sections from normal ectocervical 
squamous epithelium (a-g) and endocervicalcolumnar epithelium with reserve cells 
(h-m) after incubation with (a,h)RCK 102; (b)RCK 103; (c) 1C7; (d,m) 6B10; (e) 
LL002; (f,k) LP2K; (g) RKSE 60; (i) R CK 106; (j) M20; and (1) R CK 105. 
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Figure 4. Η& Ε (a) and immunoperoxidase staining patterns of frozen sections with cervical 
immature squamous metaplasia incubated with b) RCK 102; c) CK 18-2; d) RCK 
106; e)M20;Γ) CAM5.2;g)RCK 105; h)LP2K; i) 6B10J) 1C7; k) LL002; 
DRKSE60. 
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Mature squamous metaplasia (fig. 2d) 
This was diagnosed in 45 cervical fragments. The pattern of keratin expression was 
almost equal to that observed in ectocervical epithelium. There were, however, a few 
minor differences, i.e. LP2K showing expression in dispersed cells above the basal 
layer in 12 fragments and 1C7 and 2D7 staining basal cells in 4 cases. In two cases 
RCK 106 decorated some basal and parabasal cells. 
CIN I (fig. 2e and fig. 5a-h) 
In 15 tissue fragments CIN I was diagnosed (fig. 5a). In these the keratin expression 
showed differences as compared to the epithelia described above characterized by irre-
gularity in the pattern of keratin expression and that keratins normally occurring in 
simple epithelia could sometimes be detected. 
RCK 103 and RCK 102 (fig. 5b) were expressed throughout the full thickness of the 
dysplastic epithelium. 1C7 (fig. 5c) and 2D7 showed expression of varying intensity in 
the whole epithelium in 13 cases with basally lying cells often showing positivity. Two 
fragments were negative. 6B10 (fig. 5d) displayed immunoreactivity in the full thick-
ness of the epithelium with varying intensity with most basally lying cells staining 
rather weakly. In one fragment there was only some dispersed positivity for 6B10. 
LP2K (fig. 5e) showed homogeneous staining through the whole epithelium in 9 cases 
while 4 cases were negative and in one case there was some dispersed positivity. 
L L 0 0 2 (fig. 5Q reacted in all cases with varying intensity leaving the superficial epi-
thelial layers sometimes completely negative. 
With RGE 53, RCK 106 (fig. 5g), CK 18-2, M 20, CAM 5.2, RCK 105 and RKSE 60 
(fig. 5h) the major part of CIN I lesions was nonreactive, although there were isolated 
positive cells detectable in a few cases. These mostly basally located cells (except 
RKSE 60) showed staining of variable intensity. 
CIN II (fig. If and fig. 5i-p) 
CIN II was diagnosed in 14 fragments (fig. 5i). RCK 102 (fig. 5j), RCK 103, 2D7 and 
1C7 (fig. 5k) showed expression through the whole thickness of the epithelium. With 
2D7 and 1C7 the basal staining was less pronounced than in the other layers and with 
RCK 102 the intensity of immunoreactivity varied. 6B10 (fig. 51) showed slight stai-
ning with varying intensity in the basal part of the epithelium, with more intense deco-
ration of the superficial parts in all cases. LP2K (fig. 5m) was moderately positive 
through the whole thickness of the epithelium in all but one case which was completely 
negative. In six fragments the superficial cells did not react. LL002 showed expression 
with variable intensity in all layers (fig. 5n), seven fragments remained negative. 
RCK 106 (fig. 5o), CK 18-2, M 20 and CAM 5.2 (fig. 5p) decorated a few dispersed 
cells in only two cases, and staining was usually confined to the basal parts of the epi-
thelium. Staining with RGE 53 and RKSE 60 was negative. 
CIN Ш (fig. 2g and fig. 6) 
CIN III was diagnosed in 15 fragments. RCK 102 (flg. 6a) and RCK І03 (fig. 6b) 
decorated the full thickness of the epithelium, the basal half of the epithelium staining 
more intensly than the upper half. Antibodies 1C7 (fig. 6c), 2D7, 6B10 (fig. 6d), LP2K, 
LL002 (fig. 6e) and CAM 5.2 (fig. 60 and M 20 (fig. 6i) showed partial positivity in 
all epithelial layers, alternating with negative layers in most cases, while some were 
negative. RCK 106 (fig. 6h) stained most basal parts of the epithelium in 14 cervical 
fragments with one negative case. RGE 53 was always negative. With RCK 105, CK 
18-2, and RKSE 60 (fig. 6g) only a few immunoreactive cells were seen in some 
cervical fragments. 
DISCUSSION 
In this study the keratin polypeptide distribution in a large series of cervices with 
normal epithelium, in squamous metaplasia and the three grades of CIN were exami­
ned immunohistochemically using a panel of 14 m Abs. By using several mAbs directed 
against different epitopes of the same keratin polypeptide, (for example, the expression 
of keratin 18 and keratin 8 were monitored with 3 and 2 antisera, respectively), it is 
possible to detect structural (epitope) alterations resulting from biological activity or 
neoplastic transformation (see for example 19). An illustration of this so-called epitope 
masking phenomenon is the variability in the detection of keratin 18 with different 
mAbs. In the cervices in which CIN III was diagnosed, RCK 106 stained the basal part 
of most epithelia, while CK 18-2 stained fewer cases and the reaction was less intense. 
Staining with RGE 53 was negative in all cases. Reserve cells and epithelia with 
immature squamous metaplasia were stained by all three keratin 18 antibodies, al­
though the immunoreaction for RGE 53 was less intense when compared to CK 18-2 
and RCK 106. 
The pattern of keratin expression in ectocervical epithelium was reproducible in all 
cases with the exception of keratin 10 which is a marker of keratinization. In several 
cases this component occurred in some cells above the basal layer, though no morpho­
logical signs of keratinization could be detected in these epithelia. In accord with ear­
lier studies/2,0 we also detected keratin 4, 13 and 19 in ectocervical epithelium. The 
fact, however, that we found a reaction with 6B10 in all cells of the superficial layer 
and the majority of cells in the intermediate layer, contrasts to observations by Weikel 
et al,(4) who found a heterogeneous reaction with this antibody in the ectocervix. The 
availability of a mAb directed against keratin 14 enabled us to detect this cytoskeletal 
component as a major constituent in ectocervical cells. 
In the endocervix the keratin expression in columnar cells was consistent with reports 
in the literature.0'3* Reserve cells were not often found, but in a number of cases they 
were distinct beneath the cylindrical cells. They showed an unequivocal, albeit 
moderate expression of keratin 18 with the stronger two of the three antibodies used. 
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Figure 5. H& E (a) and immunoperoxidase staining patterns of frozen sections with cervical 
CINI(a-h)and CINII(i-p)incubated with b)RCK 102; c) 1C7; d) 6B10; e) LP2K; 
f)LL002;g)RCK 106; h)RKSE 60; i)H& E;j)RCK 102; k) 1C7; І) 6B10;m) 
LP2K; n) LL002; o)RCK 106;p) CAM5.2. 
s 
Figure 6. Immunoperoxidase staining reactions of frozen sections with CIN III, incubated with 
a)RCK 102; bJRCK 103; c) 1C7; d) 6B10; e) LL002; 1) CAM5.2;g)RKSE 60; h) 
RCK106; ι) M20. 
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Previously it was reported (3) that the antibody RGE 53, which in this study very 
weakly stains the subcolumnar reserve cells using the peroxidase technique, gave 
negative results when the indirect immunofluorescence technique was applied. This 
demonstrates the greater sensitivity of the peroxidase method. Weikel et al(4) also 
found no reaction in subcolumnar reserve cells with their keratin 18 antibody, CK.-2. 
In contrast, Gigi-Leitner et al(2) showed a positive keratin 18 reaction in reserve cells 
with antibody Ks 18.18. These discrepancies can be explained by presuming that these 
different keratin 18 antibodies recognize different epitopes or exhibit varying affinities 
for their respective antigens. Apparently, the epitopes recognized by RGE 53 and CK-
2 (1,2) are (partially) masked in subcolumnar reserve cells of the endocervix. Reserve 
cells were not immunoreactive with the keratin 7 antibody. 
Furthermore, on the basis of the intense staining with RCK 102 (detecting keratins 5 
and 8) and the weaker and variable reaction with M20 and CAM 5.2, we support the 
suggestion made by Weikel et a l w that reserve cells contain keratin 5, and conclude 
that reserve cells contain among others keratins 5, 8, 18 and 19. 
In contrast to the report of Levy et al ( , ) we were not able to detect keratin 13 in reserve 
cells with both antibodies used, i.e. 1C7 and 2D7. We also could not reproduce their 
findings concerning the staining of keratin 13 in immature squamous metaplasia, in 
which they report strong staining of all cells in the vicinity of the transitional zone 
using antibody K.S-1 A3. In immature squamous metaplasia we found only some dis-
persed reactivity with 1C7 and 2D7 of cells in the epithelium, and the whole mature 
epithelium, with exception of the basal layer, stained intensely. Epitope masking or 
recognition of other keratins by the antibody K.S-1 A3 of Levy et al 5 should be consi-
dered as explanations for these discrepancies. 
However, also different affinities of the antibodies for their respective epitopes may 
very well play a major role in the staining variability observed. For example, the diffe-
rent antibodies to keratin 18 may be ranked in the order of decreasing titrability as fol-
lows: RCK 106 > CK 18.2 » RGE 53. Therefore, if the amount of keratin 18 is low 
in a given cell type, a negative reaction with RGE 53 may be a result of its high thres-
hold of sensitivity. This may also hold true for keratins 8 and 13. The keratin 8 specific 
antibody CAM 5.2, for example, which is a strong antibody shows a somewhat more 
intense and extensive staining pattern than M 20. The keratin 13 antibody used by 
Levy et al(5) might very well show a lower threshold of sensitivity than 1C7 and 2D7, 
which are relatively weak antibodies as compared to other keratin 13 antibodies 
available (e.g. AE 8).(2" 
Immature squamous metaplasia can be considered to be a proliferation of reserve 
cells 4'5) in which they acquire squamous characteristics. This state of differentiation 
is however, far removed from normal ectocervical epithelium. No significant staining 
with keratin 13 antibodies was detected, which means the protein level must be at least 
very low, and substantial amounts of simple epithelial keratins 8 and 18 were present. 
The irregular distribution of both keratins 14 and 18 throughout most of the epithelial 
thickness suggests that these two usually non-overlapping keratins may be expressed 
reciprocally. Therefore, our results indicate that this type of squamous epithelium has 
a keratin expression pattern on the one hand characteristic of simple epithelia and on 
the other hand characteristic of squamous differentiation. This fact is emphasized 
when we compare the expression in immature squamous metaplasia to mature 
squamous metaplasia and ectocervical epithelium. The latter two show a highly 
comparable keratin expression pattern. In mature squamous metaplasia keratin 8 and 
18 are virtually absent, with the exception of two cases, while keratin 19 was restricted 
to the basal cell layer. Furthermore, as a result of this progressive stabilization the 
expression of keratins 4, 10, 13 and 14 increases. As compared to the study of Gigi-
Leitner et al who used antibody Ks 18.18, we find keratin 18 in immature squamous 
metaplasia. 
Next to these changes in keratin expression during progressive metaplastic lesions, we 
also found profound changes in keratin expression during progression of CIN. 
Through the three grades of CIN we found that keratins characteristic of simple 
epithelia were also present in dysplastic lesions. In CIN I approximately half of the 
cases and in CIN II one third of the cases showed some, dispersed reactivity for 
antibodies against keratins 8 and 18, while keratin 19, which only stains in the basal 
compartment in ectocervical epithelium, showed a loss of polarity, staining the full 
thickness of the epithelium often in an irregular fashion. CIN I and CIN II would 
appear to be somewhere in between the immature metaplastic and the mature 
metaplastic epithelium in terms of their keratin expression. They share with immature 
metaplasia the homogeneous full-thickness staining with anti-keratin 19 antibody 
LP2K. Keratin 19 has been associated with variable or transitional areas of 
differentiation(i6> or with premalignancy(2 : In this case the former would seem to fit 
better. In contrast to the sporadic staining for keratins 8 and 18 in some CIN I and 
CIN II lesions, CIN III showed reactivity for these keratins in most of the cases, with 
areas of intense, moderate or slight staining alternating with negative areas. Through­
out this study, the CIN III samples stand out as the most disorganized condition. 
Simple epithelial keratins are being synthesized by cells in the basal compartment as 
opposed to appearing preferentially in groups of cells higher up in the epithelium. All 
the keratinocyte keratins tested (keratins 19, 13, 14, 10) were highly irregular in their 
expression. This suggests that the proliferating cells are imcompletely programmed, 
leading to a degree of randomness in differentiation, possibly reflecting an origin from 
a more pluripotential progenitor cell. The degree of disorganization seen in CIN III 
samples is thus in keeping with their poorer prognosis. 
The role of other keratins, i.e., keratins 5,6,15 and 17, which may constitute an 
important part of the cytoskeleton of basal (reserve) cells and squamous epithelium 
still needs to be investigated. 
Antibody RCK 102, recognizing both keratins 5 and 8, could only be used to detect 
keratin 5 expression, when the keratin 8 antibodies M 20 and CAM 5.2 were negative. 
Based on this consideration, we conclude that keratin 5 is a major constituent of not 
only normal ectocervical epithelium but also of reserve cells, squamous metaplasia and 
CIN lesions. 
In contrast to a recent study of Raju(27), who suggested that the keralin(s) recognized 
by CAM 5.2 seldom occur in CIN III. Our findings with CAM 5.2 in frozen sections 
show a positive reaction in a varying number of cells in 13 out of 15 cases of CIN III. 
The study of Angus et al (6) largely confirms our data, although we wish to stress in our 
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report reactivity in only 30% of their cases. This difference can most probably be ex­
plained by the fact that they used formalin fixed, paraffin embedded cervical excisions. 
Also Whittaker et al ( 7 ) showed a profound difference in keratin expression when CIN I 
and II are compared to CIN III, consisting of a loss of stratification. In their study, 
however, only three antibodies were used (K. 8.60, К 8.12 and PK.K.1), each recog­
nizing more than one keratin, thus not allowing the exact determination of which kera­
tins are expressed. Furthermore, all material studied was routinely processed, which 
could partly be responsible for the unexpectedly restricted staining pattern of the kera­
tin antibody PK.K1, and for their observation that both mature and immature squa­
mous metaplasia showed comparable staining patterns. 
It is widely accepted that CIN I, II and III can progress to cervical carcinoma.(24,25) 
The probability of malignant transformation depends first of all on the severity of the 
dysplasia. Most cases of CIN I and CIN II regress, while a small percentage show pro­
gression to CIN III and carcinoma of the cervix. Future studies will have to reveal 
whether those cases of dysplasia in which we have observed fundamental changes in 
the keratin phenotypc are the ones that will show progression to carcinoma. Vice-
versa, those cervical excisions with microscopical characteristics consistent with CIN I 
and II that show no substantial alterations in keratin phenotype could well be cases 
that will revert to a normal epithelial architecture when the factors inducing the 
dysplasia are removed. 
We have also observed keratins 8,18 and 19, among others, in squamous cell carcino­
ma and adenocarcinoma of the cervix (unpublished observations). The progenitor cells 
for the adenocarcinoma are considered to be the columnar cells of the endocervical 
canal. The observation of keratins 8, 18 and large amounts of 19 in CIN III indicate 
that these cells may be the common progenitor, that can show dual differentiation on 
the one hand to a squamous cell carcinoma, and on the other hand to an adenocarci­
noma. This supposition is further supported by the occasional finding of dysplasia in 
the vicinity of adenocarcinoma. 
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ABSTRACT 
Expression of keratins 5, 14 and 17 in endocervical subcolumnar reserve cells was 
detected by means of immunohistochemical methods using polypeptide specific mono-
clonal antibodies. These particular keratins which were found among others in basal 
cells could also be detected to a variable extent in metaplastic and dysplastic cervical 
lesions. In some cases of immature squamous metaplasia all three keratin subtypes 
were expressed throughout the full thickness of the epithelium. In contrast, in mature 
squamous metaplasia a compartmentalization of these keratins was observed. Mature 
squamous metaplastic epithelium showed a keratin distribution pattern comparable to 
ectocervical squamous epithelium, with, the exception of keratin 17, which was only 
sporadically found in the basal layer of ectocervical epithelium and was always present 
in the basal cells of mature squamous metaplastic epithelium. During progression of 
cervical intraepithelial neoplasia a clear increase in the expression of keratin 17 was 
observed. However also keratins 5 and 14 were expressed. Our results demonstrate 
that a considerable number of premalignant lesions of the uterine cervix express the 
same keratins as found in the progenitor reserve cells. Lesions which lack expression of 
keratin 17 are suggested to form a distinct group, which are regressive in nature and do 
not progress into cervical cancer. 
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INTRODUCTION 
It is believed that reserve cells play a central role in the pathogenesis of cervical intra-
epithelial neoplasia/0 Considerable efforts have been undertaken in the study of the 
exact nature of these cells and the precise role they play in neoplastic transfor-
mation/2'45 One of the recent approaches that has been chosen is the characterization of 
cytoskeletal components, in particular keratins, in reserve cells and cervical intraepi-
thelial neoplastic (CIN) lesions/510)With chain specific monoclonal antibodies against 
various individual keratins, information concerning the keratin content of reserve cells 
and other cervical epithelial cells can be easily derived with immunocytochemical tech-
niques. By comparing the keratin distribution patterns in CIN with that in reserve 
cells, a possible link between the various stages of cervical carcinogensis can be 
studied. 
In previous publications(5'7,9'0)reserve cells were reported to contain keratins 5, 8, 17, 
18 and 19, with the prescence of keratin 13 in a subpopulation of these cells/' The 
presence of keratins 5 and 17 in reserve cells is based on gel electrophoretic studies. 
Endocervical columnar cells have been shown to contain keratins 7, 8, 18, 19 " , with 
variabile amounts of keratin 4. Keratin expression in mature squamous metaplasic 
epithelium and in ectocervical nonkeratinising, squamous epithelium is highly compa-
rable. Type II keratins 1, 2, 4, 5, 6 and 8 and type I keratins 10, 11,13, 14, 15, 16, 17 
and 19 have been detected with some variability in their expression. These data are 
partly based on one- and two- dimensional gel electrophoresis combined with immu-
noblotting and partly on immunocytochemical studies. 
Reserve cell proliferations can lead to immature squamous metaplasic epithelium, 
which can transform into mature squamous metaplasic epithelium on the one hand. 
On the other hand the reserve cell proliferation may be atypical and progress into 
intraepithelial neoplasia. Immature squamous metaplastic epithelium has been found 
to express keratins characteristic of simple epithelia, such as keratins 8, 18 and 19, as 
well as keratins found in ectocervical and mature squamous epithelium i.e., keratins 4, 
13 and 14.(57) 
Regarding the keratin expression in cervical intraepithelial neoplasias (CIN I , II and 
III) only little has been published. In a previous paper(5) we demonstrated that in a 
number of these lesions keratins characteristic of simple epithelia i.e. keratins 7, 8, 18, 
and 19 occurred in a scattered fashion, but in such a way that their presence was usual-
ly more pronounced in CIN III lesions than in CIN I and CIN II lesions. Further-
more, we found that with increased severity of CIN, keratins 4, 13, and 14 were less 
frequently detected, but again this change was most pronounced in CIN III. The kera-
tins were also not expressed in a uniform fashion in CIN lesions but were irregularly 
distributed, sometimes throughout the full thickness of the epithelium. 
Using a panel of newly developed antibodies that enable the separate immunohisto-
chemical detection of keratins 5, 14, and 17 at the single cell level, we were able to add 
new data to the present knowledge on keratin expression patterns in normal endocer-
vical and ectocervical epithelium. We also present new data regarding keratin expres-
sion patterns in CIN of various grades of severity. This newly derived information 
enhances our knowledge regarding the anology between normal cervical cells and pre-
neoplastic lesions and may be helpful in the diagnosis of CIN lesions and the discrimi-
nation between progressive and regressive lesions. 
MATERIALS AND METHODS 
Tissues 
The tissue specimens used in this study were taken from cervical cones removed in 40 
women in whom routine cytological examination had shown features consistent with 
dysplasia.' Before conization the lesions were visualized by applying a 4% solution of 
acetic acid to the whole cervix. Shortly after conization each cone was divided into 
equal quadrants, which were again subdivided into three equal parts perpendicular to 
the endoccrvical canal. The central part of these three was fixed in 4% buffered formal-
dehyde and further processed through paraffin for routine light microscopic diagnosis, 
made independently by three qualified pathologists. The other two parts were snap 
frozen in liquid nitrogen and stored at -70 G One part of each quadrant was used for 
the immunohistochemical assays. 
We used a total of approximately 100 tissue specimens representing normal cndocer-
vical and ectocervical epithelium, immature and mature squamous metaplasia and the 
three grades of CIN. Extra care was taken to select cases showing reserve cells and 
reserve cell hyperplasia. Furthermore, in the tissue fragments normal epithelia and or 
metaplastic as wel as dysplastic lesions were found in the same fragment. 40 cases con-
tained both ectocervical epithelium and cndocervical columnar epithelium. In 20 frag-
ments we found reserve cells, in 42 mature squamous metaplasia and in 11 immature 
squamous metaplasia. CIN I, CIN II and CIN III were diagnosed in 4, 6 and 16 cases, 
respectively. In cases of major discrepancies between the diagnoses of the three patho-
logists the case was excluded from the study. 
Antibodies 
Five monoclonal antibodies were used in this study, for comparative purposes the 
results with LL002 were taken from our previous paper.(5)The specificity of each of 
these reagents is described. 
1. LP34 is a broad spectrum antikeratin antibody reacting with most epithelia, both 
keratinizing and nonkeratinizing. It recognizes keratins 5, 6, and 18 and possibly 4, 
14 and 16 in immunoblots. 
2. AE14(l0)' specific for keratin 5, stains the basal cells of squamous and 
pseudostratified epithelia. Among others, it reacts with the basal cells in the 
endocervical canal, some myoepithelial cells, thymic reticulum cells, certain 
pancreatic duct cells, a variable subpopulation of mesothelial cells and basal cells in 
the epithelium of the respiratory tract. This antibody was a gift from Dr T. T. Sun. 
3. LLOOl (13)'specific for keratin 14, stains all stratified epithelia. Staining is most 
intense in the basal layer, but the parabasal and intermediate layers also react. The 
stratum granulosum and the stratum corneum remain negative. Outer root sheath 
cells of the hair follicle are positive, inner root sheath cells are negative. Sebaceous 
gland cells are all positive. Basal cells in complex epithelia, for example in sweat 
glands, mammary glands, salivary glands and the prostate gland are also positive. 
Figure 1. Characterization of the keratin antigen 
recognized by R CK 107. Two-dimensional immunoblots, 
containing a cytoskeJeton-preparation of'HaCaTcells, 
incubated with R CK 107 (a; recognizing keratin 14), 
LL002 (b; recognizing keratin 14), and subsequently with 
M20 (c; recognizing keratin 8). When the immunoblot in (c) 
was reincubated with RCK 107 no additional keratin spot 
appeared (d). Only the breakdown products of keratin 14 
also seen in (a;brackets) become apparent. Reincubation of 
the blot with antibody E3 (e; recognizing keratin 17) 
showed that this keratin subtype was present in the 
preparation, but not recognized by RCK 107. 
4. LL002 recognizes keratin 14, and was used in a 
previous study.(5)It has been used for comparative 
purposes. The staining pattern of this antibody is 
similar to that described above for LLOOl. The 
staining intensity is however stronger than found 
for LLOOl.(l3) 
5. Characterization of the monoclonal antibody 
RCK 107 was recently described.04'When tested 
on cultured cells containing keratins 1, 4, 5, 6, 7, 8, 
10, 11, 13, 14, 15, 16, 17, 18 and 19 a filamentous 
staining pattern was observed. Cell lines known to 
contain only keratins 7, 8, 18, and/or 17 and 19 did 
not react with RCK 107. In a series of human tis-
sues RCK 107 exhibited an exclusively epithelial 
reaction, where it preferentially stained the basal 
cell compartments and other epithelial compart-
ments described to contain keratins 5, 14 and/or 
15. Similar to what had been observed in the cell 
lines, tissues known to contain only keratins 7, 8, 
18, and/or 19 (for example liver, colon, kidney) 
were negative. Cross reactivity of RCK 107 with 
keratins 1,4, 10, 11, and 13 is unlikely because of 
the negative results in suprabasal cells in epider-
mis, esophagus as well as negativity in transitional 
epithelium of the urinary bladder. Finally, 
immunoblotling studies on cytoskelctal extracts 
prepared from A431 (epidermoid squamous cell 
carcinomas of the vulva) and HaCaT (human 
keratinocytcs; Dr N. Fusening, DKFZ Heidelberg 
Germany) cell 
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cultures, revealed a protein band with a molecular weight similar to the keratin 14 
band, also obtained after immunoblotting with LLOOl. Two dimensional immuno-
blots further substantiated the keratin 14 character of this protein (fig. 1) These 2D 
immunoblotting studies also clearly revealed that RCK 107 didnot crossreact with 
keratin 15 or 17 (fig. la, e). 
6. E3, specific for keratin 17 0 5 ) ' reacts with the basal row of pseudostratified epithe­
lium in the larynx, trachea and bronchi, It stains the basal cell layer of the transitio­
nal epithelium in the urinary bladder and the myoepithelial cells in several tissues 
including the salivary gland the sweat glands, the prostate gland and the intra- and 
extralobular zone in the breast. Furthermore, it stains duct epithelium of the 
pancreas and the outer root sheath of the hair follicle. 
Immunohistochemistry 
Cryostat sections were fixed in cold methanol (-20 C) for 5 minutes, rinsed in acetone 
and air dried. The slides were incubated with the appropriately diluted or undiluted 
monoclonal primary antibody for 45 minutes at room temperature. 
After three subsequent washing steps with phosphate buffered saline (PBS) the peroxi-
dase-conjugated rabbit-anti-mouse serum (DAKOpatts, Denmark) was applied to the 
sections for 30 minutes at room temperature. After a second series of washing steps 
with PBS peroxidase activity was detected with 4-amino-9-ethylcarbazole (AEC; 
AJdrich Chemical Сотр., St. Louis, MO) as described before. The slides were coun-
terstained with haematoxylin and mounted with Kaisers glycerin-gelatin (Boom 
B.V.Meppel, The Netherlands). 
RESULTS 
Figure 2 shows a schematic representation of keratin phenotypes of normal ecto- and 
endocervical epithelium, immature and mature squamous metaplastic epithelium and 
the three grades of CIN, as defined by the monoclonal antibodies. Distinct variations 
in the expression patterns of the various keratins will be described in detail below. 
In all sections we also carefully examined keratin expression in the subepithelial tissues 
of the cervix, as expression of keratins has been reported in smooth muscle cells of the 
endocervix.(l6) We found no reactions in the endocervical stroma and smooth muscle 
cells with the antibodies used in this study. 
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Figure 2. Schematic representation of the keratin distribution patterns as detected by tbe six 
difíerent monoclonal antibodies used. A completely Tilled bar indicates an intensly 
positive reaction in all cells. An open bar indicates that all cells are negative, while a 
small square indicates that only a few cells are positive. A partly idled bar means that 
only part of the cells in the respective layers are positive: a verticallydevided bar 
means that both positive and negative areas were seen, an obliquely divided bar 
means that tbe expression pattern differs in the individual layers, and a stippled bar 
means that a weakly positive reaction was observed. 
A bbre viations: К = keratin(s); S = superñcal cells; I=intermediate cells; 
В = basal cells; PB =parabasal cells; С = columnar cells; RC = reserve cells. 
Normal Ecto- and Endoccrvical Epithelium (fig. 2a,b and fig. 3) 
Ectocervical squamous epithelium showed a reproducible pattern of keratin expression 
in all cases investigated. 
LP34 stained the basal and parabasal epithelial layers moderately (fig. 3a), while in the 
intermediate layer the staining decreased in intensity toward the periphery. In the 
superfical layer only some dispersed cells were weakly stained. 
The antibody AE14 against keratin 5, moderately stained the basal cell compartment 
in most cases (fig. 3b). In the parabasal layer approximately 50% of the cells showed a 
reaction which varied from intense to moderate. The above lying cells showed no reac­
tion at all. 
The keratin 14 antibodies RCK 107 (fig. 3c) and LLOOl showed a similar staining 
pattern, both staining the basal layer with minor variation in staining intensity. Para­
basal cells expressed this keratin polypeptide in the majority of the specimens with 
moderate intensity. Above the parabasal layer only some dispersed cells showed a 
weak reactivity. The staining intensity of LLOOl was weaker than that of the pre­
viously described LL002. ( 5 ) 
The keratin 17 antibody E3, was practically negative in all cases (fig. 3d). However, in 
a few cases it weakly stained a few cells in the basal layer. 
Endocervical columnar cells displayed an intense staining reaction with LP34 in all 
cases (fig. 3e). Keratin 5, detected with AE14, was found in about 20% of the cases 
under investigation (fig. 30 but was only weakly positive. 
Columnar cells were usually negative with the antibodies directed against keratin 14. 
With LLOOl all columnar cells were negative (fig. 3g), while RCK 107 which was also 
usually negative, sometimes stained columnar cells weakly there were they lay above 
reserve cells. In about one third of the cases some keratin 17 posilivity was present in 
these columnar cells when the E3 antibody was used (fig. 3i). 
In many specimens groups of reserve cells were detected under the columnar cells 
lining the endocervical canal. These reserve cells reacted intensely with LP34 (fig. 3e). 
AE14 detected keratin 5 in reserve cells in about 60% of the cases under investigation. 
The staining varied, however, from intense to weakly positive (fig. 3f). Of the anti­
bodies directed against keratin 14, RCK 107 reacted with a moderate intensity with all 
riserve cells (fig. 3h). With the antibody E3, we observed keratin 17 in all reserve 
cells.the reaction usually being intense (fig. 3i). 
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Figure 3. ImwuDoperoxidase staining patterns oí'frozen sections from normal ectocervical 
squamous epithelium (a-d) and endocervical columnar epithelium with reserve cells 
(e-i)afterincubation with (a, e)LP34; (b, /)AE14: (c, h)RCK 107; (d, i)E3; and 
(g)LLOOL 
Immature Squamous Metaplasia (fig. 2d and fig. 4a-e) 
The expression pattern of immature squamous metaplasic epithelium was in part com-
parable to that observed in ectocervical epithelium and in mature squamous metaplas-
tic epithelium. The broad spectrum antibody LP34 (fig. 4a) reacted intensly with the 
basal part of this epithelium. The above lying layers also stained with LP34, although 
the number of positive cells tended to decrease towards the epithelial surface. Keratin 
5 was observed in about two thirds of the cases, with AE14 staining fairly intensely 
through the full thickness of the epithelium (fig. 4b) with the exception of most 
columnar cells. Of the keratin 14 antibodies LLOOl reacted practically with the full 
thickness of the epithelium with some variation in staining intensity (fig. 4c) in most 
tissue fragments. RCK 107 also stained about two thirds of the cases, being strongest 
in the basal part but also detectable in higher epithelial layers (fig. 4d). E3 detected 
keratin 17 through the full thickness of the epithelium with variable intensity (fig. 4e) 
in 10 cases. In those cases in which keratin 17 could be detected we also also found 
keratins 5 and 14. This means that in 70% of cases of immature squamous metaplasia 
keratins 5,14 and 17 were «»expressed. Five cases were negative for keratin 5 and 17, 
in 2 of these specimens however keratin 14 was detectable. 
Mature Squamous Metaplasia (fig. 2d and fig. 4f-j) 
Squamous epithelium cranial to the first endocervical invagination was defined as 
mature squamous metaplasia. Although the tissue fragments used were small, this 
transitional zone could usually be identifies. If there was any doubt, we used parallel 
paraffin sections, which had been taken for routine diagnosis. The keratin expression 
pattern in mature squamous epithelium demonstrated interesting differences when 
compared to the expression pattern in ectocervical epithelium. The broad spectrum 
antibody LP34 (fig. 4f) showed practically the same staining pattern in both types of 
epithelium with a more intense and more universal reaction in the intermediate and 
superfical layer of mature squamous metaplastic epithelium. Keratin 5, as detected by 
the AE14 antibody (fig. 4g), showed a similar expression pattern in both types of epi-
thelium. The intensity of the reaction was, however, stronger in ectocervical epithe-
lium. The keratin 14 antibody LLOOl (fig. 4h) stained virtually all cases of mature 
squamous metaplastic epithelium and ectocervical epithelium with reactivity decrea-
sing or diminishing towards the surface. The staining intensity in the ectocervical epi-
thelium was, however, less intense. The intermediate and superfical epithelial layers in 
mature squamous metaplasia usually showed some staining with LLOOl whereas in 
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Figure 4: Immunoperoxidase staining patterns of frozen sections with immature squamous 
metaplasia (a-e) andmature squamous metaplasia (f-j) after incubation with (a, 0 
LP34; (b, g)AE14; (c, h)LL002; (d, i)RCK 107; and(e,j)E3. 
ectocervical epithelium these layers were usually negative. RCK 107 (fig. 4i) showed a 
similar reaction in both epithelia. Antibody E3, detecting keratin 17 (fig. 4j) showed a 
moderate and somewhat variable staining intensity in the basal epithelial layer in all 
cases of mature squamous metaplasia. The reaction was less intense and was observed 
only in a quarter of the parabasal cells, while the above lying cells were negative. 
However, in the ectocervical epithelium sporadic basal cells were weakly stained. 
Cervical Intraepithelial Neoplasia I (CIN I; fig. 2e and fig. 5a-d) 
Keratin expression patterns in CIN I showed differences when compared to the proge-
nitor lesion i.e. immature squamous metaplasia. The broad spectrum antibody LP34 
(fig. 5a) stained the basal epithelial layer intensely, the parabasal and intermediate cell 
layers were less intensely stained with the superficial layer not staining at all. Staining 
resembled the staining pattern in immature squamous metaplasia. Keratin 5 (fig. 5b) 
was detected in the basal cell layer and sometimes a few above lying cells. The intensity 
of staining was moderate. LLOOl and RCK 107 (fig. 5c) both showed some dispersed 
positivity throughout the full thickness of the epithelium in one of the cases. The other 
cases were negative. These two antibodies showed a distictly diminished staining inten-
sity with also a decrease in the number of cells staining, when compared to immature 
squamous metaplasia. Keratin 17 antibody E3 was only mildly positive in the basal 
layer of one case, which also demonstrated full thickness positivity for keratin 14. The 
other cases were negative with this antibody (fig. 5d). 
Cervical Intraepithelial Neoplasia II (CIN II; fig. 2f and fig. 5e-h) 
Keratin expression in CIN II lesions is in part similar to that observed in CIN I lesi-
ons. The broadspectrum keratin antibody LP34 (fig. 5e) showed a similar reaction, al-
though the superfical layer shows some staining. Keratin 5 (fig. 5f) was found in all but 
one case, reactivity was intense throughout the full thickness of the epithelium decrea-
sing somewhat towards the superfical layer. Of the keratin 14 antibodies LLOOl, 
stained one third of the fragments in a dispersed and weak fashion, the superfical layer 
being negative. RCK 107 (fig. 5g) stained basal cells and above lying cells weakly, 
while the superfical cells were completely negative. One case was negative. Keratin 17 
(fig. 5h) weakly stained the basal and above lying cells in a single case, which was also 
positive for keratins 5 and 14. In all cases in which keratin 5 could be detected, keratin 
14 could also be found with one of the antibodies, which meant that in one case no 
keratin 5 and 14 could be demonstrated. 
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Figure 5: Immunoperoxidase staining of frozen sections from the cervix with CINI (a-d), CIN 
II(e-h)and CINIII(i-1) after incubation with (a, e, i)LP34; (b, f,j)RCK 107; (c, g, 
k) AE14; and (d, h, 1) E3. 
Cervical Intraepithelial Neoplasia ΙΠ (CIN III; fig. 2g and fig. 5i-l) 
Keratin expression in CIN III was in part similar to that in CIN I and CIN II lesions, 
and also showed similarities with the pattern in immature squamous metaplasia and in 
ectocervical epithelium. LP34 (fig. 5i) stained the lower two thirds of the epithelium 
with moderate intensity, while the upper one third was less intensly stained. Keratin 5 
(fig. 5j) was exclusively present in the lower two thirds of the epithelium, while the 
above lying cells were weakly positive and superfical cells did not react. The basal stai­
ning reaction showed some variation but was usually fairly intense. Of the keratin 14 
antibodies RCK 107 (fig. 5k) stained the lower two thirds of the epithelium with varia­
ble intensity, while LLOOl stained about half of the cases with mild intensity, in all 
except the superfical layers. E3 detecting keratin 17 (fig. 51) showed weak dispearsed 
single cell positivity throughout the full thickness of the epithelium in about half of the 
cases. 
DISCUSSION 
In this study we examined the specific distribution of keratins in epithelia lining the 
cervical canal i.e., in normal epithelia, reserve cells and reserve cell hyperplasia, imma­
ture and mature squamous metaplasia and CIN I, CIN II and CIN III lesions. This 
was done by using recently developed monoclonal antibodies, most of which specifi­
cally interacted with only one of the 20 known keratins. 
These monoclonal antibodies have been tested in extended series of normal tissues and 
malignant tumors and have to a large extent been shown to exhibit predictable reacti­
vity patterns. Not only do these antibodies allow differentiation between different 
types of epithelium, they also specifically stain certain compartments in complex epi­
thelia. We were especially interested in the keratin expression pattern in cervical 
reserve cells as these cells play a central role in the development of CIN lesions.0 Com­
paring the keratin expression patterns of reserve cells with those of metaplastic and 
dysplastic cervical epithelial cells will give us a more profound insight into the cell bio­
logical processes that determine normal and abnormal differentiation of these precur­
sor cells. In future this knowledge may serve as a diagnostic aid and indicate whether a 
reserve cell proliferation or CIN lesion will progress into a malignancy. 
Based on gel electrophoretic studies Weikel et al (6) suggested cervical reserve cells to 
contain keratins 5 and 17. In their study a reserve cell enriched cell fraction was used, 
which also contained other epithelial components. After monoclonal antibodies to 
keratins 5 and 17 recently became available we were able to test their hypothesis by 
means of immunohistochemical methods. Using the specfic antibodies AE14 (directed 
against keratin 5) and E3 (directed against keratin 17) we could confirm the gel elec­
trophoretic results, meaning that we were able to demonstrate keratin 5 at the single 
cell level in about two thirds of the reserve cells seen and keratin 17 in all reserve cells. 
Also Moll, Dhouailly and Sun (ID)in an immunohistochemical study recently demon­
strated keratin 5 in subcolumnar reserve cells. 
Since keratin 14 is generally coexpressed with keratin 5 in basal cells '3 it is surprizing 
that in both the gel electrophoretic studies of Weikel et al (6)as wel as our own previous 
study(5) keratin 14 could not be demonstrated in reserve cells. Having experienced epi­
tope masking as a common pitfall in the evaluation of keratin expression (S' '8' '9) we 
used the additional keratin 14 antibody LLOOl and our own recently developed kera­
tin 14 antibody RCK 107 in this study. This last reagent has recently been found to be 
exclusively reactive with keratin 14 which was concluded from immunoblotting studies 
and reactivity patterns of this antibody with human tissues and human cell lines. A 
possible crossreactivity with keratins 15 or 17 is very unlikely since these proteins were 
not detected in the immunoblots of cell extracts containing these cytoskeletal consti­
tuents. Moreover negative indirect immunofluorescence results with cell lines described 
to contain keratin 17 (for example Hela) or positive results in a cell line containing 
keratin 14 and 17 but not keratin 15 (TR 146) support this conclusion. Furthermore 
comparison of staining patterns of E3 and RCK 107 on frozen sections of human 
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spectra for both antibodies. With this antibody we could demonstrate this keratin type 
in reserve cells thus confirming recent results by Ivanyi et al20) Based on our findings 
the keratin profile for reserve cells comprizes the keratins 5,8, 14, 17, 18 and 19. We 
could not find keratin 13 expression as stated by Levy et al(,) We must also stress that 
only a subpopulation of reserve cells seem to contain keratin 5 contrary to what has 
been suggested by Weikel et al<6)The prominent differences in staining patterns 
between the different keratin 14 antibodies may have the following explanations. First, 
the different antibodies are directed against different epitopes. LL001 and LL002 were 
raised against the last carboxyterminal amino acids of human keratin 14 whereas 
RCK 107 was obtained after immunization with a total cytoskeletal preparation of 
T24 cells. From Figure 1, it is obvious that LL002 reacts with a broader spectrum of 
keratin 14 variants, whereas RCK 107 reacts stronger with several of the breakdown 
products of keratin 14. These different keratin 14 epitopes may be exposed differently 
under several conditions. Apparently the keratin 14 epitope recognized by RCK 107 is 
available for immunohistochemical detection in subcolumnar cells, whereas the car-
boxyterminus is probably masked under the conditions used in our studies. Finally dif-
ferent affinities of the antibodies for their respective epitopes may explain the variabili-
ty of our keratin 14 staining results. The keratin 14 antibodies may be ranked accor-
ding to staining intensity as follows: LL001 stains less intensely than RCK 107, which 
in turn stains less than LL002. Therefor if the amount or keratin 14 is low in a given 
cell, a negative reaction with LL001 may be due to its low affinity and therefore high 
threshold of sensitivity. Furthermore as observed in our previous study there was no 
expression of these basal cell keratins in the endocervical stroma, which once again is 
powerful proof that reserve cells do not originate in the endocervical stroma. This 
statement is further substantiated by recent observations of Wetzels et al (l4)'m which 
reserve cells are found above the basement membrane.(8) 
The staining pattern in endocervical columnar cells was surprizing in that these cells, in 
addition to the previously described prescence of keratins 7, 8, 18, 19, also expressed 
some keratin 5, 14 and 17 in a number of cells. This was usually observed in areas 
where columnar cells lay on top of reserve cells which supports the hypothesis that 
endocervical columnar cells develop from the underlying reserve cells. If so, reserve 
cells partly pass on their keratin profile during differentiation into columnar cells. As 
columnar cells mature keratins 5,14, and 17 are lost in part, which is accompanied by 
the initiation of keratin 7 expression/4 In the case of dediffcrentiation into an adeno-
carcinoma the tumor cells may maintain part of the keratin profile of the progenitor 
reserve cells, which may also be concluded from the observation by Czernobilsky et al 
who demonstrated keratin 17 in cervical adenocarcinomas by gel electrophoretic 
studies. 
Stratified ectocervical epithelium in gel electrophoretic studies was shown to contain 
keratins 5,6, 7,8, 13,14, 15, 16 ,17, 18, and 19.(11) Other studies(5I0) have proven the 
presence of keratins 4, 8, 10, 13, 14,and 19 at the single cell level using monoclonal 
antibodies. The present study demonstrates additionally keratin 5 and to a much lesser 
extent keratin 17 in the ectocervical epithelium. The observation that keratin 17 is only 
detected in a restricted number of cases explains why Troyanovsky et al (15)did not 
detect keratin 17 in ectocervical epithelium in their two cases. 
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Taking into account the keratin expression pattern in reserve cells it is not surprising 
to observe that keratins 5, 14, and 17 are co-expressed in 10 cases with immature squa-
mous metaplastic epithelium. This paper is the first report of the presence of keratins 5 
and 17 in this type of epithelium. The process of squamous metaplasia is a dynamic 
one, with reserve cell hyperplasia at one end of the spectrum and at the other end fully 
matured squamous epithelium. The presence of keratins 5, 14 and 17, and more parti-
cularly the fact that these cytoskeletal proteins show a random distribution throughout 
the cell layers rather than a specific compartimentalisation, indicates that their expres-
sion correlates closely to the stage of maturation of the squamous metaplastic 
epithelium. 
Only a limited number of studies on keratin expression in CIN lesions have been pu-
blished.(5,2l'22) In a previous study(5) we demonstrated that keratin expression patterns 
in CIN lesions could be compared to those of immature squamous metaplasia. Some 
keratins characteristic for simple epithelia and reserve cells, i.e. keratins 8,18, and 19 
were detected in a number of cases of CIN lesions in an irregular fashion. We also 
observed that the number of cells, the intensity of staining as well as the number of 
positive cases increased with progression of the lesion. This observation led us to the 
hypothesis that CIN lesions that express these markers of simple epithelia may pro-
gress into cervical cancer.*4 
This hypothesis is further supported by the present study which shows keratin 17 is 
sporadically found in the basal cell layer of epithelium with CIN I and CIN II lesions 
while it is present in a higher percentage of the CIN III lesions. We also noted that the 
staining intensity in CIN III had slightly increased when compared to CIN I and CIN 
II lesions and that in CIN III epithelium staining is often seen throughout the full 
thickness of the epithelium. We would like to stress that approximately 50% of the 
CIN III lesions contain keratin 17. Keratin 17 is present in reserve cells from which 
these lesions originated as wel as in immature squamous metaplasia. We, however, 
comment that in the tissue fragments with immature metaplasia there was frequently 
also a displastic lesion present. This may be indicative of the malignant potential of 
immature metaplasia. 
Since Czemobilsky et al " °' on the basis of gel electrophoretic studies, described kera-
tin 17 in all often cases of cervical squamous cell carcinoma we hypothesize that pro-
gression of CIN III to carcinoma is restricted to a subpopulation of keratin 17 positive 
CIN III lesions. Therefore studies are in progress to evaluate the keratin expression 
patterns of cervical carcinomas, using a panel of well-defined and chain-specific mono-
clonal keratin antibodies. 
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Chapter four 
Keratin Expression in Cervical Cancer 
Frank Smedts, Frans Ramaekers, Sergey Troyanovsky, 
Maciej Pruszczynski, Monique Link, Birgitte Lane, Irene Leigh, 
Charles Schijf and G. Peter Vooijs 
(American Journal of Pathology 1992, 141:497-511) 
ABSTRACT 
Using a panel of 21 monoclonal and 2 polyclonal keratin antibodies, capable of detec-
ting separately 11 subtypes of their epithelial intermediate filament proteins at the 
single cell level, we investigated keratin expression in 16 squamous cell carcinomas, 9 
adenocarcinomas and 3 adenosquamous carcinomas of the human uterine cervix. 
The keratin phenotype of the keratinizing squamous cell carcinoma was found to be 
most complex comprizing keratins 4, 5, 6, 8, 13, 14, 16, 17, 18, 19 and usually keratin 
10. The nonkeratinizing variety of the squamous cell carcinoma expressed keratins 6, 
14, 17 and 19 in all cases, usually 4, 5, 7, 8 and 18, and sometimes keratins 10, 13 and 
16. Adenocarcinomas displayed a less complex keratin expression pattern comprizing 
keratins 7, 8, 17, 18 and 19, while keratin 14 was often present and keratins 4, 5, 10 
and 13 were sporadically found in individual cells in a few cases. 
These keratin phenotypes may be useful in differential diagnostic considerations when 
distinguishing between keratinizing and nonkeratinizing carcinomas (using keratin 10, 
13 and 16 antibodies), and also in the distinction between nonkeratinizing carcinomas 
and poorly differentiated adenocarcinomas, which do not express keratins 5 and 6. 
Keratin 17 may also be useful in distinguishing carcinomas of the cervix from those of 
the colon and also from mesotheliomas. Furthermore the presence of keratin 17 in a 
CIN I, II or III lesion may indicate progressive potential while its absence could be 
indicative of a regressive behaviour. 
As most carcinomas express keratins 8,14, 17, 18 and 19 we propose that this expres-
sion patterns reflects the origin of cervical cancer from a common progenitor cell, i.e. 
the endocervical reserve cell which has been shown to express keratins 5, 8, 14, 17, 18 
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INTRODUCTION 
Based on biochemical and immunochemical studies a considerable volume of 
information has been derived concerning keratin expression in the normal uterine cer-
vix, in cervical intraepithelial neoplasia (CIN) and in cervical cancer. Not only have 
the prevalent keratins in each of these types of epithelium been characterized by gel 
electrophoresis, but the intraepithelial distribution pattern of many of these keratins 
has also been clarified immunohistochemically using polypeptide specific keratin anti-
bodies <3_6). The distibution of the keratins in the cervix can be summarized as follows 
(see fig. 1). 
Ectocervical epithelium (fig. la) has been shown to contain Type I keratins 13, 14, 
15, 16 and 19 with the sporadic expression of keratins 10, 11 and 17 and also Type II 
keratins 4, 5, 6 and 8 with sporadic expression of keratins 1 and 2.°"} 
Endocervical columnar cells (fig. lb) contain keratins 7, 8, 18 and 19 '" and varia-
ble amounts of keratin 4(3) In the direct vicinity of reserve cells small amounts of kera-
tins 5, 14 and 17 4 have sometimes been observed. 
Endocervical reserve cells (fig. lb) have been shown to contain keratins 5, 8, 14, 17, 
18 and 19.(3S) 
Immature squamous metaplastic epithelium (fig. lc) expresses keratins in relation 
to the level of its maturation. In the very immature forms, which are hardly distin-
guishable from reserve cell hyperplasia, considerable amounts of keratins 5, 8, 17 and 
18 are found. In the somewhat more mature forms of immature squamous metaplasia 
these simple keratins are expressed to a lesser extent and the expression of keratins 4, 
13 and 14 appears. Keratin 19 is found throughout the full thickness of this type of 
epithelium/ A6) 
Mature squamous metaplasic epithelium (fig. Id) expresses keratins in much the 
same way as observed in ectocervical nonkeratinizing squamous epithelium. Keratins 
5, 17 and 19 are invariably found in the basal layer of this epithelium. Keratin 14 is 
found in the basal, parabasal and intermediate epithelial layer with intensity of expres-
sion gradually diminishing towards the surface of the epithelium. In contrast keratin 4 
is detectable only sporadically in parabasal cells, with expression increasing in the 
intermediate and superfical epithelial layers. Keratin 13 is found throughout the full 
epithelial thickness except in the basal epithelial layer, which is usually not stained. 
Keratins 8 and 18 are sporadically detectable in basal cells.<3) There have been only a 
few reports on keratin expression in CIN I (fig. le), CIN II (fig. If) and CIN III 
(fig. lg).(3,4) The pattern of keratin expression in these lesions is reminiscent of keratin 
expression in reserve cells and in immature squamous metaplastic epithelium. In CIN I 
and CIN II keratins 4, 5, 13, 14 and 19 are usually found, although with somewhat 
erratic expression patterns. Keratins 8, 10, 17 and 18 are incidentally found, usually in 
the basal part of CIN I and CIN II lesions. 
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Figure 1 Schematic o verview of 
the keratin expression patterns m 
the various epitheha of the human 
uterine cervix under physiologic 
and pathologic conditions The 
keratins found in the different 
epithelial layers are represented by 
numbers on the right Numbers m 
brackets indicate that the keratin m 
question is only found m some cells 
and expression is usually weak In 
other cases the keratin indicated is 
found m the majority o f cells and 
expression is moderate to intense 
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In CIN III lesions a considerable change has taken place in keratin expression in com-
parison to CIN I and CIN II lesions. The keratins 5, 8, 14, 17, 18 and 19 found in 
reserve cells, are only irregularly present with variable staining intensity in many of the 
CIN III lesions. Keratins 4 and 13 are also found in CIN III although expression is 
usually less than in CIN I and II lesions. 
In the past we have hypothesized that CIN III lesions showing the keratin profile of 
reserve cells, may well be lesions which will progress into cervical cancer. We have also 
suggested that adenocarcinomas may originate from CIN III lesions. These supposi-
tions are based partly on gel electrophoresis studies which showed nonkeratinizing 
squamous cell carcinomas to contain keratins 5, 6, 7, 8, 13, 14,15, 17, 18 and 19. Kera-
tinizing carcinomas displayed a less complex keratin expression pattern, lacking kera-
tins 7, 8 and 18. Adenocarcinomas were found to contain keratins 7, 8, 18 and 19 and 
sometimes 17.(l,2) There are only a few studies in which cervical carcinomas have been 
investigated using specific keratin antibodies/7'81 In these studies squamous cell carci-
nomas were shown to invariably express keratins 8, 14, 18 and 19 and sometimes kera-
tins 4, 10 and 13. In adenocarcinomas keratins 8, 18 and 19 were found and in some 
cases also keratin 4. 
Using a large panel of monoclonal antibodies, allowing the separate detection of kera-
tins 1, 4, 5, 6, 7, 8, 10, 13, 14, 16, 17, 18 and 19 at the single cell level, we investigated 
the expression of these keratins in a large number of squamous cell carcinomas and 
adenocarcinomas of the cervix. The data support previous speculation regarding the 
relationship between reserve cells, immature squamous metaplasia and CIN lesions on 
the one hand and cervical cancer on the other hand. Furthermore specific keratin 
expression patterns may be indicators of the propensity of lesions to regress or to 
progress. 
MATERIALS AND METHODS 
Tissues 
The tissue specimens used in this study were taken from hysterectomies or biopsies 
performed because of carcinomas of the uterine cervix. The ages of the patients varied 
between 30 and 65 years. The tissues were brought to the pathology department imme-
diately after removal where small representative samples from the tumor were removed 
and snap frozen in liquid nitrogen or liquid nitrogen cooled isopentane and stored in 
liquid nitrogen. The rest of the specimen was routinely fixed in formalin and further 
processed through paraffin for light microscopic diagnosis. In total 28 specimens 
representing 16 squamous cell carcinomas, 9 adenocarcinomas and 3 adenosquamous 
carcinomas of the cervix were analyzed. 
The tumors were classified according to the World Health Organization (WHO) classi-
fication.010 Squamous cell carcinomas were subdivided into 5 cases of keratinizing and 
11 cases of nonkeratinizing squamous cell carcinomas. Also neoplasms with a glandu-
lar component were classified according to the WHO classification m into adenocarci-
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nomas of endocervical type, 5 specimens, subdivided into 3 moderately 2 poorly diffe-
rentiated carcinomas, 4 endometriod adenocarcinomas of which one well, two mode-
rately and one poorly differentiated and 3 adenosquamous carcinomas. In all cases the 
slides were diagnosed independently by 3 pathologists. 
Antibodies 
Twenty-three monoclonal keratin antibodies were used in this study. Their characteris-
tics are summarized in Table 1 and described in the references 3, 4, 10-24. 
Tabic 1. Overview of the antibodies used in this study 
Antibody 
AF87 
6B10 
AE14 
RCK102 
KA12 
AFI 24 
ROCÍOS 
M20 
CAM5.2 
LE41 
RKSE60 
2D7 
1C7 
LLOOl 
LL002 
RCK107 
LL025 
E3 
RGE53 
RCK106 
га 
LP2K 
RCK108 
Ig subtype 
polyclonal 
IgGl 
IgGl 
polyclonal 
IgGl 
IgGl 
IgG2a 
IgGl 
IgG2a 
IgG2a 
IgG2b 
IgG2a 
IgG3 
IgGl 
IgG2b 
IgGl 
IgGl 
IgGl 
IgG2b 
IgGl 
Keratin(s) 
recognized 
1 
4 
5 
5 and 8 
5 and 6 
6 
7 
8 
8 
8 
10 
13 
13 
14 
14 
14 
16 
17 
18 
18 
18 
19 
19 
Species 
Rabbit 
Mouse 
Mouse 
Mouse 
Rabbit 
Mouse 
Mouse 
Mouse 
Mouse 
Mouse 
Mouse 
Mouse 
Mouse 
Mouse 
Mouse 
Mouse 
Mouse 
Mouse 
Mouse 
Mouse 
Mouse 
Mouse 
Mouse 
Ref 
10 
11 
12 
13 
14 
10 
13 
IS 
3 
16 
17 
11 
11 
18 
18,19 
4,14 
-
20 
21,22 
13 
23 
24 
-
Source 
D. Roop, Bethesda, MD 
G. van Muijen, Nijmegen, NL 
T.T.Sun, New York. NY 
F. Ramaekers, Maastricht, NL 
R. Nagle, Tuscon. AZ 
D. Roop, Bethesda. MD 
F. Ramaekers, Maastricht, NL 
G. van Muijen, Nijmegen, NL 
Bccton & Dickinson, Ellen-Leur, NL 
E. Lane, Dundee, UK 
F. Ramaekers, Maastricht, NL 
G. van Muijen, Nijmegen, NL 
G. van Muijen, Nijmegen, NL 
E. Lane, Dundee, UK 
E. Lane, Dundee, UK 
F. Ramaekers, Maastricht, NL 
E. Une, Dundee, UK 
S. Troyanovsky, Moscow, USSR 
F. Ramaekers, Maastricht, NL 
F. Ramaekers, Maastricht, NL 
G. van Muijen, Nijmegen, NL 
E. Lane, Dundee, UK 
F. Ramaekers, Maastricht, NL 
Immunohistochemistry 
Cryostat sections were fixed in acetone at room temperature for 10 minutes and air 
dried. The slides were incubated with the appropriately diluted or undiluted primary 
antibody for 60 minutes at room temperature. After three subsequent washing steps 
with phosphate buffered saline (PBS) the peroxidase-conjugated rabbit-anti-mouse or 
swine-anti-rabbit serum (DAKOpatts, Glostrup, Denmark) was applied to the sections 
for 30 minutes at room temperature. After a second series of washing steps with PBS, 
peroxidase activity was detected with 4-amino-9-ethylcarbazole (AEC; Aldrich 
Chemical Сотр., St. Louis, MO) as described before.(3) The slides were counterstained 
with Harris haematoxylin and mounted with Kaisers glycerin-gelatin (Boom BV. 
Meppel, The Netherlands). 
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RESULTS 
General Considerations Concerning Immunohistochcmistry 
Before describing the staining patterns of the individual antibodies some general state-
ments must be made. Although the staining intensity with each of the antibodies was 
variable within each tumor. We frequently observed a consistent pattern of compart-
mentalization of antibody expression to well defined parts of the tumor islands. In 
general, in squamous cell carcinomas the following compartments could be defined: a) 
a basal cell compartment which consisted of the layer of cells directly adjacent to the 
tumor stroma and at most two above lying cell layers. Morphologically these cells 
showed basaloid features with relatively large nuclei and scant cytoplasm, b) Above 
this layer a second intermediate compartment, approximately three to four cells thick 
could be distinguished. The cells in this compartment were generally somewhat larger 
with more cytoplasm. There was some resemblance to the intermediate layer of mature 
squamous metaplastic epithelium or ectocervical epithelium, c) Above this layer there 
was a third layer comprizing more mature squamous cells that demonstrated varying 
degrees of maturation and sometimes keratinization. A second feature worth mentio-
ning is the variability of staining intensity between antibodies recognizing the same 
keratin. As it is a well known fact that epitope masking may explain apparently nega-
tive results several antibodies recognizing the same keratin were used. For reasons of 
clarity we will only describe the most salient features of our staining results. Table 2 
shows the reaction pattern of the most strongly reacting antibody in cases where more 
than one reagent was used for the same keratin subtype. For reasons mentioned above 
some antibody reaction patterns do however need further specification. We also refer 
to figures 2-6 as illustrations of the various staining patterns. 
Keratinizing Squamous Cell Carcinomas (Table 2, Figures 2) 
In all keratinizing squamous cell carcinomas keratins 4, 5, 6, 8, 13, 14, 16, 18 and 19 
were detectable with the respective monoclonal antibodies. In 4 cases, also keratin 10 
and in 2 cases keratin 7 could be detected. The antibody against keratin 1, was negati-
ve in all 5 specimens (fig. 2a). The keratin 4 antibody (fig. 2b) displayed a variable stai-
ning intensity in all cases. Part of the central compartment of the tumor always stained 
intensly. Staining in other compartments was variable, the basal layer often being 
negative. Keratin 8 detectable with the antibodies M20, CAM 5.2 and LE41 showed 
considerable variations in staining intensity. CAM 5.2 (fig. 2h) stained all cases, 
showing areas staining with moderate intensity, alternating with negative areas. Fur-
thermore, there was some compartmentalization of staining, with one case showing 
stronger expression in the basal layer and other fragments giving a more intense stai-
ning reaction in the inner cell compartment. The M20 (fig. 2i) antibody displayed posi-
tivity in all but one case, the staining pattern in the positive cases being much the same 
as CAM 5.2, although staining was sometimes more intense with M20. 
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LE 41 was completely negative in 2 cases and in 3 cases there was some positivity 
restricted to the inner most cell compartment. Keratin 10, a marker for keratinization 
(fig. 2j) was found in dispersed cells in the intermediate and inner most cell compart-
ments. The basal cell compartment was only partly positive for keratin 13 (fig. 2k) and 
the intensity was less than in the more central compartments. Of the 3 antibodies that 
are monospecific for keratin 14 (LLOOl, LL002 and RCK 107), RCK 107 (fig. 21) 
showed the most intense staining. The inner most cell compartment was usually negati-
ve with occasionally a few dispersed weakly staining cells. LLOOl and LL002 were 
both completely negative in one case, the other 4 cases in general showing positivity in 
the basal cell compartment, which tended to decrease toward the inner cell compart-
ment. Keratin 16 (fig. 2m) could be found in all cases, although only a minority of cells 
reacted in the intermediate and central cell compartments. E3 (fig. 2n) which detects 
keratin 17 decorated with weak to moderate intensity most of the cells in the basal cell 
compartment. In the intermediate cell compartment and the inner cell compartment 
only a few dispersed cells stained. Three antibodies against keratin 18 were used i.e. 
RGE 53, RCK 106 and 2C8. Of these the RCK 106 antibody (fig. 2o) was the stron-
gest and stained a minority of cells in all 5 tumors with most of these cells located in 
the basal cell compartment. Virtually all cells in the intermediate and inner cell 
compartments were negative. 
Large Cell Nonkeratinizing Carcinoma (Table 2, Figure 3) 
In the 11 large cell nonkeratinizing carcinomas keratins 6, 14, 17 and 19 were detecta-
ble. In 10 specimens keratin 18 was detectable, while in 9 cases keratins 5, 7 and 8 were 
also expressed. In 8 neoplasms keratin 4 and in 7 cases keratin 13 were also found. In 6 
carcinomas keratin 10 was detected, while 5 tumors showed keratin 16 along with the 
afore mentioned keratins. Keratin 1 was not found in any of these specimens. 
Keratin 7 was restricted to the basal cell compartment in 8 cases (fig. 3f). The three 
keratin 8 antibodies M20, CAM 5.2 and LE 41 showed different staining patterns. 
CAM 5.2 stained 10 specimens, of which 5 cases were completely positive (fig. 3g) with 
varying intensity. Of the other 5 cases, 2 displayed reactivity in 1-2% of cells. In the re-
maining 3 specimens varying numbers of cells stained for CAM 5.2 with variable in-
tensity. M20 decorated 9 specimens. In 4 of them all cells stained, with variable inten-
sity. 
The remaining 5 neoplasms showed intense positivity of most of the cells in the basal 
cell layer. In three of these cases, cells in the intermediate and inner cell compartments 
also stained, with weak intensity. Seven specimens were weakly positive with LE41 
(fig. 3h). In general the staining intensity of CAM 5.2 and M20 was comparable, how-
ever the reactivity of LE41 was significantly less. Also LLOOl, LL002 and RCK 107, 
which detect keratin 14, showed a variable staining pattern. RCK 107 (fig. 3k) was 
positive in all cases with the majority of the cells in the basal cell compartment usually 
staining intensly. Cells in the other two compartments were also sometimes 
Figure 2. Immunoperoxidase staining pattern of frozen sections from keratinizing squamous 
cell carcinomas after incubation with (a) A F87 (keratin 1), (b) 6B10 (keratin 4), (c) 
AE14(keratin 5), (d)RCK102 (keratins5+8), (e)KAl2 (keratins 6+5), (QAF124 
(keratin 6), (g)RCK105(keratin 7), (h) CAM52(keratin 8), (t)M20(keratin 8), (j) 
RKSE60 (keratin 10), (k) 1C7 (keratin 13), (1)RCK 107 (keratin 14), (m) LL025 
(keratin 16), (n)E3(keratin 17), (o)RCK106(keratin 18), (p)RCK108(keratin 19) 
Original magnification a,c,d,f,i,k,o,p x250, bj,n x300, e,g,l, x400, b,m x500 
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Figure 3. Immunoperoxidase staining pattern of frozen sections from large cell nonkeratmi-
zing squamous celi'carcinomas after incubation with (a) 6B10 (keratin 4), (b)AE14 
(keratin 5), (c)RCK!02 (keratins5+8), (d)KA12 (keratins5+6), (e) A F124 (keratin 
6), (ORCK105 (keratin 7), (g) CAM52 (keratin 8), (h)LE41 (keratin 8), (i)RKSE10 
(keratin 10), (]) 1C7keratin 13, (k)RCK107(keratin 14), (1)LL025(keratin 16), (m) 
E3 (keratin 17), (n)RCK106(keratin 18), (o)RGE53 (keratin 18), (p)RCK108 
(keratin 19) Originalmagmifícation b,c,fj,k,lx250, ехЗОО, d,g,h,i,m-px400, a x500 
positive. LL002 was positive in 9 cases, with obvious compartmentalization of the 
staining reaction mainly restricted to the basal cell compartment. LLOOl showed 
moderate positivity in 8 carcinomas and staining was mainly restricted to the basal 
compartment with dispersed weak positivity in the other compartments. Of the three 
antibodies RCK 107 reacted the strongest and LLOOl the weakest. In most of the 
cases the majority of the cells in the basal cell compartment stained intensly with RCK 
106 (fig. 3n), while in the other compartments considerably less cells stained for keratin 
18. 2C8 was the least reactive of the 3 keratin 18 antibodies as only 4 cases showed 
weak positivity with this reagent in dispersed cells 
Endocervical Adenocarcinomas (Table 2, Figure 4) 
In all moderately differentiated adenocarcinomas keratins 7, 8, 14, 17, 18 and 19 were 
detected. In 2 cases we also found keratin 6 and keratin 4 (fig. 4a). Keratins 1,10, (fig. 
4i) 13 and 16 were not detectable in any of the specimens. 
Keratin 5 was negative in 2 carcinomas, while in one specimen a few dispersed cells 
stained very weakly (fig. 4b). The keratin 8 antibodies M20 and CAM 5.2 decorated all 
cells in the 3 specimens. M20 (fig. 4g) stained the cells most intensly, with the CAM 5.2 
antibody the staining intensity displayed some variations. The third keratin 8 antibody 
LE41 (fig. 4h) stained the cells weakly and in one case there were dispersed cells that 
did not stain at all. The keratin 14 antibodies LLOOl and LL002 did not stain any of 
the tumors, the third keratin 14 antibody, RCK 107 displayed positivity in all three 
cases (fig. 4j). Keratin 18 was expressed in all cases where RGE 53 and RCK 106 (fig. 
41) stained all cells intensly with only minor variations in staining intensity for the 
RGE 53 antibody. The 2C8 antibody only weakly stained a minority of cells in each 
specimen. 
In the 2 poorly differentiated adenocarcinomas keratin expression was very much the 
same as in the moderately differentiated adenocarcinomas, with the difference that 
keratin 14 was only expressed in 1 tumor and keratin 4 was not detectable at all. In 
both poorly differentiated adenocarcinomas keratin 6, 7, 8, 17, 18 and 19 were detec-
table and in one case also keratin 14. Keratins 1,4, 5, 10, 13 and 16 were not detected 
in these carcinomas. 
Endometrioid Carcinoma (Table 2, Figure 5) 
In 4 specimens an endometrioid carcinoma was diagnosed. One tumor was classified as 
a grade I, 2 as grade II and 1 as grade III. The keratin expression in these carcinomas 
showed differences as compared to endocervical carcinoma. The grade I endometrioid 
carcinoma expressed keratins 4, 6, 7, 8,14, 17, 18 and 19, while keratins 1, 10, 13 and 
16 were not found. The 2 grade II carcinomas both expressed keratin 6, 7, 8, 14, 17, 18 
and 19, one additionally expressed the keratins 4, 10, 13 and 16. The grade III carcino-
ma expressed keratins 4, 5, 6, 7, 8, 10, 13, 14, 17, 18 and 19, while keratins 1 
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Figure 4. Immunoperoxidase staining patterns of moderately differentia ted endocervicaJ 
adencaremomas (a-m) and poorly differentiated endocervical adenocarcinomas (n-p) 
after staining with (a) 6B10 (keratin 4), (b)AE14 (keratin 5), (c)RCK102 (keratin 
5+8), (d)KA12 (keratin 5+6), (e,n) AFI24 (keratin 6), (f)R CK 105 (keratin 7), (g) 
M20(keratin 8), (h)LE41 (keratin 8), (ι)RKSE60(keratin 10), (], o)RCK 107 
(keratin 14), (k)E'3 (keratin 17), (l)RCK 106(keratin 18), (m)RCK108 (keratin 18), 
(p)2C8(keratin 18) Originalmagimfication η,ο,ρ x400. a-d,f-i,k,l,mx500, ejx600 
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Figure 5. Immunoperoxidase staining patterns of endometrioid adenocarcinomas of the 
cervix, grade I (c, e,J, 1-n, p), grade II (a, d, f) and grade III(b, g-h, к, o) after 
staining with: (a) 6B10 (keratin 4), (b)AE14 (keratin 5), (c)RCKW2 (keratin 5+8), 
(d)KA12(keratin 5+6), (e)AF124(keratin 6), (f,g)RCK105 (keratin 7), (h)M20 
(keratinS), (i) RKSE60 (keratin 10), (j)RCK107(keratin 14), (k, 1)E3(keratin 17), 
(m)RCK106(keratin 18), (n)2C8(keratin 18), (o, p)RCK 108 (keratin 19). Original 
magnification ij,kx400; a-e,g,b,l-p x500; fx600. 
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and 16 were not expressed. RCK 107 detecting keratin 14 was present in all specimens 
(fig. 5j) with a minority of cells staining intensly. The other 2 keratin 14 antibodies 
LLOOl and LL002 both stained a minority of cells intensly in the grade III carcino-
ma. The other three carcinomas were negative. 
Adenosquamous Carcinoma (Table 2, Figures 6) 
The 3 adenosquamous carcinomas showed a somewhat different keratin expression 
pattern when compared to the previously described tumors. All carcinomas expressed 
keratins 5, 6, 14, 17, 18 and 19 while in 2 carcinomas keratins 4, 7 and 8 were additio-
nally expressed and in one case also keratins 10 and 13. Keratins 1 and 16 were not 
detected in these tumors. 
DISCUSSION 
Keratin epitope detection and antibody affinity 
In this study the presence of keratins in 28 carcinomas of the cervix was investigated 
using an extended panel of 23 antibodies capable of separately detecting 13 individual 
keratin subtypes at the single cell level. The use of more than one keratin antibody 
directed against the same keratin protein allowed us to detect structural alterations in 
keratin filament organization probably resulting from epitope alterations due to bio-
logic behaviour during neoplastic transformation. This phenomenon commonly refer-
red to as epitope masking, was frequently observed. For example keratin 8 could be 
detected by 3 different antibodies, of which the M20 antibody reacted with more cells 
than CAM 5.2 in all carcinomas while also the intensity of staining was somewhat 
higher. The 2C8 antibody reacted with less intensity. When comparing the two keratin 
13 antibodies this effect was observed only once and the staining patterns of both anti-
bodies was usually the same. Keratin 14 was monitored by 3 antibodies which showed 
considerable variations in their staining patterns. RCK 107 stained varying numbers of 
cells in all tumors intensly, while LLOOl and LL002 were less reactive, LLOOl 
stained less tumors and the staining intensity was also considerably lower than found 
for the 2 aforementioned keratin 14 antibodies. An effect much like this was observed 
with the keratin 18 antibodies of which the antibody RCK 106 was most reactive, stai-
ning cells in practically every carcinoma, RGE 53 was slighly less reactive than RCK 
106 and 2C8 was least reactive with only a minority of cells staining weakly. The two 
keratin 19 antibodies gave similar results. 
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Figure 6. Immunoperoxidase staining patterns ofadenosquamous carcinomas of the cervix 
after staining with: (a) 6B10 (keratin 4), (b)AE14 (keratin 5), (c)RCK102 (keratin 
5+8), (d)KA 12 (keratin 5+6), (e)AF124 (keratin 6), (f)RCK105 (keratin 7), (g+h) 
M20 (keratin 8), (i)RKSE60 (keratin 10), (j) 2D7 (keratin 13), (k)RCK 107 (keratin 
14), (1)LL025 (keratin 16), (m) E3 (keratin 17), (n)RCK 106 (keratin 18), (o) 
RGE53 (keratin 18), (p)RCK108 (keratin 19). Originalmagnification a-h x250; 
ij,m-p x400; k,l x500. 
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Keratin composition of cervical carcinomas 
Squamous cell carcinoma 
Based on the underlying study the keratins common to all squamous cell carcinomas 
included nrs. 6,14,17,18 and 19, In all keratinizing carcinomas keratins 4, 5, 8,13 and 
16 were additionally found. These keratins were only detected in a subfraction of the 
nonkeratinizing carcinomas. This indicates that the keratin expression pattern of kera­
tinizing cervical cancer is most complex of the two subtypes, especially if we consider 
the fact that in 4 of the 5 keratinizing carcinomas wc also found keratin 10 which was 
only detectable in half of the nonkeratinizing carcinomas in which it was usually 
expressed to a lesser degree. These results complement and partially contradict 
previous reports. For example in gelectrophoretic studies Czemobilsky et al ' and 
Moll et al showed that the keratin content of nonkeratinizing carcinomas was the 
most, complex, comprising keratins 5, 6, 7, 8, 13, 14, 15, 16, 17, 18 and 19 while in 
keratinizing cervical carcinomas keratins 5, 6, 13, 14,16,17 and 19 were found. Our 
study additionally demonstrates the presence of keratins 4,8, and 18 in all keratinizing 
carcinomas, the frequent presence of keratin 10 and sometimes keratin 7. To the kera­
tin content of nonkeratinizing carcinomas known to date we may add the presence of 
keratins 4 and 10 which were found in a number of cases. Our interpretation of the 
expression of simple keratins 7,8 and 18 will be discussed below. The fact that the pre­
sent immunohistochemical techniques using specific antibodies are capable of detec­
ting individual keratins at the single cell level explains the discrepancy between our 
recent data and those of others.0- ' The immunohistochemical study of Ivanyi et al(β> 
also demonstrates the presence of keratins 4 and 10 in nonkeratinizing carcinomas. 
Apparently a number of the nonkeratinizing carcinomas have a keratin expression 
phenotype normally observed in keratinizing squamous cell cancers, although there 
are no histological signs of cornification. We consider these to be examples of cancers 
which on the basis of purely morphological criteria would be classified as nonkeratini­
zing, on the basis of their keratin expression patterns however they should be classified 
as being of the keratinizing variety. The implications of this statement are far reaching 
as this means that these carcinomas could have a worse prognosis than the true 
nonkeratinizing variety. 
The fact that all keratinizing carcinomas usually display a more complex keratin 
expression pattern than all nonkeratinizing carcinomas is not surprizing as expression 
of keratins 4, 10 and 13 accompanies squamous cell differentiation and keratinization. 
Adenocarcinoma 
In the moderately as well as in the poorly differentiated endocervical adenocarcinomas 
keratins 7, 8,17, 18 and 19 were expressed in all cases. In 2 cases keratins 4 and 14 
were found in a minority of cells. 
The endometrioid adenocarcinomas of the endocervix showed an expression pattern 
that was similar to that of the previously descibed adenocarcinomas, but all cases con­
tained a minor fraction of cells expressing keratin 14. Czemobilsky et al ( l ) and Moll et 
95 
al only report the presence of keratins 7, 8,17,18 and 19 in cervical adenocarcino­
mas on the basis of their gel electrophoretic studies but failed to detect keratins 4, 6, 10 
and 13 which we find sporadically expressed in this type of malignancy. More striking 
however, is the fact that neither these authors nor Yvani et a l № found keratin 14, 
which we detected in most cases of cervical adenocarcinoma. 
Adenosquamous carcinoma 
Based on the previously described keratin expression patterns in cervical cancer, we 
expected the keratin expression pattern of adenosquamous carcinomas to be complex. 
To our surprize in these carcinomas the overal pattern was less complex than expected 
with keratins 14, 17, 18 and 19 common to all, while two specimens additionally 
expressed keratins 4, 7 and 8. The keratins characteristic of squamous differentiation 
i.e. 10, 13 and 16 were oddly enough only found in one out of three adenosquamous 
carcinomas. 
Consensus keratin phenotypes 
As may be evident from the foregoing the keratin composition of cervical carcinomas 
is particularly complex with up to 12 different keratins being coexpressed in the same 
tumor. In an attempt to simplify the high degree of complexity we propose the defini­
tion of a "consensus keratin phenotype" for a given tumor type. This consensus will 
solely describe the most frequent keratin composition found in a specific tumor type 
(see fig. 7). This idealized description will only in part match the determined keratin 
profile of an individual tumor. In this study we were able to identify differences 
between distinct carcinoma groups. Thus, the most differentiated cervical tumors of 
the keratinizing squamous cell type exhibit the most stable keratin phenotype. The 5 
tumors in our study varied only slightly from the consensus phenotype i.e. positive for 
keratins 4, 5, 6, 8, 10 13, 14, 16, 17, 18,19 and mostly negative for keratin 7. The deter­
mination of the consensus for nonkeratinizing squamous cell carcinomas is somewhat 
more difficult. The most obvious difference from the first group is the presence of 
keratin 7 in most cases. As discussed before the keratins 10, 13 and 16 were only detec­
ted in about 50% of tumors. The phenotype of cervical adenocarcinomas is again 
rather uniform i.e. positive for keratins 7, 8, 14, 17, 18, 19. The most frequent diffe­
rence from the first two groups is the absence of keratin 5. Some doubt still remains 
concerning the expression of keratin 6 in these tumors because of the generally weak 
reactivity. In addition there are significant differences in the probability of deviation 
from the "consensus" phenotype for individual cytokeratins. We may divide these 
nonobligatory keratins into two groups - highly varible keratins and unusual ones. 
Thus, the high variability in the detection of keratins 10, 13 and 16 in nonkeratinized 
squamous carcinomas may be caused by difference in tumor origin, level of differentia­
tion or by inaccuracies in the pathological diagnosis. The same reasons may be respon­
sible for unusual keratin expression patterns, for example, expression of keratins 4 and 
5 in one adenocarcinoma (case 18). 
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Figure 7. Schematic representation of the "consensus keratin phenotypes " of the different 
cervica1carcinomas. These are represented as the probablility of expression of a 
single keratin in a each of the subgroups of carcinomas. A completely Filled box 
means the probability of expression o f a particular keratin is between 75% and 100%. 
A batched box denotes a probability of expression between SO and 75%. A box 
containing dots represents probability of expression between 25 and 50%. An open 
box represents a probabi/ty of expression between О and 25%. Abbreviations: 
KSQ=keratininng squamous cell carcinoma of the cervix; NKSQ=nonkeratinizing 
squamous cell carcinoma of the cervix; AC=adenocarcinoma of the cervix; 
ASQ=adenosquamous carcinoma of the cervix. 
Reserve cell keratias occur in cervix carcinomas 
The information we have amassed in this study with regards to keratin expression in 
cervical carcinoma allows the following hypothesis on the etiology of cancer in the 
uterine cervix and also allows a firmer basis to previous speculation regarding which 
CIN lesions are progressive and which are regressive. From the literature it is 
known that the progenitor cell of the majority of squamous cell carcinomas of the 
cervix is the subcolumnar reserve cell. From these cells a squamous cell carcinoma may 
develop via squamous metaplastic transformation going through progressive intraepi­
thelial dedifferentiation. Adenocarcinomas of the cervix are thought to develop from 
the columnar cells lining the endocervical canal through grades of of atypia, ultimately 
developing into cervical adenocarcinoma. The keratin expression pattern we have des­
cribed above however does not support this theory. As a matter of fact the keratin ex­
pression pattern of adenocarcinomas of the cervix is more reminescent of the keratin 
expression pattern of reserve cells which contain keratins 5,8, 14, 17, 18 and 19. In 
squamous cell carcinomas these keratins were also found. On the basis of these fin­
dings we suggest that both adenocarcinomas and squamous carcinomas of the cervix 
develop from a common progenitor cell, namely the reserve cell. This also explains the 
persistence of simple keratins i.e. keratins 8, 17 and 18 in squamous cell carcinomas. 
In a recent publication Dallenbach-Hellweg et a l p 6 ) state that keratin 8 is found in the 
reserve cell type of squamous cell carcinoma of the cervix and not in the squamous cell 
type. We found significant expression of keratin 8 in both keratinizing and nonkera-
tinizing squamous cell carcinoma of the cervix, as well expression of keratins 5, 14, 18 
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and 19. We therefore consider the more comprehensive theory regarding the origin of 
both squamous and adenocarcinomatous cervical cancer to be the subcolumnar 
reserve cells as the most likely explanation on the basis of cell biology. 
Application of keratin antibodies in cervical carcinoma diagnosis 
Keratinizing versus nonkeratininzing squamous cell carcinoma 
The exact classification of a squamous cell carcinoma into the keratinizing or non-
keratinizing subtype may be rather difficult, since comified cells that mark the distic-
tion between these two subtypes may be difficult to detect. When keratin pearls are not 
found a squamous cell carcinoma will usually be subclassified as being of the non-
keratinizing variety which, according to some authors is expected to have a better 
prognosis/ ) Immunohistochemical methods may be of considerable help to differenti-
ate between these two subtypes. Keratinizing squamous cell carcinomas contain kera-
tins 13 and 16, and usually keratin 10, which are found considerably less frequently in 
the nonkeratinizing variety. We proprose that on the basis of the presence of these 
keratins a cervical carcinoma should be classified as keratinizing. Antibodies RKSE60, 
1C7, 2D7 and LL025 may become important tools for this differential diagnosis. This 
means that considerably more squamous cell carcinomas will be classified as keratini-
zing than is presently the case. Whether or not the tumors expressing keratin 10, 13 
and 16 but without morphologic signs of evident comification will have a poorer prog-
nosis than the subtype in which keratins 10, 13 and 16 are not should be the subject of 
future research. 
Squamous cell carcinoma versus adenocarcinoma 
A panel of keratin antibodies may also allow distinction between poorly differentiated 
squamous cell carcinomas and poorly differentiated adenocarcinomas. The presence of 
keratin 5 is very unusual in an adenocarcinoma and when present, it is only detectable 
in a few scattered cells. On the other hand it is found in most nonkeratinizing and all 
keratinizing squamous cell carcinomas of the cervix. Also keratin 6 may serve as a dis-
criminator since it is present in all squamous cell carcinomas and found only in a 
minority of cells in adenocarcinomas. A similar effect was also observed for keratin 14 
when the RCK. 107 antibody was used. In line with a previous report<28) the results 
presented in this paper demonstrate that antibodies to keratins 8 and 18 can not be 
used reliably to distinguish between adeno- and squamous cell carcinoma, since the 
latter of the two when originating from the cervix or the lung, express these simple 
keratins. 
Adenocarcinomas of the cervix versus adenocarcinomas from other origins 
Keratin 17 was detected in variable amounts in all cervical carcinomas irrespective of 
their subclassification. Preliminary studies have indicated that this keratin subtype is 
present in approximately one third of invasive ductal carcinomas of the breast ' , in 
all squamous cell carcinomas of the lung and usually not in adenocarcinomas of the 
lung.(JI) Moll and Czernobilsky °'5) did not detect keratin 17 in adenocarcinomas of the 
endometrium they studied by gel electrophresis. Troyanovsky et al (2° have shown that 
keratin 17 is not found in normal intestinal epithelia, the epithelium of the oviduct or 
mesothelial cells. Quinlan et al ( M ) demonstrated by means of gel electrophoresis that 
no keratin 17 could be detected in several subtypes of adenocarcinomas including 
those of the ovary, stomach, gall bladder, as well as mesotheliomas. In all adenocarci­
nomas of the cervix however, keratin 17 was detectable. In a previous study we 
demonstrated that carcinomas of the colon did not contain this keratin type(30), 
meaning that this antibody may be extremely helpful in the distinction between adeno­
carcinoma of the cervix and colon. This differential diagnosis may pose difficult pro­
blems because the close anatomical relationship of both organs may not always allow 
an easy distiction on the basis of topography alone. We therefore propose that keratin 
17 may be potcntally important for the distinction between adenocarcinomas of the 
cervix and these other types of adenocarcinomas, and between cervical adenocarcino­
ma and mesothelioma. 
Progression versus regression of CIN lesions 
In a previous study we demonstrated that keratin 17 was detectable in approximately 
50% of the CIN III lesions and only in a small percentage of CIN I and CIN II 
lesions №We proposed that those CIN lesions which expressed keratin 17 may be of 
the progressive type and that keratin 17 could indicate whether a CIN III lesion will 
become malignant or not. The fact that in the underlying study we were able to detect 
keratin 17 in all carcinomas further supports this hypothesis and means that keratin 17 
could be a marker for progression in cervical intraepithelial neoplasia. 
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Chapter five 
Expression of Keratins 1,6, 15, 16 and 20 in Normal 
Cervical Epithelium, Squamous Metaplasia, Cervical 
Intraepithelial Neoplasia and in Cervical Carcinoma 
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ABSTRACT 
Expression of keratins 1,6, 15, 16 and 20 was examined in normal cervical epithelia, 
squamous metaplasia, different grades of CIN, and both squamous cell carcinomas 
and adenocarcinomas of the cervix with monospecific antibodies. Ectocervical epithe-
lium contains all of these keratins except keratin 20. They show a heterogeneous distri-
bution, with a basally restricted detection of keratin 15. Endocervical columnar cells 
were found to contain significant amounts of keratin 16, while the subcolumnar 
reserve cells expressed considerable amounts of keratin 15 and 16, and frequently kera-
tin 6. These reserve cell keratins were also found in immature and mature squamous 
metaplastic epithelium. In the CIN lesions they were generally found with increasing 
intensity as the severity of the lesion progressed. In the keratinizing variety of squa-
mous cell carcinoma of the cervix these three keratins seem to constitute an important 
part of the intermediate filament cy toskeleton, while in nonkeratinizing squamous cell 
carcinoma they occur to a much lesser extent. Surprisingly in adenocarcinomas these 
keratins were also occasionally found. 
From these data we conclude that the keratin phenotype of reserve cells and endocer-
vical columnar cells is more complex than previously suggested. In particular, the 
keratins occuring in reserve cells are also present in most of the premalignant and in a 
considerable number of the malignant lesions of the cervix. The different differentia-
tion features of the various carcinoma types are, however reflected by their specific 
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INTRODUCTION 
Human keratins comprise a family of at least 20 separate intermediate filament pro­
teins (1,2), numbered from 1 to 20, which are distributed in a tissue specific fashion 
throughout epithelia. 
By using specific monoclonal antibodies directed against individual keratin polypep­
tides it is possible to study changes in the type of epithelial differentiation in premalig-
nantand malignant cervical lesions. The keratin phenotypes of the various normal epi­
thelia lining the uterine cervix as well as those of the aforementioned lesions are known 
to a large extent/3 9) One of the objects of these studies has been to associate the keratin 
expression patterns with the metaplastic or malignant potential of cervical epithelia. 
Suggestions have been put forward by which the progressive or regressive nature of 
cervical intraepithelial neoplasia (CIN) may be predicted on the basis of keratin 
expression patterns. 
The expression patterns of the various cervical epithelia as known to date are shown in 
figure 1. 
Recently, polyclonal and monoclonal antibodies against keratins 1,6, 15, 16 and 20 
<l l0
"
l2)
 have become available, of these, the antibodies to keratins 1, 6 and 16 have been 
tested in cervical carcinomas , but as yet not in the normal cervix, in metaplastic and 
CIN lesions. The observations in cervical carcinoma, the fact that keratin 15 is known 
to indicate metaplasia in the lung<ltM3) and the suggestion that keratin 16 is a marker of 
hyperproliferation, in themselves justify a study of the expression of these keratins in 
cervical tissue. Furthermore, we feel that an extension of our studies on keratin expres­
sion in the cervix may enhance our understanding of the processes governing epithelial 
metaplastic and malignant transitions. 
Figure 1. Schematic representation of keratin expression patterns in normal, premalignant 
and malignant cervical tissues. The human keratins are indicated by their respective 
numbers according to the Moll-catalogue?'1' *The asterisks indicate the keratins 
examined in this study. The percentage of cases staining is indicated as follows: A 
completely filled bar indicates that between 75 and 100% of the cases stain. A bar 
filled 3/4 indica tes that between SO and 75% of the cases stain. A bar filled half 
denotes staining between 25 and 50% o f cases. A bar filled 1/4 indicates that less 
than 25% of cases stain. An open bar indicates that no cases stain. A black bar 
indicates that ali'cells stain intensely horizontal'lines indicate that most cells stain 
and that the intensity is weak to moderate. Hatched lines mean that dispersed cells 
stain weak to moderately with also negative cells. Dots denote only scattered 
positive cells. 
Abbreviations: S = superficial cells; I = intermediate cells; В = basal cells; 
PB = para basal cells; С=columnar cells; RC=reserve cells. 
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MATERIALS AND METHODS 
Tissues 
The tissue specimens used in this study were taken from diathermy loop excision speci-
mens or cervical cone biopsies of 70 women with cytologically verified dysplasia. The 
tissue specimens representing cervical carcinomas were taken from hysterectomy speci-
mens or biopsies of 31 women with cervical carcinomas. The diathermy loop excision 
specimens, cone biopsies and hysterectomy specimens were brought to the pathology 
department immediately after removal, where a small tissue fragment was removed 
from each specimen and snap frozen in liquid nitrogen or liquid nitrogen cooled iso-
pentane. The major part of the specimen was further processed through paraffin after 
routine fixation in 4% buffered formalin, for light microscopic diagnosis. In total 98 
specimens were used representing normal epithelia, metaplastic lesions, the three 
grades of CIN and also cervical cancer. Often more than one type of epithelium was 
detected in the same fragment. In this way normal ectocervical epithelium was diag-
nosed in 32 fragments, columnar endocervical epithelium in 54 fragments, reserve cells 
in 25 fragments, immature squamous metaplasia in 14 fragments, mature squamous 
metaplasia in 19 fragments, CIN I in 6 fragments, CIN II in 16 fragments, CIN III in 
21 fragments, keratinizing squamous cell carcinoma in 5 fragments, nonkeratinizing 
squamous cell carcinoma in 13 fragments, adenocarcinoma in 10 fragments and ade-
nosquamous carcinoma in 3 fragments. These diagnoses were confirmed by compari-
son with companion formalin fixed paraffin embedded preparations. Furthermore, the 
subepithelial connective tissue was meticulously examined for keratin expression in all 
fragments. 
Antibodies 
The specificity of the five antibodies used in this study is described below: 
1. AF 87 is a polyclonal rabbit antiserum raised against a synthetic carboxy-terminal 
peptide of keratin 1. In immunoblotting studies keratin 1 was specifically recogni-
zed. The antibody was a gift from Dr D. Roop (NIH, Bethesda). 
2. AF 124 is a polyclonal rabbit antiserum raised against a synthetic carboxy-terminal 
peptide of keratin 6. In immunoblotting studies only keratin 6 is recognized (S.H. 
Yuspa personal communication). The antibody was a gift from Dr D. Roop. 
3. Gp 15.1 are guinea pig antibodies from an animal immunized with an affinity-puri-
fied fusion protein from E.coli containing the carboxy-terminus of human keratin 
15. This antiserum reacts specifically with human keratin 15 in immunohistochemis-
try and immunoblotting (10"). 
4. LL025 which recognizes keratin 16 was raised against a synthetic peptide corres-
ponding to the carboxy-terminus of human keratin 16.(l4) Courtesy of Dr E.B. Lane, 
(Dundee, UK). 
5. K.20 has been shown to exclusively react with human keratin 20 in immunoblotting 
studies and was obtained from Sambio B.V., Uden, The Netherlands. It stains 
amongst others columnar cells lining the digestive tract.(1,l2) As a positive control we 
tested the reactivity of this antibody on normal colon epithelium. 
Immunohistochemistry 
Cryostat sections were fixed at room temperature in acetone for 10 minutes, air dried 
and incubated for immunohisto- chemical detection of keratin as described before.(3> 
Both positive and negative control experiments were performed in parallel. 
RESULTS 
Figure 1 shows a schematic representation of the reactivities of the keratin antibodies 
used in this study along with those previously described in the various cervical tissues. 
The keratin antibodies used for the first time in this study did not react with cells in the 
subepithelial connective tissue. 
Figure 2. Immuaoperoxidase staining patterns of frozen sections from normal ectocervical 
(a-d) and endocervical (e-b) epithelium with reserve cells, stained with: (a) AF87 
(keratin 1), (b & e) AF124 (keratin 6), (c&QKl S (keratin 15), (d&g)LL025 
(keratin 16), (h) K20 (keratin 20). Originalmagnifications a-dχ 250; e-b χ 400. 
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Ecto- and Endoccrvical Epithelium (Figures la, lb and 2) 
The basal cell compartment of ectocervical nonkeratinizing squamous epithelium was 
always negative for keratin 1, while in the parabasal cell compartment dispersed cells 
stained weakly in only 4 cases. Also in the intermediate and superfical layers a few 
dispersed cells reacted in a number of cases (fig. 2a). Keratin 6 was found extensively 
in the superfical layers of all but 2 cases. Basal cells were found positive in 7 cases, 
parabasal cells in 18 cases and intermediate cells in 20 cases, staining with weak to 
moderate intensity (fig. 2b). Keratin 15 was present in the basal cells of all cases (fig. 
2c), while in 28 cases the parabasal compartment was positive with varying intensity, 
also showing negative areas. Dispersed decoration was found in the intermediate cell 
compartment of 20 cases, although the intensity of antibody staining and the number 
of positive cells was considerably less. The superficial compartment was usually 
completely negative, and only 4 specimens showed a weak reaction. Keratin 16 was 
present in the basal cell compartment of half the cases studied (fig. 5d). The above 
lying layers were usually negative, but in 5 specimens variable and sometimes strong 
staining was found through the full thickness of the epithelium. Sixteen cases were 
completely negative. Keratin 20 was not detected in ectocervical squamous epithelium. 
The columnar cells (fig. lb) lining the endocervical canal did not contain keratin 1. 
Keratin 6 was detected in less than 1% of cells in only 5 specimens (fig. 2e). Keratin 15 
was not found in 40 cases, while in 14 fragments up to 25% of the cells displayed weak 
to moderate positivity (fig. 2f). Keratin 16 was detected in virtually all columnar cells 
(fig. 2g) and keratin 20 was weakly detectable in approximately 5% of cells in only 5 
cases. In general however columnar were not cells decorated (fig. 2h). 
Reserve cells (fig. lb) did not contain keratin 1. In dispersed cells of 5 cases keratin 6 
could be detected (fig. 2e), in 8 cases all reserve cells stained with the keratin 15 anti­
body. In the other cases approximately half of the reserve cells weakly expressed kera­
tin 15 (fig. 2f). Keratin 16 was found in all reserve cells showing moderate positivity 
(fig. 2g). Keratin 20 was not detected in reserve cells (fig. 2h). 
Figure 3. Immunoperoxidase staining patterns of frozen sections from immature squamous 
metaplasia after staining with: (a) AF87 (keratin 1), (b)AF124 (keratin 6), (c)K15 
(keratin 15), (d) LL025 (keratin 16). Origina] magnifications a,b,d χ 300; с χ 400. 
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Immature Squamous Metaplastic Epithelium (figures lc and 3) 
Keratin 1 was not detected in this type of epithelium (fig. 3a), and the keratin 6 anti-
body showed weak to moderate positivity in 10 cases with roughly 50% positive cells, 
irregularly distributed through the epithelium (fig. 3b). In 2 fragments only a few cells 
seemed to express keratin 6. Two cases were completely negative. Keratin 15 was 
found in all cases with the majority of cells positive. The intensity of immunostaining 
and the number of reactive cells was usually highest in the basal cell layers. In the 
superficial cell layers there were both positive and negative cells (fig. 3c). Keratin 16 
was weakly to moderately expressed in all cells of 7 cases (fig. 3d), and in 2 cases 
between 25 and 75% of the cells were weakly positive. In one case only a few cells 
stained, and one case was completely negative. Keratin 20 was not found in immature 
squamous metaplasic epithelium. 
Mature Squamous Metaplastic Epithelium (figure Id) 
As expected the keratin phenotypc of this type of epithelium was much the same as 
described for ectocervical epithelium. This was definitely the case for keratin 1,6,15, 
and 20. Keratin 16, however, showed a less predictable staining pattern, as in 2 cases 
the full thickness of the epithelium displayed an intense immunorcaction, 2 cases 
showed positively in the majority of cells through the full thickness of the epithelium 
and 5 cases displayed a variable staining pattern. The other 10 cases were completely 
negative. 
CIN I (figures le and 4a-d) 
Keratin expression in CIN I was in general less consistent than previously described 
for the non-neoplastic lesions. Keratin 1 antibody was usually not found to react (fig. 
4a). Keratin 6 was found in all cases. About half of the cells stained with varying 
intensity and location (fig. 4b). Keratin 15 was found throughout in the full thickness 
of the epithelium in 3 cases, with moderate intensity of staining. In the other 3 cases 
both negative and positive cells were found (fig. 4c). The Keratin 16 antibody was 
moderately positive in most cells of the basal cell compartment in all cases (fig. 4d). In 
3 cases the superficial cell compartments were completely negative, while in the other 3 
cases both negative and positive areas were observed throughout the full thickness of 
the epithelium. Keratin 20 was not detected in CIN I lesions. 
CIN II (figures If and 4 e-h) 
As observed for CIN I keratin 1 was usually not found in CIN II (fig. 4e). The Keratin 
6 antibody was found to stain moderately intensly in the basal cell compartment of 14 
cases (fig. 4f), with also dispersed positivity of the above lying cells. Two cases were 
completely negative. Keratin 15 was detected in all basal cells, where immunostaining 
intensity was usually moderate (fig. 4g). In the above lying layers dispersed decoration 
was seen in about 50% of the cells in 11 specimens. In 5 fragments the cells lying above 
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the basal layer were all negative. Keratin 16 was found diffusely in the basal cell 
compartment of 12 cases, and in 3 cases about half of the basal cells reacted weakly 
(fig. 4h), with one case negative. Keratin 20 was not found in CIN II lesions. 
Figure 4. Immunoperoxidase staining patterns of frozen sections from CIN I lesions (a-d), 
CIN JI lesions (e-h)and CIN III lesions (i-1), after staining with: (a,e,i)AF87 
(keratin 1), (b,fj)AF124 (keratin 6), (c,g,k)Kl5 (keratin 15), (d,b,l)LL025 
(keratin 16). Original magnifications a-h,j-l χ 300; i χ 250. 
CIN ΙΠ (figures lg and 4 i-1) 
Keratin 1 was found in only 4 cases with dispersed weak positivity in scattered cells 
lying above the basal layer (fig. 4i). One case displayed weak diffuse positivity through 
the full thickness of the epithelium. Keratin 6 was found irregularly distributed 
through the full epithelial thickness in more than half of the cells of 12 fragments. In 6 
cases there was diffuse positivity (fig. 4j), with 3 cases showing scattered cells or no ex­
pression at all. Keratin 15 was detectable with moderate intensity through the full thic­
kness of the lesion in 10 cases (fig. 4k), and in some cases diminished toward the 
epithelial surface. The other 11 cases showed dispersed positivity, with both keratin 15 
positive and negative areas, while the staining intensity tended to be strongest in the 
basal compartment. The Keratin 16 antibody showed a diffuse reaction in 11 
specimens, staining the full thickness of the epithelium (fig. 41). Eight cases displayed 
varying decoration which was strongest in the basal compartment, but both staining 
intensity and number of positive cells decreased as the epithelial surface was 
approached. Staining for keratin 20 was negative in all specimens. 
Keratinizing Squamous Cell Carcinoma (figures lh and Sa) 
The expression of keratins 1,6, and 16 in these malignancies has been previously des­
cribed and is presented in figure lh. Keratin 15, was found to be diffusely distri­
buted in all cases of keratinizing squamous cell carcinoma (fig. 5a). The intensity of 
staining however varied from weak to strong. A reaction for keratin 20 was not found 
in these cases. 
Large Cell Nonkeratinizing Carcinoma (figures li and 5b,c) 
Again, the previously described staining pattern of keratins 1,6, and 16 are schema­
tically represented in figure li. Contrary to prior observations(5) we found keratin 1 to 
be expressed in scattered cells of 3 new fragments (fig. 5b). The intensity of the immu-
nostaining reaction was moderate to strong, and no particular localization was noted 
within the tumor islands. Keratin 15 displayed an irratic staining pattern. In 4 cases 
strong expression was found in all cells (fig. 5c). Six cases were not decorated at all. 
Four cases displayed a highly variable staining pattern, with negative to intensly posi­
tive areas, and the number of cells staining per fragment ranging from 5% to 60%. 
Keratin 20 was negative in all but one case, in which approximately 40% of the cells 
showed moderate staining in a scattered fashion (fig. 5d). 
Adenocarcinoma (figures lj and 5e-h) 
The cervical adenocarcinomas were subdivided into 5 adenocarcinomas of the endo-
cervical type, 3 moderately differentiated and 2 poorly differentiated and 4 carcinomas 
of the endometrioid type, one Grade I, two grade II and one grade III. 
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Figure 5. Immunoperoxidase Stauung patterns of frozen sections from (а) кета timzing 
squamous cell carcinoma, (b,c,d)nonkeratimzmg squamous celi'carcinoma, (e) 
adenocarcinoma of the endocervical type, (f&g) adenocarcinoma of the endome­
trioid type (h) adenosquamous carcinoma after staining with (a,c,e,f,h)K15 (kera­
tin 15), (b) AF87(keratin I), (d,g) K20 (keratw 20) Original magnifications a-hj-1 
χ 300; ex 400 
Endocervical adenocarcinoma 
Keratin 15 was detected in 4 of 5 cases with a few dispersed cells staining (fig 5e) 
Keratin 20 was not found in these carcinomas 
Endometrioid adenocarcinoma 
Keratin 15 was present in 3 of the 4 endometrioid adenocarcinomas, and as described 
in the endocervical carcinomas only a few cells stained, while the intensity varied from 
weak to moderate (fig 5f) Keratin 20 was present in one poorly differentiated endo­
metrioid adenocarcinoma, with approximately 40% of cells staining with variable 
intensity (fig 5g). 
Adenosquamous carcinoma 
Keratin 15 was found in all 3 cases adenosquamous carcinomas studied In one case all 
cells stained with moderate intensity (fig 5h) in the other 2 cases a few cells expressed 
keratin 15 Keratin 20 was not found in adenosquamous carcinoma 
DISCUSSION 
New aspects keratin expression in the cervix 
In this study we present a number of features of keratin expression in the cervix which 
to date have not yet been described. The exact distribution of keratins 1,6, 15 and 16 
in the ectocervix is presented (For gel electrophoretic data see 15 and 16). In endocer-
vical columnar epithelium we describe the presence of keratin 16 and sporadic expres-
sion of keratins 6,15 and 20. Concerning the keratin phenotype of endocervical 
reserve cells we prove that these contain large amounts of keratins 15 and 16, and also 
some weak expression of keratin 6. This means that the keratin phenotype of reserve 
cells is more complex than previously thought and comprizes the keratins 8, 14, 16, 17, 
18 and 19 in all reserve cells and frequently additional expression of keratins 5, 6 and 
15. In immature and mature squamous metaplasia(4,6) expression of keratins 6, 15 and 
16 is described. To our previous observations on the keratin expression in CIN lesions 
(3,4 and figure 1) we add the expression of keratins 1,6, 15 and 16 of which the 
expression of keratins 6, 15 and 16 seems to increase as the severity of dysplasia 
progresses (see however 15 and 16). 
[n cervical carcinomas we previously described the presence of keratins 6 and 16, to 
which we can now add expression of keratin 15, which was always found in keratini-
zing squamous cell carcinoma and usually also in the nonkeratinizing variety. To the 
known keratin expression pattern of adenocarcinomas and adenosquamous carcinoma 
we add keratin 15, which is found in varying numbers of cells in most of these malig-
nancies. In contrast to findings of Moll et al(l2) we found considerable posilivity of 
keratin 20 in one case of squamous cell carcinoma of the cervix. 
Reserve cell keratins persist in benign and premalignant cervical lesions 
When comparing the keratin complement of reserve cells with that of columnar cells 
(fig. 1), it is obvious that most keratins found in columnar cells are also found in 
reserve cells, with the exception of keratins 4 and 7. Also the levels of expression of 
several of the columnar epithelial keratins is low in reserve cells. On the basis of these 
findings we hypothesize that expression of keratins 4 and 7 is initiated during the 
transformation of reserve cells into columnar cells, while expression of keratins 5,6,14, 
15 and 16 is lost and expression of keratin 18 increases. Occasionally, small amounts of 
typical reserve cell keratins persist in columnar cells (see figure lb and ref 17). 
When reserve cells are programmed to proliferate and differentiate into mature squa-
mous metaplastic epithelium through immature squamous metaplasia, keratins 8 and 
18 characteristic for both reserve cells and columnar cells are lost, while keratins 5,6,1-
4, 15, 16, 17 and 19 become compartmentalized, showing a restricted expression to one 
or two epithelial layers of the metaplastic epithelium. Most important, however, is the 
initiation of expression of keratins 4 and 13, which are characteristic of nonkeratini-
zing squamous epithelia. These keratins appear during immature squamous metaplasia 
and become more abundant as the immature squamous metaplastic epithelium diffe-
rentiates. Finally these keratins are located above the basal cell layer in mature squa-
mous metaplastic epithelium. Keratin 15 is characteristic of certain differentiation 
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basal cells of certain stratified epithelia such as in esophagus. In accord with these 
findings is our recent observation of the varying presence of keratin 15 in cervical 
reserve cells, possibly indicating differences in the differentiation status of individual 
reserve cells. In our model those reserve cells expressing keratin 15 are predistined to 
progress into metaplastic epithelium. This is further supported by the observation that 
in reserve cell hyperplasia a considerable number of these cell contain keratin 15 and 
that consequently expression of this keratin in intermediate phases of squamous 
metaplasia and immature squamous metaplasia is considerable. In the CIN lesions 
keratin 15 antibodies exhibit considerable although often erratic staining patterns 
increasing with the progression of lesion. 
In the case of atypical proliferation of reserve cells resulting in the development of 
CIN lesions, the expression of keratins 6 and 16 is of particular interest. These two 
keratins have been described as markers of hyperproliferation or keratinocyte differen-
tiation in studies on regenerating epithelium of the comea.(H) In keeping with this as-
sumption keratin 16 showed a restricted expression pattern in the cervix, staining 
approximately half of the cells in the basal cell compartment, of ectocervical epithe-
lium and most of the reserve cells, in line with the proliferative capacity of these cells. 
In our hands keratin 6 was hardly detectable in these cells, while it showed an incre-
asing expression, both in intensity and number of cells staining, as the superficial cell 
layer in the ectocervix was approached. Apparently, keratin 6 in ectocervix does not 
mark proliferation but seems to indicate a higher degree of differentiation. Further-' 
more, in the endocervical epithelium keratin 6 did not follow keratin 16 in its expres-
sion pattern. Surprisingly, all endocervical columnar cells stained moderately with the 
keratin 16 antibody, thereby being the first observation of keratin 16 expression in 
normal columnar cells. Expression of keratins 6 and 16 increases irregularly during 
immature squamous metaplasia. In mature squamous metaplasia keratin 6 expression 
seems to be restricted to the suprabasal cell compartment, reflecting the end stage of 
differentiation of this epithelium. Again, keratin 16 does not show the expected co-
expression pattern with keratin 6. 
With increasing grades of severity of CIN lesions, keratins 6, 15 and 16 show a pro-
gressive increase in the number of cells staining and in the staining intensity. This 
effect is most pronounced when CIN I and II on the one hand are compared with CIN 
III on the other hand. The quantitative difference i.e. stronger staining intensity of 
keratin 6 and 16 antibodies in CIN III, is the only feature distinguishing CIN III lesi-
ons from immature squamous metaplasia. 
Reserve cell keratins in cervical carcinoma 
In keratinizing squamous cell carcinoma keratin 15 expression persists. This is not 
surprising as keratin 15 has been identified as a stratification-related keratin protein. 
The fact that only half of the nonkeratinizing squamous cell carcinomas express kera-
tin 15 may indicate that these carcinomas display differentiation features not light 
microscopically discernable. Out of keeping with the supposition that keratin 15 is a 
stratification marker is the fact that it is expressed in the majority of adenocarcinomas, 
albeit in a small number of cells. This however is further proof for the supposition that 
the common progenitor cell of adenocarcinomas of the cervix are the endocervical 
reserve cells. 
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Figure 6. Schematic representation of "consensus keratin phenotypes " of the different 
cervical'поп-neoplastic, premahgnant epithclia and carcinomas. These are 
represented as the probability of expression of a single keratin ¡Ω each of the 
subgroups. A completely filled box denotes a probability of expression between 
75-100%. A hatched box denotes a probability of expression between 50 and 75%. 
A dotted box represents a probability of expression between 25 and 50%. An open 
box denotes a probability ofexprcssion between 0 and 25%. 
Abbreviations: *=thisstudy;RC=reservecells; CYL=columnarcells; EC-
TOC=ectocervicalnonkeratinizing squamous epithelium. fSM=Immature 
squamous metaplastic epithelium; MSM=mature squamous metaplastic 
epithelium; CIN=cervical intra-epithelial neoplasia; KSQ= keratinizing squamous 
cell carcinoma; NKSQ=nonkeratinizing squamous cell carcinoma; 
A C=adenocarcinoma; ASQ=adenosquamous carcinoma. 
Consensus keratin phenotypes in the cervix (fig. 6) 
The information amassed in our previous studies and destilled from the literature, 
show a complex keratin expression pattern in the cervix and in cervical lesions. For 
reasons of simplification we previously proposed a consensus keratin phenotype for 
carcinomas of the cervix.'4 Such a representation indicates the presence of specific 
keratins within the various tissues, without giving quantitative information on the 
number of cells staining and the intensity of staining (fig. 6). Columnar epithelium may 
be distinguished from cctocervical epithelium on the basis of the absence of keratins 5, 
6, 13 and 14 in the latter while simple keratins 7, 8 and 18 are present in columnar cells 
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and not in ectocervical epithelium. 
CIN I and II can be distinguished from CIN III by the absense of the reserve cell kera-
tins 8, 18 and 17. 
Keratinizing squamous cell carcinoma may be distinguished from nonkeratinizing car-
cinoma by the frequent absence of keratin 7 while keratins 4,10,13,15 and 16, which 
are always present in keratinizing squamous cell carcinomas are, often absent in the 
nonkeratinizing type. 
The complexity of the consensus keratin phenotype for adenocarcinomas of the cervix, 
comprizing keratins 7, 8, 14, 15, 17, 18,19, frequently keratins 4 and 6 and sometimes 
5, and the similarity to the reserve cell keratin phenotype is remarkable. In our view 
this indicates that the adenocarcinoma keratin phenotype is more closely related to 
that of squamous cell carcinoma of nonkeratinizing type than previously thought. 
Can the regressive or progressive nature of a CIN lesion be predicted on the 
basis of its keratin expression pattern? 
It is tempting to speculate that those CIN lesions showing increased staining of the epi-
thelium for keratins 6, 15 and 16 may represent a subfraction destined to progress into 
cervical cancer. Based on the findings described above we propose the following theory 
for the pathogenesis of cervical cancer. Reserve cells, containing keratins 5, 8, 14, 15, 
16, 17, 18, 19 and sometimes keratin 6, proliferate through the different grades of CIN, 
finally progressing into carcinoma. Those CIN lesions which maintain the keratin 
phenotype of the progenitor reserve cells may be destined to eventually develop into 
malignant lesions, while those losing reserve cell keratins such as keratins 8 and 18 are 
suggested to be regressive in nature. This is indicated by the fact that only a small 
number of CIN I and CIN II lesions retain the complete reserve cell keratin expression 
pattern. The remaining cases loose simple keratins, meaning that the lesions will 
remain static or possibly revert into mature squamous metaplasia. In CIN III the 
number of lesions with the complete reserve cell keratin profile has increased up to 
50%, which percentage equals the anticipated chance of progression into cervical carci-
noma from CIN III. In the case a CIN III lesion develops into a keratinizing carcino-
ma it maintains the aforementioned keratin expression pattern, and also initiates the 
sy thesis of keratins 4,13 and 10. In nonkeratinizing squamous cell carcinoma the 
reserve cell keratins 15 and 16 are frequently lost and keratin 7 expression is acquired. 
In case CIN III develops into an adenocarcinoma, the keratins typical of the squa-
mous differentiation pathway are lost. Variable expression of keratin 13 in an 
adenocarcinoma could mean that this carcinoma represents an adenosquamous 
variety. 
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Chapter six 
The Dynamics of Keratin Expression in Malignant 
Transformation of Cervical Epithelium 
A Review 
Frank Smedts, Frans CS. Ramaekers, G. Peter Vooijs, 
(Obstetrics and Gynaecology (accepted)) 
ABSTRACT 
Basic and clinical aspects of cytoskeletal keratin expression in normal cervical epithelia 
as well as preneoplastic and malignant epithelia of the uterine cervix are reviewed. In 
ectocervical epithelia keratins characteristic of the squamous type of differentiation are 
found, while in endocervical columnar cells keratins typical of simple epithelia are pre-
sent. Reserve cells display a bidirectional keratin pattern comprising keratins typical of 
both squamous and simple types of differentiation reflecting the bipotential nature of 
these cells. 
Cervical intraepithelial neoplasia can be divided into two subpopulations, one being 
characterized by the "reserve cell keratin phenotype", and the other by a keratin phe-
notype characteristic of nonkeratinizing squamous epithelia. The first population also 
contains the simple keratins, the relative percentage of which increases with increasing 
degree of dysplasia. We therefore suggest that these lesions are progressive in nature. 
Carcinomas show a differentation related keratin expression pattern in addition to the 
basic reserve cell keratin phenotype. Adenocarcinomas have also been shown to 
express most of the reserve cell keratins. The latter observation indicates a common 
progenitor for both carcinoma types. 
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INTRODUCTION 
Intermediate filament proteins (IFP) are important constituents of the cytoskeleton in 
eukaryotic cells. They seem to be involved in providing internal stability within the 
cell, in transport functions and gene regulation.0' Six different groups of IFP have 
been discovered, which are to a certain extent expressed in a tissue specific fashion. 
Keratins represent the class I and class II family of IFP and are by far the most 
complex group. The 20 members of the keratin family are distinguishable on the basis 
of their molecular weight, isoelectric pH, their amino acid sequence and immunologic 
properties. They have a number of interesting characteristics, justifying the extensive 
studies into their nature and tissue distribution, which follows certain rules. These 
human keratins (K(s)) which have been catalogued and numbered from 1 to 20 
(designated K1-K20 in this review; are expressed in pairs combining a class I (acidic) 
and a class II (basic to neutral) protein. ' Many of the various types of epithelial 
differentiation in the body express specific keratin combinations. For example, in 
epithelia with skin type differentiation (keratinization) the most characteristic keratins 
are K l , K.2, and К10. If squamous epithelium does not display keratinization, K4 and 
К13 along with keratins found in both keratinizing and nonkeratinizing squamous 
epithelia e.g. K.5 and K14 are found. In the so-called simple epithelia, K8 and K.18 
often in combination with K7, K19, and K20 are the most important IFP. Complex 
epithelia lining for instance glands or the urinary tract, are found to express both 
simple epithelial keratins as well as keratins found in squamous epithelia. K6 and K16 
have been associated with hyperproliferation of squamous epithelial cells.4) 
Another important characteristic of IFP, making them extremely interesting for fur­
ther research, is that their patterns of expression are to a great extent preserved during 
malignant transformation. Thus an epithelial neoplasm will frequently express those 
keratins which are found in the epithelial tissue from which they originated/4 The 
rapid development of monoclonal antibodies specific for most of the individual 
keratins ( 6 ) has enabled the accurate mapping of many epithelia. 
The aim of this review is: 
1. to summarize the literature on keratin expression in the normal cervix and cervical 
neoplastic lesions, 
2. to discuss the patterns of keratin expression in both endocervical and ectocervical 
epithelia.(7"H) 
3. to analyse the complex keratin expression of reserve cells in context to their role as 
progenitor cells for benign metaplastic processes immature and mature squamous 
metaplasia and in the derailment of normal differentiation in cervical intraepithelial 
neoplasia (CIN) lesions, which may eventually progress into cervical carcinoma. 
It has previously been suggested that the keratin phenotype of these lesions may 
supply valuable information on whether or not a CIN lesion is progressive or re­
gressive in nature . 0 4 ' 4 The keratin phenotypes of carcinomas will be compared to that 
of reserve cells. Possible implications of keratin expression patterns on the classifica­
tion of the various types of cervical cancer will be considered.04 The keratin patterns 
in CIN lesions and cervical cancers may have diagnostic implications. A number of 
possibilities to distinguish cervical carcinomas from carcinomas arising in other organs 
on the basis of their keratin phenotypes will briefly be discussed. Finally suggestions 
will be put forward for possible future studies in which results from keratin studies 
may be combined with observations emanating from molecular biologic research in 
cervical pathology. 
KERATIN EXPRESSION IN THE EPITHELIA LINING THE 
NORMAL CERVIX 
Based on gel electrophoretic analyses, ectocervica] nonkeratinizing epithelium was 
shown to contain type II keratins 1, 4, 5, and 6 and type I keratins 13, 14, 15, and 19, 
with also some variable expression of keratins 2, 8, 10, 11, 16, and 17 (fig. la)/7"'3·14"'5·' 
On the basis of immunocytochcmical evaluations(ΚΙΪ,17) using mostly monoclonal anti­
bodies to the individual cytokeratins, ectocervical epithelium (fig. la) was shown to 
have a specific keratin distribution pattern with very little variation (fig. lb-f). K4 and 
K13 (fig. 10, characteristic for nonkeratinizing epithelia, are expressed in the supra-
basal cell compartments. Basal cell keratins K5, K.14 and K15 were detected in the 
ectocervical basal cell layer, but also sometimes in the parabasal cell compartment with 
K14 (fig. Id) and K15 well into the intermediate cell layer. Keratins characteristic of 
keratinization (Kl and КЛ0) and abundantly found in the epidermis, were occasionally 
found in ectocervical nonkeratinizing epithelium, with only incidental cells in the inter­
mediate and superficial cell layers staining. K6 and K16, which are considered to be 
associated with hyperproliferative epithelia, demonstrated a rather suprising expres­
sion pattern, in that K6 was frequently detected in the parabasal, intermediate and 
superficial cell layers, thus indicating a differentiation related, but not a hyper-
prolifcration related expression. K16 showed a more or less expected pattern, being 
detectable in the proliferating basal cell compartment, but was also often found in the 
overlaying epithelial layers (fig. lg), which are at an end stage of differentiation. The 
keratins characteristic of simple epithelia (e.g. fig. lb) were only sporadically found in 
ectocervica] epithelium with the exception of K19 (fig. lc) which was always present in 
the basal cell layer. 
As observed in gelelectrophoretic studies, columnar cells (fig. Ih) lining the endocervi-
cal canal were immunohistochemically shown to express the simple keratins K7, K8 
(fig. li), K18, and K19 (fig. lj). Surprising however was the fact that considerable 
expression of K4, K.16 (fig. In) and also K15 was found in morphologically normal 
columnar cells. K.4, a marker for nonkeratinizing squamous epithelium, has already 
been described in other (non-cervical) columnar cell types.(24) These unexpected 
features of columnar cell keratin expression will be discussed below in the light of the 
reserve cell keratin-phenotype. Sporadically the columnar cells have been shown to 
contain K20 which is mainly restricted to glandular epithelia, lining the gastrointesti­
nal tract.<3) Therefore K20 (»expression may indicate intestinal metaplasia of endocer-
vical columnar cells before it becomes morphologically evident. K.5, K6, K14, K15, 
and К17 are also sporadically found in columnar cells when they lie above reserve 
cells, in which these aforementioned keratins are abundantly found (see Figs lh-n). 
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Figure I. Schematic overview of the keratins expressed in (A) ectocervical'non-
keratimzing squamous epithelium, (H) endocervicalcolumnar cells and 
reservecells and (O) immature squamous metaplastic epithelium 
Immunoperoxidase staining pattern of(B-G) ectocervical epithelium, (I-N) 
endocervical epithelium and (P-U) immature squamous metaplastic 
epithelium after m cubation with antibodies reactive to (Β,Ι,Ρ) K8, (C,J,Q) 
K19, (D,K,R)K14. (E,L,S)K17, (F,M,T)K13, (G,N,U)K16 
A bbreviations K=keratm, number indicates number m Molls catalogue (2) 
Distinct expression numbers without parenthesis Weak expression numbers 
m parenthesis 
KERATIN EXPRESSION IN RESERVE CELLS AND 
METAPLASTIC EPITHELIA 
As opposed to normal endo- and ectocervical epithelia, which can be considered to be 
in an end stage of differentiation from which metaplastic changes into other types of 
epithelium do not occur(24, reserve cells and immature squamous metaplastic epithelia 
retain the capacity to proliferate and to differentiate The span of differentiation 
phenotypes of reserve cells under physiologic conditions, extends from pure reserve 
cell hyperplasia through the various phases of immature squamous metaplasia to 
mature squamous metaplastic epithelium Furthermore, there is evidence that reserve 
cells are not only progenitors of mature squamous metaplastic epithelium, but they 
may also differentiate into endocervical columnar cells IS) The complex keratin expres­
sion pattern of the progenitor reserve cells (fig lh-τι) provides support for the multidi­
rectional differentiation capacity of these cells into columnar cells as well as into squa­
mous metaplastic epithelia Reserve cells have been shown to contain the simple 
keratins K7, K8 (Fig h), К18, and K19 (fig lj), which are all found in (mature) endo­
cervical columnar cells 
Furthermore, K.14 (fig Ik), Kl 5 and K16 (fig In) arc usually found in reserve cells 
and K5 and K6 are sometimes found there These keratins, often found in nonkeratini-
zing squamous epithelia are expressed along with K17 (fig 11), which is more related 
to metaplastic squamous epithelium With differentiation into immature squamous 
metaplasia (fig lo-u) reserve cells loose keratins characteristic of simple epithelium 
(eg K8 fig lo), with the exception of Kl 9 (fig lq) and show an increased expression 
of K5, K6, K14 (fig lr), K15, and K16 (fig lu) which are normally found in squa­
mous epithelia Oddly enough Kl7 expression (fig Is) decreases as immature 
metaplastic epithelium matures, but it usually does not disappear entirely K4 and K13 
(fig 11) have as yet not been demonstrated in reserve cells Expression of these keratins 
emerges during immature squamous metaplasia, eventually becomes compartmen­
talized and ultimately is found in suprabasal cells of nonkeratinizing squamous 
epithelia Keratin 4 is also found in 50% of columnar cells Transformations in the 
keratin phenotype of immature squamous epithelium are accompanied by distinct 
morphological changes, characterized by stratification and compartmentahzation 
A comparison of the keratin expression patterns of reserve cells with endocervical 
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Figure2. Schematic overview of 
the keratins expressed'in (A) 
CIN I and CIN II lesions and 
(H) CIN III. Immunoperoxidase 
stahüng of(B-G) CIN I and CIN 
Hand (I-N) CINIIIañer 
staining with antibodies reactive 
to(B,I)K8, (C,J)K19, (D,K) 
K14, (E,L)K17, (F,M)K13, 
(G,N)K16. 
¡фЩ Abbreviations :see legends 
Ï N . figure 1. 
columnar cells albeit to a lesser degree. As endocervical columnar cells are in an end 
stage of differentiation and probably display very little metaplastic activity, we have 
proposed that these cells are derived from reserve cells most of which loose expression 
of K5, K6, K.14, and K15 during differentiation into columnar cells and for unex­
plained reasons initiate expression of KA When reserve cells proliferate and transform 
into squamous metaplastic epithelium, the keratins found in simple epithelia cease to 
be expressed, and synthesis of keratins characteristic of nonkeratinizing epithelia, such 
as K.4 an K13 is initiated. Based on these observations we consider reserve cells to be a 
common progenitor of both immature squamous metaplasia and endocervical colum­
nar cells. 
In mature squamous metaplastic epithelium keratin expression is identical to that 
found in ectocervical epithelium, with the exception of keratin 17 which is sporadically 
expressed in the basal cell layer of ectocervical epithelium. Furthermore, keratin 
expression is not compartmentalized as strictly as in the ectocervical noncornifying 
epithelium. This probably indicates that mature squamous metaplastic epithelium, 
though on the basis of morphological criteria seems mature is not yet fully matured on 
the basis of its keratin phenotype. 
KERATIN EXPRESSION IN CERVICAL INTRAEPITHELIAL 
NEOPLASIA (CIN) 
More than 90% of dysplastic cervical lesions are thought to arise from the transforma­
tion zone between ecto- and endocervical epithelium, also referred to as the squamo-
columnar junction/2'4 Preferentially at this site reserve cells situated below the colum­
nar cells, can proliferate into mature squamous metaplastic epithelium as described 
above. However if the stimulus inducing proliferation also, to a variable degree blocks 
differentiation of the reserve cells into a mature lesion, they may proliferate into an 
atypical immature squamous metaplastic epithelium also decribed as one of the three 
grades of CIN. In this respect it is important to note that many CIN lesions are not 
really progressive in nature, but represent a nonspecific tissue respons to chronic 
irritation or inflammation. ч Therefore the objective of research in this field should be 
directed towards a search for prognosticators capable of indicating whether an 
individual CIN lesion is progressive or regressive in nature. Since the progressive or 
indolent nature of a lesion cannot be predicted on the basis of light microscopic 
examination only, a search for discriminating markers is a prerequisite in solving this 
diagnostic dilemma. 
Early studies(l8-20) into keratin expression in CIN lesions showed that K8 as detected 
with CAM 5.2, was found in a high percentage of CIN III lesions and to a lesser extent 
in CIN II lesions. All squamous cell carcinomas of the cervix stained with this anti­
body. On this basis it was concluded that those CIN lesions expressing K.8 were pro­
gressive in nature, while those not expressing this simple type keratin were considered 
to be regressive. Later studies(14,l517) elaborated on this work by using more extended 
panels of antibodies and all grades of CIN lesions. 
As reserve cells are the progenitor cells of CIN lesions the fact that K.8 is detectable in 
some of these is not surprizing, but this observation elicits some questions: 1) which 
other "reserve cell keratins" are also found in CIN lesions, and 2) why do a number of 
CIN lesions not express "reserve cell keratins", when keratin expression is thought to 
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Figure 3. 
Schematic o verview of the keratins expressed in (A) keratinizing squamous cell carcinoma of the 
cervix (H) nonkeratinizing squamous cell carcinoma of the cervix and (O) adenocarcinoma after 
incubation with antibodies reactive to (Β,Ι,Ρ)K8, (C,J,Q)K19, (D,J,K)K14, (E,L,S)K17, 
(F,M,T)K13, (G,N,U)K13. Abbreviations: see legends figure 1. 
Studies on fresh CIN lesions gave an answer to the first question M l '^ showing that 
the keratin phenotype of most CIN lesions was comparable to that of ectocervical and 
mature squamous metaplastic epithelium (fig. 2a-n). Approximately 10% of CIN I and 
CIN II lesions expressed the combination of keratins found in reserve cells, with 
discrete expression of the combination of K.8 (fig. 2b) and К18 and also for K.17 (fig. 
2e). In general the level of expression of individual keratins was highly variable. K6 
and К16 (fig. 2g and 2n) related to hyperproliferation displayed an increased level of 
expression with increasing atypia of the lesion. 
Comparison of the keratin phenotypes of CIN III lesions (fig. 2h-n) with CIN I and II 
lesions showed profound differences. The expression of reserve cell keratin phenotype 
was increased up to about 50% of cases and the intensity of expression of simple epi­
thelial keratins had increased considerably. In our series the combination of K8 (fig. 
2i) and K18 expression found in up to 80% of CIN III lesions was considerably higher 
than the percentage found by Bobrow and Angus ('8l50), possibly due to the effect of 
formalin fixation and paraffin embedding. In lesions demonstrating the complete 
reserve cell keratin profile, keratins typical for nonkeratinizing squamous cpithelia 
were expressed to a lesser extent. The hyperproliferation related K6 and K16 (fig. 2n) 
showed a more intense expression than observed in lower grades of dysplasia. 
Based on these observations the following theory regarding the origin and character of 
CIN lesions may be forwarded. CIN lesions expressing the keratin phenotype of reser­
ve cells, in particular K8, К17, and K18 are progressive in nature. CIN lesions, mor­
phologically classified as CIN I, II or III, but contain the keratin combination found 
in nonkeratizing ectocervical epithelium, without expression of the reserve cell keratins 
K.8, K.17, and K18, are regressive in nature or will persist without progression.04"175 
Observations in cervical carcinoma offer support to this hypothesis. 
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KERATIN EXPRESSION IN CERVICAL CANCER 
Studies on changes in keratin expression of CIN III lesions progressing into carcinoma 
allow an alternative classification of carcinomas. Also these studies have provided 
some evidence for the hypothesis that cervical squamous cell carcinomas and adeno­
carcinomas have common progenitor cells. 
The keratin phenotype of keratinizing squamous cell carcinoma of the cervix was very 
complex (fig. 3a), with expression of simple epithelial keratins i.e. K8 (fig. 3b), K18 
and K19 (fig. 3c) in all cases and less frequently K.7. Most of these carcinomas combi­
ned expression of the simple epithelial keratins and K10 (fig. 3g), an ultimate marker 
for keratinization. Also keratins characteristic of nonkeratinizing epithelia i.e. K.4, K.5, 
K6, K.13 (fig. 30, K14 (fig. 3d), K15 and to a certain extent K17 (fig. 3e) were always 
found in these keratinizing carcinomas. 
Nonkeratinizing cervical squamous cell carcinomas (fig. 3h) expressed most of the ke­
ratins found in the keratinizing variety although K10 (fig. 3n), indicating keratini­
zation and K13 (fig. 3m) were expressed to a lesser extent. Again these squamous cell 
carcinomas also usually expressed K8 (fig. 3e), K.17 (fig. 3i), K18 and K19 (fig. 3j). 
All adenocarcinomas contained the simple keratins K7, K.8 (fig. 3e), K.17 (fig. 3g), K.18 
and K.19 (fig. 3q), while surprizingly K14 (fig. 3k) was also frequently present and 
some keratins related to squamous differentiation (K4, K.5, K10 (fig. 3n) and K13 
(fig. 3m) were sometimes found. 
To explain these observations, we hypothesize that reserve cells containing the basic 
keratin expression pattern proliferate through grades of squamous metaplastic 
intraepithelial neoplasia (CIN) during which progression their keratin phenotype 
changes as outlined in the foregoing paragraph. A number of CIN III lesions will 
progress into a carcinoma of the keratinizing variety, which expresses all the keratins 
found in reserve cells, combining markers of simple epithelia as well as markers of 
squamous differentiation. As the carcinoma shows signs of keratinization, synthesis of 
К10 is initiated. If the CIN HI lesion progresses to a nonkeratinizing carcinoma, its 
keratin expression pattern also reflects this type of differentiation. 
Variable expression of K10 indicates that the carcinoma is of the keratinizing variety. 
We noticed the existence of a subgroup of morphologically nonkeratinizing carcino­
mas, which on the basis of their keratin expression pattern, i.e. K10 and high K13 
expression would be better classified as being of the keratinizing variety.'"0 
The keratin expression pattern of adenocarcinomas was considerably more complex 
than expected on the basis of results obtained with adenocarcinomas arising in other 
tissues.'2*0 Expression of K17 was always and K14 frequently observed. Furthermore, 
sporadic expression of K4, K5, К10 and К13 was seen. None of these aforementioned 
keratins are present in the normal columnar cells lining the endocervical canal 
although these are considered to be progenitor cells for this type of carcinoma.' To 
explain this apparent discrepancy we propose that cervical adenocarcinoma does not 
usually arise from columnar cells but from reserve cells. A CIN III lesion may thus 
evolve into an adenocarcinoma with persistence of all the reserve cell keratins except 
K5, K6, and K16 which are only occasionally found. These latter keratins are usually 
not expressed in normal reserve cells. The foregoing would then implicate that diffe-
rent types of cervical carcinoma form a continuum with at one end the keratinizing 
squamous cell variety and at the other end the adenocarcinoma. We therefore state 
that in the classification of a cervical carcinoma not only the results of a H&E and 
mucin staining, but also the keratin phenotype should be considered. 
CAN KERATIN ANTIBODIES ELUCIDATE THE ORIGIN 
OF ENDOCERVICAL RESERVE CELLS AND COLUMNAR 
CELLS? 
Ever since the first microscopic investigation of the endocervical canal, the presence of 
reserve cells was noted. What the precise origin of these cells is remains controversial. 
Some authors have suggested that they represent undifferentiated stem cells which 
develop from the primitive cervical lining/28"34 Meyer(3I) proposed the columnar cells 
to be fully differentiated cells, present in each cervix. Fluhmann (32) advocated the 
origin of reserve cells from the overlying columnar cells, based on the fact that these 
cells were found in endocervical tissue repair. Fairly strong evidence for a stromal 
origin has been put forward by Song(33) and Lawrence °A who studied both embryonal 
and normal cervices and described "stromal" cells passing through the basement mem-
brane, supporting their supposition with electron microscopic studies. Based on immu-
nokeratin phenotyping of the cervix we feel the discussion is again open after so many 
years. The keratin content of reserve cells has been shown to be highly com-
plex. (9·|4·,5·17) Stromal cells have as yet not been shown to contain keratins. Vimentin 
which has been found in all stromal cells has not been observed in reserve cells. In 
general transitions from one type of epithelium to another have been shown to be 
correlated with gradual keratin changes. It therefore seems highly unlikely that stromal 
cells migrating through a basal membrane will initiate the expression of up to 10 diffe-
rent keratins, while in the transitional phase, when they are in the endocervical stroma, 
they contain no cytoskeletal proteins of the keratin type at all. In general when non-
epithelial cells obtain keratins, they normally comprise only a limited subset of 
keratins 8 and 18.<5) 
We have shown that the keratin phenotype of reserve cells is more complex than that 
of endocervical columnar cells. Thus columnar cells would have to initiate synthesis of 
a considerable number of differentiation related keratins when transforming into 
reserve cells. This is an extremely unlikely pathway for the genesis of reserve cell. In 
contrast the argument that multipotent stemcells (reserve cells) are present in the endo-
cervical canal having originated there during embryonal development, is still valid. 
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DIAGNOSTIC IMPLICATIONS OF KERATIN EXPRESSION 
The results of the studies described above noL only enable a more profound insight 
into the pathogenesis of cervical carcinoma, but equally important they have diag­
nostic and therapeutic implications. Some of the results of studies are already appli­
cable, while for others there is strong evidence that further research in this field is 
justified and will provide a new impulse in the approach to the patient suffering from a 
cervical carcinoma or a CIN lesion. 
In histopathological diagnosis it can be difficult to distinguish between a (metastatic) 
cervical adenocarcinoma and a (metastatic) carcinoma arising from the bowel, a des-
cision with therapeutic implications. By determining the keratin phenotypes of these 
carcinomas with monoclonal antibodies this dilemma may be solved. Adenocar­
cinomas of the colon have a simple keratin expression pattern consisting of 
K8,K18,K19,and K20, while as outlined above cervical carcinoma contains K7.K17, 
frequently K14 and usually lacks K20. Absence of K.5 (metastatic) in cervical 
adenocarcinoma can help the distinction from mesothelioma/2*0 In discriminating 
between (metastatic) cervical adenocarcinoma and ovarian serous or mucinous 
carcinoma, absence of К14 and К17 in the ovarian malignancies may be a differential 
diagnostic tool. In lymph node metastases knowledge of the keratin profiles of various 
(adenocarcinomas will often help to distinguish between such malignacies arising 
from various locations. 
Regarding the differential diagnosis between keratinizing and nonkeratinizing carcino­
ma of the cervix, keratin antibodies may have some use. The keratinizing variety of 
carcinoma is suggested to have a poorer prognosis than the nonkeratinizing type.' " 
Taking the expression of K10 as well as K13 and K16 as being sufficient proof of kera-
tinization, would increase the group of keratinizing carcinomas considerably. In this 
way it might be possible to select a subgroup of carcinomas which have a poor 
prognosis, next to a group with another keratin expression pattern which may have a 
better prognosis. 
Another differential diagnostic consideration with therapeutic and prognostic 
implications is the distinction between poorly differentiated adenocarcinomas and 
poorly differentiated squamous cell carcinomas, which may also be decided on basis of 
antibodies to K5 and K6 which are mainly absent in cervical adenocarcinomas. 
The question of whether it is possible to distinguish between a progressive and a 
regressive CIN lesion based on keratin expression is still open. Our present studies 
have given some new insights in this respect. Keratin 17 is present in approximately 
10% of CIN I and CIN II lesions. About 50% of the CIN III lesions contain this 
keratin and all carcinomas of the cervix are positive for this keratin subtype, without 
respect for their type of differentiation. We therefore suggest that К17 is a marker of 
progression and that its presence indicates the potential of a CIN lesion to progress 
into a cervical carcinoma. The fact that its expression is maintained in cervical carcino­
ma is in keeping with the general rule that keratin expression is conserved throughout 
the entire evolution from reserve cell to cervical carcinoma. 
FUTURE STUDIES 
Keratin expression studies in the normal, preneoplastic and neoplastic cervix have 
been quite comprehensive since antibodies to most of the keratin subtypes have been 
tested in these epithelia. However, at present, only one antibody is available to some of 
the keratins. Past studies have demonstrated that certain epitopes are not detected by 
certain keratin antibodies.0,0 For this reason often more than one antibody to the same 
keratin subtype is used in staining assays. In practice this means that the keratin 
phenotype of the cervix may be modified in the future on the basis of newly developed 
keratin antibodies. 
Studies that still need to be performed include the keratin rihenotyping of primary and 
metastatic cervical cancer in an effort to see whether or not certain keratin phenotypes 
correlate with the metastatic capacity of these malignacies. 
Another important area of research comprises the keratin expression patterns during 
embryonal development since this may throw more light on the origin of endocervicaJ 
reserve cells and columnar cells. 
The use of keratin expression as a prognosticator for the progressive or regressive 
nature of a CIN lesion needs a firmer basis before it can be applied in routine diag-
nosis. To this end studies that examine the correlation between keratin expression and 
clinical outcome are urgently needed. For this purpose retrospective studies using 
archival material should be performed. Such studies are, however, greatly hampered 
by the fact that most subtype specific keratin antibodies are not reactive in formaline 
fixed paraffin embedded tissue. We are now addressing this problem by testing 
conditions under which such immunoreagents become reactive in routinely processed 
tissue. 
Finally, the correlation between the expression of simple keratins and the presence of 
human papilloma virus which is also a prognostic factor needs further study. Previous 
results have shown a collapse of the keratin network in human keratinocytes in the 
presence of HPV-16 late proteins.(36) 
In summary it can be stated that keratin expression patterns in the carcinogenesis of 
the cervical epithelia allow certain conclusions on the etiology of these lesions and can 
be applied as diagnostic and prognostic markers. 
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Chapter seven 
Detection of Keratin Subtypes in Routinely 
Processed Cervical Tissue: 
Implications for Tumor Classification and 
the Study of Cervix Cancer Etiology 
Frank Smedts, Frans Ramaekers, Monique Link, Ludmila Lauerová, 
Sergey Troyanovsky, Charles Schijf and G. Peter Vooijs 
(submitted) 
SUMMARY 
In this study we investigated the expression of keratin subtypes 7, 8, 10, 13, 14, 17, 18 
and 19 in the normal cervix, in CIN lesions and in cervix carcinomas, using a selected 
panel of monoclonal keratin antibodies, reactive with routinely processed, formalin 
fixed paraffin embedded tissue fragments. The reaction patterns derived for each 
keratin antibody were compared to known expression patterns of the various epithelia, 
previously examined in frozen tissues. 
Although the reactivity of the antibodies was generally acceptable, considerable modi-
fications to the manufacturer's staining instructions were often necessary. For some 
antibodies, which were previously thought to be reactive with fresh frozen tissue only, 
we developed staining protocols rendering them reactive with routinely processed 
material. 
In accordance with previous findings in frozen tissue sections we observed increasing 
expression of keratins 7, 8, 17, 18 and 19 with increasing severity of the CIN lesions. In 
cervical carcinomas the differences in keratin detectability between the main catego-
ries, were more pronounced than in frozen sections, probably due to fixation and pro-
cessing. Therefore, for routine pathology, keratin phenotyping of cervical lesions can 
be of value in the classification of these malignancies. 
The fact that keratin 7 was detected for the first time in reserve cells, and that this ke-
ratin was also found to be expressed in a considerable number of CIN lesions and cer-
vical carcinomas further supports the suggestion that reserve cells are a common 
progenitor cell for these lesions. 
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INTRODUCTION 
Keratins comprise a family of at least 20 intermediate filament proteins catalogued 
from 1 to 20 exhibiting a tissue specific distribution pattern in epithelial1'4 Their distri-
bution has been shown to be partly conservative during neoplastic transformation/31 
During this process additional keratins may become expressed, or others may be lost, 
depending on the degree of differentiation of the tumor under investigation. In many 
cases the tumor keratin phenotype indicates the tissue type from which the malignant 
tumor originated, thus allowing a more exact classification.01 
In previous studies(4-7) we extensively investigated the keratin expression patterns in 
the normal cervix, in metaplastic epithelia, in cervical intraepithelial neoplasia (CIN) 
and in cervical cancer, using recently developed monoclonal and polyclonal anti-
bodies, reacting separately with most of the known keratin subtypes. The most 
salient features of these assays, all carried out on frozen tissue sections, may be 
summarized as follows: Ectocervical nonkeratinizing squamous epithelium shows a 
keratin pattern characterized by intense expression of keratins 4 and 13. In addition, 
keratins specific for basal cell compartments, i.e. nrs. 5, 14 and 19 are also found. The 
expression pattern in endocervical columnar cells is characteristic of the keratins found 
in most of the so called simple epithelia, i.e. keratins 7,8, 18 and 19. Surprisingly some 
expression of keratins 4, 15 and 16, normally related to squamous differentiation are 
also noted in columnar endocervical cells. Endocervical reserve cells combine expres-
sion of keratins typical of squamous epithelium as well as keratins characteristic of 
simple epithelium. In addition keratin 17 was found to be specific for reserve cells in 
the cervix. The keratins present in squamous metaplastic epithelium, reflect the degree 
of squamous maturation/"4 When this epithelium exhibits high expression levels of 
keratins typical of simple epithelia and less keratins characteristic of nonkeratinizing 
epithelia it is in general morphologically immature. Metaplastic epithelia showing the 
opposite keratin expression pattern are usually more mature. Regarding the keratin 
phenotype of cervical intraepithelial neoplasia (CIN), CIN I and CIN II cannot be dis-
tinguished on the basis of their keratin expression patterns. Most of these lesions show 
patterns reminescent of that found in ectocervical epithelium, while 10% of these lesi-
ons express in addition the keratins typical of the progenitor reserve cells. In CIN III 
the number of cases containing these reserve cell keratins has increased up to 50%. 
Previously we postulated that the group of CIN lesions which express reserve cell kera-
tins may well be premalignant in nature/4,4 This theory is to a certain extent supported 
by the keratin expression patterns observed in cervical cancer.<6) In keratinizing squa-
mous cell carcinoma of the cervix a complex keratin expression pattern is found, inclu-
ding all keratins found in reserve cells, as well as keratins indicating squamous matura-
tion and keratinization. The keratin make up of large cell nonkeratinizing carcinoma 
was somewhat less complex, but again the basic reserve cell keratin expression pattern 
is usually observed. Adenocarcinomas also express a number of typical reserve cell 
keratins. We have interpreted these findings as support for the hypothesis that both 
squamous cell carcinomas and adenocarcinomas of the cervix have a common proge-
nitor cell, i.e. the reserve cell. The results of the studies outlined were all based on 
observations in frozen tissue material. Recently monoclonal keratin antibodies reactive 
with routinely processed tissues have made it possible to investigate whether these 
results are reproducible in routinely fixed paraffin embedded tissue. In the course of 
the study we found that protocols for the application of these antibodies often had to 
be considerably modified to obtain optimal results. Furthermore the observations have 
allowed some modifications to our views on cervical keratin expression. Finally possi­
bilities regarding the applications of these antbodies in general practice are evaluated. 
MATERIALS AND METHODS 
Tissues 
Routinely processed formalin fixed and paraffin embedded (tumor) tissue blocks were 
used. The tissues fragments analysed represented diathermy loop excision specimens 
and cervical cone biopsies from 52 women with cytologically verified dysplasia. The 
Table 1. Overview of the characteristics of the antibodies used in this study and the most 
important steps of the staining protocols. 
Anti­
body 
pKer 
34D12 
OV-TL 
12/30 
Cam 5.2 
DE-K-10 
ΛΕ8 
LL002· 
E3 
DC10 
DA7 
RCK1Û8 
Ig sub-
type 
Polycl. 
IgGl 
IgG2a 
IgGl 
IgG2a 
IgG2b 
IgGl 
IgGl 
IgGl 
Species Keratin(s) Pronasc Antibody 
rabbit 
mouse 
mouse 
mouse 
mouse 
mouse 
mouse 
mouse 
mouse 
mouse 
mouse 
Recognized 
several 
1,5 + 7 
7 
8 
10 
13 
14 
17 
18 
18 
18 
+ 
+ 
-
+ 
+ 
+ 
+ 
+ 
dilution 
1:80 
1:500 
1:2 
1:20 
1:20 
1:2 
undiL 
1:2 
1:10 
1:10 
1:10 
Incubation 
time 
lh/RT 
12h/4"C 
12h/4'C 
lh/RT 
12h/4"C 
lh/RT 
12h/4"C 
lh/RT 
lh/RT 
lh/RT 
lh/RT 
Detection system 
SwaRPo 
RaMPo/SwaRPo 
RaMPo 
RaMPo 
RaMPo/SwaRPo 
RaMPo 
RaMPo/SwaRPo 
RaMPo 
RaMPo/SwaRPo 
RaMPo/SwaRPo 
RaMPo 
Ref. 
9 
10,11 
11,12 
14 
15 
16,17 
18 
19 
20 
20 
-
Source 
Euro-Diagnostic BV, 
ApeldoomjNL 
ENZO, Biochem Inc. NY, 
USA 
BioGcncx labs, München, 
Germany 
Becton & Dickinson, 
Elten Leur, NL 
BioGcncx labs, München, 
Germany 
Sanbio, Uden, NL 
BioGcncx labs, München, 
Germany 
Dr S. Troyanovski, 
Moscow, USSR 
BioGcncx labs, München, 
Germany 
BioGenex labs, München, 
Germany 
BioGenex labs, München, 
Germany 
* Prior to staining the slides were placed in demineralized water and cooked for] О minutes in a 
microwa ve o ven. 
RT=roomtemperature; SwaRPo = horse radish peroxidase conjuga ted swine anti ra bbit IgG; 
RaMPo = horse radish peroxidase conjugated rabbit anti mouse IgG 
136 
tissue samples representing 41 cases of oervical carcinoma were taken from hysterec­
tomy specimens and excision biopsies, and included 3 cases with both material from 
the primary cervical carcinoma and a lymph node metastasis. Many cases comprised 
more than one tissue fragment per block, which were all analysed as one case. A total 
of approximately 250 tissue fragments were analysed, representing both normal endo-
and ectocervical epithelia, metaplastic epithelia, the three grades of CIN and cervical 
carcinoma. Often more than one type of epithelium could be distinguished in the same 
fragment. As a result nonkeratinizing ectocervical epithelium was detected in 50 speci­
mens, endocervical columnar epithelium in 58 specimens, reserve cells in 29 specimens, 
immature squamous metaplasia in 16 specimens and, mature squamous metaplasia in 
19 specimens. CIN I was diagnosed in 16 specimens, CIN II in 25 specimens, CIN III 
in 26 specimens. There were 4 keratinizing squamous cell carcinomas, 19 large cell 
nonkeratinizing squamous cell carcinomas, 11 adenocarcinomas of which 2 were of the 
clear cell variety, 3 neuroendocrine carcinomas and 2 adenosquamous carcinomas 
were diagnosed. In 3 cases we also examined the keratin phenotype of lymph node 
adenocarcinoma metastases, of which one was of the clear cell variety. The subepithe­
lial, stromal tissues were meticulously examined for keratin expression in all cases. The 
diagnoses in each individual case had been verified by at least three pathologists. In 
cases of discrepancy, the case was discarded from the study. 
Antibodies 
Ten monoclonal antibodies and one polyclonal antibody were used in this study. Their 
characteristics and references , 2 0 ) are summarized in table 1. The horseradish peroxi­
dase conjugated swine anti Rabbit IgG and the horse radish peroxidase conjugated 
rabbit anti Mouse IgG were obtained from Dakopatts, Denmark. 
Immunohistochemistry 
Considerable modifications to the staining procedures as indicated in the manu­
facturer's instructions were often necessary to obtain immunoreactivity with certain 
antibodies. The modifications to the routinely used staining procedure giving the best 
results, are indicated in table 1. All tissue fragments had been fixed in 4% buffered 
formalin for at least 24 hours but not longer than 72 hours, before being processed 
through paraffin for routine diagnosis. The blocks were then stored in our archive for 
at least 1 year, prior to retrieval for this project. From these blocks 4 μτη thick sections 
were cut, and deparaffinized with xylene and ethanol. 0.1 % pronase (Sigma, St Louis, 
USA) digestion in PBS (phosphate buffered saline), at 37°C, for 10 minutes was 
necessary to obtain optimal results for certain antibodies (see Table 1). Endogenous 
peroxidase activity was blocked by immersion for 20 min in 3% H202 in PBS, after 
which the slides were rinsed in PBS. After preincubation with 20% normal swine serum 
for 15 minutes the primary antibody was applied in the appropriate dilution for the 
time period indicated (see Table 1). After washing in PBS, the appropriately 
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Table 2. Schematic representation of keratin expression patterns in cervix: (a) normal ectocervi-
cal epithelium, (b) columnar and reserve cells, (c) immature squamous metaplasia, (d) mature 
squamous metaplastic epithelium, (e)CINI, (l) CIN II, (g) CIN III, (h) keratinizing squamous 
cell carcinoma, (i) nonkeratinizing squamous cell carcinoma, (j) adenocarcinoma, (k)adeno-
squamous carcinoma and (1) neuroendocrine carcinoma, as detected by the antibodies used in 
this study, using routinely processed paraffin sections. The keratins are indicated by their res­
pective number according to Moll's catalogue." An empty box indicates that no cases stain, a 
1/4 filled box indicates that between 1-25% of cases stain, a 1/2 filled box indicates that between 
25-50% of cases stain, a 3/4 Filled box indicates staining of 50-75%> of the cases, a completely fil­
led box indicates staining in 75-100% of the cases. Staining intensity is indicated by the shading 
of the box; black indicates intense staining of most or nearly all cells, horizontal lines indicate 
moderate to strong staining o f all or most cells, parallel oblique lines indicate mild, moderate or 
intense staining of some of the cells with also negative cells, dots indicate that scattered cells 
stain. К = kera tin(s); S = super ficai cells; I = in termedia te cells; В = basal cells; 
PB = parabasal cells; С - columnar cells; RC = reserve cells. 
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diluted peroxidase conjugated secondary antibody was applied in PBS. In some cases 
an amplification step was applied, followed by a third series of washing steps. Peroxi­
dase activity was detected with 3-amino-9-ethylcarbazole (AEC; Aldrich Chemical 
Comp., St Louis, MO) by incubation for 10 minutes the slides counterstained with 
Harris hematoxylin and mounted with Kaisers glycerine. 
RESULTS 
The results are summarized in table 2 and depicted in figures 1 -4. 
In general, the antibodies used showed satisfactory to excellent staining results when 
the modifications in the immuno-detection protocols (as summarized in table I) were 
followed. 34012, OV-TL 12/30, DE-K-10, LL002, E3 and DA7 generally displayed 
strong immunoreactivity, while AE8 showed a moderately strong expression. The 
immunoreactivity of E3 was generally even more intense than the patterns previously 
observed in the frozen sections. DC 10 reactivity was constantly less than DA7 al­
though both react with keratin 18. CAM 5.2 and RCK 108 on the contrary stained less 
cells, less intensely in paraffin sections (4'5), than previously observed in frozen tissue 
sections. We will extensively describe the reactivity patterns of the individual anti: 
bodies for the different types of epithelial cells in normal cervix in order to illustrate 
their usefulness for keratin immunophenotyping in routinely processed tissue material. 
Ectocervical nonkeratinizing epithelium (table 2a and figure 1A-G) 
The polyclonal keratin antibody and 34012 were found to stain the ectocervical epithe­
lium in all cases with usually an intense reaction throughout the full thickness of the 
epithelium. The antibodies OV-TL 12/30 (fig. 1A), CAM 5.2 (fig. IB) and E3 (fig. IF) 
detecting keratins 7,8 and 17, respectively, did not react in ectocervical epithelium. In 
13 cases keratin 18 was detected only by the antibody DA7 (fig. IG) which revealed a 
weak staining reaction in most cells of the basal cell compartment and sporadically in 
the parabasal and intermediate cell compartment. DC10 also reactive with keratin 18, 
remained negative in all cases. RCK 108 recognizing keratin 19 was found to stain the 
basal cells of half of the specimens. The keratin 10 antibody DE-K-10 (fig. 1С) 
occurred in dispersed cells above the intermediate and superfical cell compartments in 
14 cases. Keratin 13 detected with the antibody AE8 (fig. ID) decorated most cells. 
Figure 1. Immunoperoxidase staining patterns of formalin fixed paraffin embedded sections 
from (Α-G) normal ectocervical epithelia, (Η-N) columnar and reserve cells and (Ο­
υ) immature squamous metaplasia, after staining with (Α,Η,Ο) OV-TL 12/30 
(keratin 7), (Β,ί,Ρ) CAM5.2 (keratin 8), (CJ,Q)DE-K-10 (keratin 10), (D.K.R) 
AEg (keratin 13), (E,L,S) LL002 (keratin 14), (F,M, T)E3 (keratin 17) and 
(G,N, U)DA7 (keratin 18). 
1ЩШ 
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above the basal layer, usually staining intensely. Keratin 14 (fig. IE), as detected by 
the antibody LL002, was always present in the basal and parabasal cell layer. In the 
more superfical layers the number of cases staining and the staining intensity 
decreased. 
Endocervical columnar cells and reserve cells (table 2b and figure 1H-N) 
In the tissue fragments from 58 patients in which we observed columnar cells, the poly­
clonal antibody revealed an intense staining reaction. 34B12 only stained some cells in 
10 cases with moderate intensity. These cells stained with the simple keratin antibodies 
OV-TL 12/30 (keratin 7 ,fig IH), CAM 5.2 (keratin 8, fig II), DA7 (keratin 18, fig IN) 
and RCK 108 (keratin 19), with moderate to strong intensity. The keratin 18 antibody 
DA7 showed a more distinct expression than DC10. 
Immunostaining for DE-K-10, (keratin 10, fig U), AE8 (keratin 13, fig IK) and E3 
(keratin 17, fig IM) was not found. LL0O2 (keratin 14) was only sporadically found 
in a few cases however this keratin was usually not detected (fig. 1L). Reserve cells 
were intensely stained by the polyclonal keratin antibody and also 34D12 in all 28 
cases. Of the simple keratin antibodies, OV-TL 12/30 (keratin 7, fig IH) showed an 
intense staining in the reserve cells in all cases. Also keratin 8 as detected by CAM 5.2 
(fig. II) was moderately expressed. Again, staining with the keratin 18 antibody DA7 
(fig. IN) was more intense than DC10. Keratin 19 as detected by the antibody RCK 
108 showed a moderate reactivity with most reserve cells. Keratin 17 (fig. IM), related 
to squamous and basal cell differentiation was present in 25 cases, but the staining 
intensity with E3 varied considerably from case to case. DE-K-10 (keratin 10, fig U) 
and AE8 (keratin 13, fig IK) immunoreactivity related to squamous differentiation, 
were not found in reserve cells. LL002 (keratin 14, fig IL) however, was weakly 
detectable in a few cases. 
The results for metaplastic cpithelia, CIN lesions and cervix carcinomas as obtained 
with the various antibodies will be summarized briefly with emphasis on the most 
salient features. For details we refer to the table 2c through 21 and figures 2 to 4. 
Figure 2. Immunoperoxidase staining patterns of formalin fixed paraffin embedded sections 
from (Α-G) CIN I lesions, (Η-N) CIN II lesions and (O-U) CIN III, after staining 
with (Α,Η,Ο) OV-TL 12/30 (keratin 7), (Β,Ι,Ρ) CAM5.2(keratin 8), (QJ.Q)DE-K-
10(keratin 10), (D,K,R)AE8(keratin 13), (E,L,S)LL002(keratin 14), (F,M,T)E3 
(keratin 17) and (G,N, U)DA7 (keratin 18). 
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Immature and mature squamous metaplastic epithelium (table 2c and figure lO-U) 
Keratin expression in these types of epithelia generally reflected the level of matura­
tion. In immature squamous metaplasia (fig. ΙΟ-U) the keratin antibodies OV-TL 
12/30 (fig. IO) and DA7 (fig. 1U), detecting the simple keratins 7 and 18, were mode­
rately positive, while keratin 8 (CAM 5.2, fig IP) was less constantly detected. Keratin 
17 as detected by E3 (fig. IT) was usually present. Keratin 10 and 13 detected with 
DE-K-10 (fig. 1Q) and AE8 respectively (fig. IR) and indicating squamous matura­
tion, were found in approximately half of the cases of immature squamous metaplasia, 
with varying expression levels, while keratin 14 (LL002, fig IS) was consistently 
present. 
In mature squamous metaplasia (table 2D) expression of the simple keratin markers 
had decreased considerably compared to immature squamous metaplasia. There was 
only slight reactivity of OV-TL 12/30 (keratin 7), CAM 5.2 (keratins 8) and DA7 
(keratin 18). In a few cases positive reactivity was also observed for E3 detecting kera­
tin 17. On the other hand the intensity and the number of cases reactive for keratin 10 
(DE-K-10) keratin 13 (AE8) and keratin 14 (LL002) compared to their expression in 
immature squamous metaplasia had increased slightly, while keratin 10 (DE-K-10), 
was less constantly found. 
Cervical intraepithelial neoplasia (CIN) (table 2e-g and figure 2A-U) 
In general keratin expression in the different grades of CIN was often irregular and the 
intercellular variation in staining intensities was high. 
In only a small portion of the CIN I lesions simple keratin antibodies OV-TL 12/30 
(keratin 7, fig 2A), CAM 5.2 (keratin 8, fig 2B) and DA7 (keratin 18, fig 2G) were 
found to react. In the CIN II lesions these keratins were expressed in a higher percen­
tage of samples and in CIN III lesions, expression of these simple keratins had increas­
ed up to more than 50% of cases (fig. 20,P,U). Also the intensity of labeling had usual­
ly increased. The percentage of lesions expressing keratin 17 increased with the severity 
of dysplasia (fig. 2F,M,T). Keratin 19 was always found, usually in the basal cell layer. 
It was also observed in the other epithelial layers with increasing severity of CIN. The 
number of lesions expressing keratin 10 (fig. 2C,J,Q) and keratin 13 (fig. 2D,K,R) 
decreased slightly with increasing severity of CIN, this was also the case for the keratin 
14 antibody, LL002 (fig. 2E.L.S). 
Figure 3. Immunoperoxidase staining patterns of formalin fixed paraffin embedded sections 
from (Α-G) keratinizing squamous cell carcinomas, (Η-N) под-keratinizing 
squamous cell carcinoma (O-If) and adenocarcinoma after staining with (Α,Η,Ο) 
OV-TL 12/30 (keratin 7), (Β,Ι,Ρ) CAM5.2 (keratin 8), (C,J,Q)DE-K-10 (keratin 
10), (D,K,R)AE8(keratin 13), (E,L,S)LL002(keratin 14), (F.M.T)E3(keratin 
17) and (G,H UJDA7 (keratin 18). 
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Carcinomas (Table 2h-l and Figures 3,4) 
In carcinomas keratin expression was related to type and grade of differentiation. 
In keratinizing squamous cell carcinoma (table 2h) the simple keratins were only 
sporadically found in a single case, as detected by OV-TL 12/30 (keratin 7, fig ЗА), 
CAM 5.2 (keratin 8, fig 3B) and DA7 (keratin 18, fig 3G). In the nonkeratinizing car­
cinomas (table 21) these simple keratins were frequently found, although there were 
major differences between cases with regards the number of positive cells (fig. 3H,I,M). 
As could be expected, these simple keratins were strongly expressed in the adenocarci­
nomas (fig. 30,P,U), table 1 J). Keratin 17 as detected by E3 was found in only 2 kera­
tinizing squamous cell carcinomas (fig. 3F), in the majority of nonkeratinizing squa­
mous cell carcinomas (fig. 3M) and only sporadically in adenocarcinomas (fig. 3T). 
Figure 4. Immunoperoxidasc staining patterns of formalin fixed paraffin embedded sections 
from (A -D) adenosquamous carcinomas of the cervix, (Ε-H) neuroendocrine 
carcinomas of the cervix and (I-L) lymph node metastasis of cervical 
adenocarcinomas after staining mth (A,E,IJ) OV-TL 12/30 (keratin 7), (B,F,K,L) 
DA 7(Aeratili IS). (C.G)RCK 108(keratin 19), and(D,H)LL002(keratin 14). 
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RCK 108, detecting keratin 19, showed a similar staining pattern as compared to E3 in 
the squamous cell carcinomas. As expected, however all adenocarcinomas expressed 
keratin 19. DE-K-10 and AE8, detecting keratin 10 and 13, respectively, were always 
detected in the keratinizing squamous cell carcinomas (fig. 3C,D). In the nonkerati-
nizing squamous cell carcinomas approximately half of the cases reacted with these 
keratin antibodies (fig. 3J,K). As expected, adenocarcinomas were not decorated by 
these reagents (fig. 3Q,R). Keratin 14 was found in all 3 types of carcinomas (fig. 
3E,L,S). 
The 2 cases of adenosquamous carcinoma (table 2k, figure 4A-E) expressed all the 
simple keratins i.e. keratins 7 (fig. 4A), 8,18 and 19 (fig. 4C), which were usually found 
in the adenocarcinomatous component. Strikingly in one case keratin 18 (fig. 4B) was 
expressed weakly in the squamous component and not in the adenocarcinomatous 
component. Expression of keratin 10,13 and 17 was not noted. Keratin 14 (fig. 4D) 
was sometimes present. 
In the 3 cases in which the relatively infrequent neuroendocrine carcinoma (table 21, fig 
4E-H) was diagnosed only keratins 8,18 (fig. 4F) and 19 (fig. 4G) and oddly keratin 14 
(fig. 4H), were observed, usually in the majority of cells. Keratin 7 (fig. 4E) was spora­
dically present in one case. Carcinomas with metastases (figure 4I-L) 
In 3 cases of adenocarcinoma we could compare the keratin expression pattern of the 
primary tumor and the autologous lymph node metastasis. The reaction patterns were 
very similar (fig. 4I,L) with the intensity of expression approximately the same in 
primary and metastatic tumor. 
DISCUSSION 
Keratin detectability in formalin fixed, paraffin embedded tissue as compared 
to frozen tissue 
In general most of the antibodies used in this study displayed a staining pattern similar 
to what has been previously described in studies in frozen material(4Λ<ή, we however 
noted a number of quantitative and qualitative differences which require discussion. 
Firstly, staining intensities of some of the antibodies were lower than found in frozen 
tissues, however usually with other antibodies. This is the case for the keratin 18 anti­
bodies DA7 and DC 10, the keratin 7 antibody OV-TL 12/30, and the keratin 10 and 
keratin 13 antibodies DE-K-10 and AE8. Comparison of these antibodies with anti­
bodies reactive with frozen tissue usually shows a lower level of staining and less posi­
tive cases in paraffin sections. For DA7 and DC 10 when compared to RCK 106 this 
was definitely the case. AE8 recognizing keratin 13 when compared to 1C7 in frozen 
tissue, also stained less intensely when applied to routinely processed tissue. DE-K-10 
displayed a pattern in the formalin fixed paraffin embedded tissues comparable to that 
observed with RKSE 60 (keratin 10) in fresh frozen tissues. The keratin 8 and keratin 
19*antibodies CAM 5.2 and RCK 108 respectively, have been extensively tested in 
frozen tissue sections and show a significantly lower level of staining and less cases 
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positive in the paraffin embedded material. The results with E3 and OV-TL 12/30 will 
be described below. LL002 staining in formalin fixed paraffin embedded tissue was as 
strong as in fresh frozen tissue. 
From our study it became obvious that often considerable modifications to the stan-
dard procedure were necessary in order to obtain optimal results in routinely proces-
sed tissue material. For this study tissue blocks had been formalin fixed for at least 24 
hours. Tissue fixation of shorter duration has been shown to provide better staining 
results/20 Therefore it seems advisable to include this parameter in the manufacturer's 
instructions. As a matter of fact we often noted that the concentrations of the reagent, 
as well as the immunocytochemical detection procedure often required considerable 
modification when applied in a routine setting. 
New aspects to keratin expression in the cervix 
Keratin expression in frozen material from the normal cervix, premalignant lesions 
and cervical carcinomas has been extensively described/4"7' A comparison between 
these previous studies and this study, using archival formalin fixed paraffin embedded 
tissue however, shows a number of new characteristics of keratin expression in the 
cervix. 
The most striking observation is the expression of keratin 7 in reserve cells. In the cer-
vix this keratin subtype has only been demonstrated in columnar cells and in a few 
CIN III lesions.0" We found this keratin polypeptide to be a constituent of the cyto-
skeleton of most reserve cells, and that it remained present during immature squamous 
metaplasia. It was also sporadically found in mature squamous metaplastic epithelium, 
but not present in ectocervical epithelium. With increasing severity of CIN lesions an 
increase in keratin 7 expression was noted. Keratin 7 was present in most carcinomas 
except for the keratinizing variety, expressing keratin 7 only, in a few dispersed cells. 
In squamous cell carcinomas keratin 7 expression is apparently related to the direction 
or degree of differentiation. This was also observed in studies in frozen tissues/4 The 
fact that keratin 7 has been observed in epithelia in which it was previously considered 
absent, may be explained on the basis of the high affinity of OV-TL 12/30 for its kera-
tin epitope and the high titer of the antibody. 
Expression of keratin 17 was more intense in CIN lesions after formalin fixation and 
paraffin embedding than observed previously in frozen sections. Keratin 17 was 
however not found in all carcinomas, in contrast to what was found observed in frozen 
tissue sections. One suggestion to explain this discrepancy could be an effect of 
pronase treatment on the exposure of the E3 epitope. 
Using the DA7 antibody we sometimes observed minor expression of keratin 18 in 
ectocervical epithelium. 
Surprisingly keratin 14 and 19 were found in cervical neuroendocrine carcinomas. 
Keratin 19 has previously been observed in some small cell lung carcinomas( , while 
keratin 14 has not yet been detected in such neoplasms. 
Keratin expression in clear cell carcinomas of the cervix comprises the simple keratins 
7, 8, 14, 18 and 19. On the basis of this pattern a clear cell carcinoma may be distin-
guished from endocervical adenocarcinoma which sometimes contains keratin 17. 
Interpretation of keratin expression patterns in the cervix 
Although this study was performed with a smaller panel of keratin antibodies as com-
pared to previous investigations, it still allows an interpretation along the same lines as 
previously described. Central to any interpretation is the role of the reserve cells. When 
these cells proliferate into a CIN lesion, the reserve cell keratin phenotype is main-
tained in a number of cases. We postulated earlier(4^ that this subclass of CIN lesions 
is progressive in nature, while those that acquire a keratin expression phenotype of 
ectocervical epithelium, loosing simple keratin expression, are regressive in nature. In 
frozen tissue studies we observed expression of keratins 8,17 and 18 in practically all 
cervical carcinomas, which complies with the general rule that keratin expression is in 
part maintained upon malignant transformation. This was not found in all formalin 
fixed, paraffin embedded carcinoma samples and justifies further investigation into 
antigen retrieval protocols, and the sensitivity enhancement of detection systems. 
Keratin expression patterns of the carcinomas are not always consistent with their 
classification on morphological grounds. For example keratin 10 an absolute marker 
for keratinization, is expressed in a number of carcinomas which on the basis of mor-
phological criteria have been classified as being of the nonkeratinizing variety. Fur-
thermore, a number of morphologically classified squamous cell carcinomas showed a 
keratin phenotype reminiscent of adencarcinomas. We feel that future research should 
look into these keratin phenotypes in relation to prognosis. It is quite possible that 
some cervical carcinomas classified as nonkertinizing carcinomas would on the basis of 
keratin expression patterns be better classified as adenocarcinomas. 
Thus staining of a cervical carcinoma with a number of keratin antibodies in addition 
to mucin staining, may become useful in the differential diagnosis of cervical nonkera-
tinizing carcinoma and poorly differentiated adenocarcinoma. 
Practical applications of keratin phenotyping in surgical pathology 
The most interesting observations of this study were the significant differences between 
known keratin expression patterns previously observed in frozen tissues and those 
observed in formalin fixed paraffin embedded tissues. The observation that modifica-
tions to staining procedures often enhanced our results considerably, or gave positive 
results where they had previously been negative, indicate that caution is necessary 
when interpreting immunohistochemical results, and one should take into account the 
immunohistochemical procedures used. 
In differential diagnostic considerations keratin phenotypes have been shown to be of 
some value in the differentiation of different types of carcinomas. For example, immu-
nostaining for keratin 10 may distinguish a keratinizing carcinoma, from a nonkerati-
nizing carcinoma even in the absence of morphologically evident keratinization. As the 
keratinizing carcinoma is considered to have a poorer prognosis by some(23), investi-
gations into the relationship between keratin expression and the prognosis of squa-
mous cell carcinoma seem necessary. Keratin 7 has been shown to distinguish between 
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which is negative. When the antibody OV-TL 12/30 is used, mesothelioma can be dis-
tinguished from certain carcinomas, which may be especially important in cytologic 
preparations/24* The observation that the keratin staining patterns of the different 
types of carcinomas in paraffin sections were less complex and differences more pro-
nounced than observed in frozen tissue sections, can be advantageous to the classifica-
tion of cervical carcinomas on the basis of these keratin staining patterns. For in-
stance, keratin 8 is not detectable in paraffin embedded, keratinizing carcinomas, while 
it is usually detected in the nonkeratinizing variety. 
These differential staining characteristics therefore make the set of monoclonal keratin 
antibodies described here applicable in routine diagnostic pathology. 
FUTURE STUDIES 
New approach to the taxonomy of cervical cancer 
Based on their individual keratin expression patterns it is possible to classify the 
various types of cervical cancer more accurately as outlined above. This new classifi-
cation scheme in which the keratin phenotype is important in determining the exact 
classification of the carcinoma, could then be correlated to clinical parameters of indi-
vidual patients. In this way it may be possible to relate differentiation as indicated by 
keratin expression to the biologic behavior of the tumor, such as its metastatic poten-
tial. Recent studies into the presence of vimentin in cervical adenocarcinoma have 
shown that expression of this intermediate filament protein in the tumor cells is related 
to a poorer prognosis.'20 
Another question with important practical implications is whether-or not it is possible 
to distinguish a group of patients with progressive CIN lesions. As'we have pointed 
out, a subgroup of CIN lesions expresses keratins 8, 18 and 17. 
We are investigating whether or not this is a group of patients with a progressive 
lesion, for instance by comparing keratin patterns to HPV expression or the presence 
of certain oncogenes. 
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General Discussion 
Intermediate filament proteins are the most important part of the intracy toplasmic 
matrix in most vertebrate cells. In epithelial cells the type I and II keratins are the main 
constituents of the intermediate filaments and comprize a total of 20 different sub­
types, each characterized by its molecular weight and isoelectric pH. They are number-
sd from 1 to 20 according to Moll's catalogue. Keratin expression in epithelial tissues 
is not random but adheres to a number of rules, the most important of which are: 
1. various types of epithelial tissues have a specific keratin composition; 
2. keratin expression in various epithelial tissues is related to the degree of diffe­
rentiation within the epithelium; 
3. keratin expression is usually retained during malignant transformation of an epithe­
lial tissue, although changes may occur; 
\. at least one acid and one basic keratin subtype have to combine to form filaments. 
Using a large number of monoclonal antibodies, capable of separately recognizing 
specific keratins, it was found that the keratin expression pattern in cervical reserve 
cells is highly complex in nature comprizing, on the one hand keratins characteristic of 
simple epithelial tissues, and on the other hand keratins characteristic of basal cell 
compartments. During the process of squamous metaplasia, the expression of the 
simple keratins decreased considerably, while expression of the basal cell keratins was 
conserved. In addition expression of keratins characteristic of nonkeratinizing squa­
mous epithelium became apparent, and sometimes even keratins characteristic of kera­
tinizing epithelium could be found. The distribution of keratin expression in meta­
plastic epithelia was often erratic, not localized to a specific epithelial compartment, 
furthermore the intensity of keratin expression with the various antibodies was irre­
gular (see figure 1). 
In mature squamous metaplastic epithelium, keratin expression was ordered, with spe­
cific patterns, being more or less confined to specific epithelial compartments. The 
keratins expressed in mature metaplastic epithelium were much the same as found in 
the ectocervical nonkeratinizing epithelium, comprizing a number of the keratins cha­
racteristic of basal cell compartments and furthermore the keratins considered to be 
characteristic of the suprabasal nonkeratinizing epithelial cell compartment. The kera­
tin expression pattern observed in cervical intraepithelial neoplasia (CIN), of which the 
reserve cell is considered to be the progenitor cell, displayed a surprizing pattern of 
keratin expression. In most of the CIN I and CIN Π lesions, constituting mild and 
moderate dysplasia, keratins characteristic of simple epithelia were usually not present, 
but in the CIN III lesions, constituting severe dysplasia, about 50% of the tissue 
fragments examined expressed the simple keratins and also frequently other keratins 
typical of reserve cells. These observations triggered us to propose the hypothesis, that 
those lesions still expressing the set of reserve cell keratins or a part thereof, may be the 
ly developing into a cervical carcinoma Expression of simple keratins has also been 
observed in premahgnant skin lesions pnor to malignant transformation 
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Gguic I. Schematic representation of changes in keratin expression occurring during trans­
formation of reserve cells to mature squamous metaplastic epithelium via immature squamous 
metaplasia and during the development of cervical carcinoma from CIN lesions Reserve cells 
containing a large number of keratins may develop into an immature squamous metaplastic epi­
thelium, which progresses further into mature squamous metaplastic epithelium, during which 
process expression of keratins characteristic of simple epitbelia is lost and expression of keratins 
characteristic of поп-keratinizing epithelium and keratinizing epithelium is initiated, or increa­
ses In case reserve cells proliferate into a CIN lesion, these lesions may be subdivided into CIN 
lesions containing simple keratins 8 and 18 and also keratin 17, (suggested to follow a progres­
sive course) or CIN lesions not expressing these keratins (regressive m nature) When during 
progression of a CIN lesion to a carcinoma, expression of the differentiation related keratins 1, 
4, 10 and 13 is initiated a keratinizing squamous cell carcinoma develops, while it'onlykeratins4 
and 13 are expressed the carcinoma should be classified as being ofthenonkeratimzing variety 
If none of the differentiation related keratins are expressed the carcinoma should be classified as 
an adenocarcinoma Exceptions to this general concept are discussed m the foregoing chapters 
Those CIN lesions expressing keratins characteristic of ectocervical squamous epithe­
lium are considered to be regressive in nature and to transform into a mature 
squamous metaplastic epithelium 
The keratin phenotype observed in cervical carcinomas further supported the hypothe­
sis proposed above, in that keratinizing carcinoma expressed the full set of reserve cell 
keratins as did practically all nonkeratinzing carcinomas Oddly enough, also most of 
the adenocarcinomas expressed the majority of the keratins found in reserve cells This 
last observation allowed a modification to the aforementioned hypothesis, namely that 
the progenitor cell of an adenocarcinoma is in most cases not the endocervical colum-
nar cell, but the endocervical reserve cell. This would then mean that the reserve cell is 
a multipotent cell which can give origin to a squamous as well as a columnar cell 
anomality. This would also explain the frequent observation of both a squamous and 
an adenomatous dysplasia in the vicinity of an invasive cervical lesion and would also 
be an explanation for the occurrence of an adenosquamous carcinoma or simultaneous 
presentation of both a squamous cell carcinoma and an adenocarcinoma. 
The observed keratin phenotypes in the different types of carcinoma did not always 
correspond to their morphologic classification. Keratins which are considered markers 
of keratinization were often expressed in tumors which on morphological grounds 
alone would not be considered as having attained this degree of differentiation. We 
propose that the classification of the various types of carcinomas according to their 
keratin phenotypes may be more exact than the present morphologic classification. 
Keratin phenotyping may also show a correlation to the clinical behaviour of these 
carcinomas. In surgical pathology, comparison of the keratin phenotypes of the diffe-
rent types of cervical carcinomas by means of immunohistochemistry with the known 
keratin phenotypes of other carcinomas arizing from other tissues, allows the dis-
tinction of cervical adenocarcinoma and for example colonic adenocarcinoma on the 
basis of keratin 7 and keratin 20. 
Implementation of these staining techniques in routine pathology would help to test 
the outlined hypothesis in an everyday setting. To investigate the feasibility of such an 
approach we examined the keratin expression patterns of normal cervical epithelium, 
CIN lesions and cervical carcinomas in routinely processed formalin fixed, paraffin 
embedded tissue specimens. Using monoclonal antibodies suggested to be reactive 
with such pretreated tissue samples. The keratin staining patterns corresponded to a 
large extent with those previously observed in the frozen tissues. There were however 
also differences, which may on the one hand lead to misinterpretations regarding the 
pathogenesis of cervical carcinoma, but could on the other hand be useful in 
distinguishing between the main carcinoma types, and corresponding more closely to 
the most commonly used classification schemes. Often considerable modifications 
were necessary to the staining procedures recommended by the distributors of the 
antibodies, before immunoreactivity was ascertained in routinely processed material. 
Furthermore, using these modifications, antibodies previously thought to be nonre-
active in formalin fixed, paraffin embedded tissue were found to be strongly reactive. 
In this respect we recommend further research into the problem of immunoreactivity 
of antibodies in routinely processed tissue specimens. 
Algemene discussie 
Intermediaire filamenteiwitten vormen een belangrijk onderdeel van de intracytoplas-
matische matrix van de cel. In epitheliale cellen vormen de type I en type II kératines 
dit deel van het cytoskelet. Er zijn 20 verschillende, zogenaamde zachte kératines gede-
tecteerd. Die worden gekarakteriseerd op basis van hun molecuulgewicht en isoelectri-
sche pH. Ze zijn genummerd van 1 tot en met 20, volgens de katalogus van Moll en 
medewerkers. 
Keratine-expressie in epitheliale weefsels is niet willekeurig, maar volgt bepaalde 
regels. De meest belangrijke van deze regels zijn: 
1. Verschillende epitheeltypen bezitten een specifieke keratinesamenstellingen; 
2. de keratine-expressie in een epitheliaal weefsel is gerelateerd aan de 
differentiatiegraad binnen het epitheel; 
3. keratine-expressie is deels conservatief, hetgeen betekent dat over het algemeen 
tijdens maligne ontaarding het keratine-expressiepatroon van het epitheel type 
waarvan een maligne tumor uit is gegaan, behouden blijft; 
4. keratine-expressie kombineert altijd een of meerdere zure en een of meerdere basi-
sche subtypen. 
Gebruikmakend van een groot panel monoclonale antilichamen die in staat zijn de ké-
ratine subtypen apart te detecteren, werd in deze studie aangetoond dat het keratine-
expressie-patroon van reservecellen in de endocervix zeer complex is. Enerzijds worden 
kératines aangetroffen welke karakteristiek zijn voor simpele epitheliale weefsels. 
Daarnaast worden kératines aangetroffen die karakteristiek zijn voor basaalcelcom-
partimenten, zoals gevonden in niet-verhoomend plaveiselepitheel. Bij squameuze me-
taplasie neemt de expressie van simpele kératines (d.w.z. kératines van klierepitheel, 
b.v. kératines 8 en 18) sterk af, terwijl de expressie van de basaalcel-keratines behou-
den blijft. Aanvullende kératines, die karakteristiek zijn voor niet-verhoomend plavei-
selepitheel komen tot expressie. De verdeling van de verschillende kératines in dit type 
epitheel is meestal onregelmatig en niet beperkt tot een of meerdere lagen van dit epi-
theel, zoals in het ectocervicale plaveiselepitheel. 
In het rijpe squameus metaplastisch epitheel worden dezelfde kératines tot expressie 
gebracht als worden aangetroffen in het ectocervicale epitheel. Zowel kératines 
karakteristiek voor het niet-verhoomend plaveiselepitheel (b.v. kératines 4 en 13) als 
kératines karakteristiek voor het basaalcelcompartiment (b.v. kératines 5 en 14), 
worden tot expressie gebracht. De verdeling van expressie is ongeveer dezelfde als in 
ectocervicaal epitheel, d.w.z. dat de basaalcel-keratines gevonden worden in de basale 
cellaag en de differentiatie geassocieerde kératines 4 en 13 vanaf de parabasale laag in 
het epitheel voorkomen. 
De keratine-expressiepatronen waargenomen in de dysplasieën (CIN lesies), die uit een 
proliferatie van reservecellen ontstaan, zijn verrassend. Slechts een klein percentage 
van de CIN I (geringe dysplasie) en CIN II (matige dysplasie) lesies toonde het 
keratine-expressiepatroon van de reservecel. Bij de ernstige dysplasieën was dit percen-
taee toeeenomen tot 50%. waarbii onvalt dat tevens de kératines 8 en 18 (simoele kera-
tines) vrij aanzienlijk tot expressie komen. Keratine expressie in dit type epitheel is niet 
beperkt tot een bepaalde epitheellaag maar onregelmatig door de volledige breedte van 
het epitheel, met soms ook gebieden zonder expressie. Ook de kleuringsintensiteit met 
de gebruikte antilichamen varieert sterk. 
Gebaseerd op deze bevindingen wordt de volgende hypothese voorgesteld (zie blz 152): 
De dysplasieën die het keratine-fenotype van de reservecellen, of een deel daarvan 
bezitten, zijn mogelijk lesies die progressie naar een cervixcarcinoom zullen tonen. 
Lesies die het keratine-fenotype vertonen van ectocervicaal epitheel zouden een 
regressief gedrag tonen en mogelijk tot rijp squameus metaplastisch epitheel uit-
groeien. 
Het keratine-expressiepatroon gekonstateerd in het cervixcarcinoom ondersteunt deze 
hypothese verder. Alle verhoomende plaveiselcelcarcinomen en de meeste niet-ver-
hoomend plaveiselcelcarcinomen van de cervix brengen onder andere reserve-celkera-
tines tot expressie. Opvallend is verder dat ook kératines gevonden in de adenocarci-
nomen een vergelijkbaar expressie tonen als in reservecellen. 
Deze laatste bevinding resulteert in een modificatie van de eerder vermelde hypothese. 
Op basis van de expressie van een groot aantal reservecelkeratines in adenocarcinomen 
wordt voorgesteld dat de reservecel niet alleen de stamcel is voor het plavciselcelcarci-
noom, maar ook voor het adenocarcinoom. Dit zou kunnen betekenen dat een CIN 
III lesie een gemengde samenstelling heeft met de elementen die zowel in squameuze 
als in adenomatcuze richting kunnen transformeren. 
Verder constateren we dat de keratine-expressie van de verschillende cervixcarcinomen 
niet altijd correspondeert met de classificatie toegekend aan het carcinoom op 
morfologische gronden. Kératines die een hoge differentiegraad aanduiden (b.v. 
kératine 10) worden soms tot expressie gebracht in carcinomen die op basis van hun 
morfologische karakteristieken niet als zodanig worden gediagnostiseerd. 
Naar aanleiding van deze bevinding wordt voorgesteld om carcinomen exacter te 
klassificeren op basis van hun keratine-expressiepatroon. Deze klassificatie is wellicht 
exacter dan een morfologische indeling, en verder toont deze indeling mogelijk een 
betere correlatie met de klinische gegevens. 
Vergelijking van de keratine-fenotypen van de verschillende cervixcarcinomen met 
andere epitheliale maligniteiten die in de buikholte ontstaan, laat vaak grote 
verschillen zien. Hierdoor kunnen kératine antilichamen gebruikt worden om sommige 
maligniteiten naar hun primaire origine te onderscheiden. Bijvoorbeeld antilichamen 
tegen kératine 20 en kératine 7 kunnen gebruikt worden om adenocarcinomen van de 
cervix te onderscheiden van adenocarcinomen van het colon. 
Om te zien in hoeverre de hierboven samengevatte gegevens toepasbaar gemaakt kun-
nen worden in de routine diagnostiek zijn de keratine-expressie patronen van normaal 
cervicaal epitheel, CIN lesies en het cervix carcinoom in formaline gefixeerd en via pa-
raffine opgewerkt materiaal geïnventariseerd. Hierbij werd gebruik gemaakt van kéra-
tine antilichamen waarvan beschreven was dat ze reactief zouden zijn met formaline 
gefixeerd materiaal. De keratine-expressie patronen waargenomen in het routine mate-
riaal kwamen in grote lijnen overeen met die eerder geconstateerd waren in 
vriescoupes. Toch werden ook verschillen gekonstateerd die tot moeilijkheden kunnen 
leiden bij de interpretatie van resultaten en de vergelijking met eerder gekonstateerde 
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De methode kan wel gebruikt worden om onderscheid te maken tussen de belangrijk-
ste typen carcinomen. Aanzienlijke modificaties op de door de fabrikant voorgestelde 
kleuringsvoorschriften waren echter vaak nodig, voordat immunoreactiviteit gekonsta-
teerd kon worden. De reactiviteit in paraffine-coupes van enkele monoclonale 
antilichamen, waarvan beschreven was dat ze alleen reactief waren op vriescoupes kon 
door deze modificaties geoptimaliseerd worden. Wat dit laatste betreft is verder 
onderzoek nodig naar het bruikbaar maken van antilichamen voor de routine diagnos-
tiek, temeer omdat de resultaten van immunohistochemische kleuringen zo'n verstrek-
kende gevolgen kunnen hebben bij de klassificatie van een kwaadaardige woekering 
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